<?xml version="1.0"?>
<data>
	<tumours>
		<tumour name="adrenal gland adrenal cortical adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="adrenal gland adrenal cortical carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="adrenal gland adrenal cortical hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="adrenal gland adrenal cortical neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="adrenal gland pheochromocytoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="autonomic ganglia neuroblastoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="autonomic ganglia paraganglioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract dysplasia-carcinoma in situ">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract hamartoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="biliary tract primary sclerosing cholangitis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone ameloblastoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone chondroma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone chondrosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone chordoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="bone ewings sarcoma-peripheral primitive neuroectodermal tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone malignant fibrous histiocytoma-pleomorphic sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone odontogenic keratocyst">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="bone osteosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast carcinoma in situ">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast papilloma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="breast phyllodes tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="central nervous system atypical teratoid-rhabdoid tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="central nervous system central neurocytoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="central nervous system dysembryoplastic neuroepithelial tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="central nervous system ganglioglioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="central nervous system glioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="central nervous system neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="central nervous system primitive neuroectodermal tumour-medulloblastoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="cervix adenoma malignum">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="cervix carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="cervix in situ neoplasm">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="endometrium carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="endometrium endometrial polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="endometrium endometriosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="endometrium hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="endometrium solitary cyst">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="eye benign melanocytic nevus">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="eye carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="eye malignant melanoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="eye pterygium">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="eye retinoblastoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="gastrointestinal stromal tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="gastrointestinal tract (site indeterminate) carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="gastrointestinal tract (site indeterminate) hamartoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="gastrointestinal tract (site indeterminate) juvenile polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="genital tract germ cell tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="haematopoietic and lymphoid tissue haematopoietic neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="haematopoietic and lymphoid tissue idiopathic erythrocytosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="haematopoietic and lymphoid tissue lymphoid neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="haematopoietic and lymphoid tissue normal">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="haematopoietic and lymphoid tissue secondary erythrocytosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="haematopoietic and lymphoid tissue splanchnic vein thrombosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="kidney carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="kidney oncocytoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="kidney wilms tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine aberrant crypt foci">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine crohn disease">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine malignant melanoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine ns">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine serrated polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="large intestine ulcerative colitis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="liver adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="liver carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="liver hepatoblastoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="lung carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="lung carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="lung hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="lung neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="meninges meningioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ns carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ns carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ns malignant melanoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="NS malignant melanoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ns ns">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus barrett oesophagus">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus dysplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus intraepithelial neoplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="oesophagus oesophagitis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary germ cell tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary low malignant potential (borderline) tumour">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary neoplasm">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="ovary sex cord-stromal tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas acinar-ductal metaplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas alcoholic pancreatitis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas borderline tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas chronic pancreatitis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas dysplasia-in situ neoplasm">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas normal">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pancreas pancreatic intraepithelial neoplasia (panin)">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="parathyroid adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="parathyroid adenoma-hyperplasia ns">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="parathyroid carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="parathyroid hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="penis carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="peritoneum carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="peritoneum mesothelioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pituitary adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pituitary carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="pituitary craniopharyngioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="placenta hydatiform mole">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="pleura mesothelioma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="prostate adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="prostate carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="prostate hyperplasia">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="salivary gland adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="salivary gland carcinoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin adnexal tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin atypical spitzoid tumour">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin benign melanocytic nevus">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin epidermal nevus">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin in situ epithelial neoplasm">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin keratoacanthoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin keratosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin lentigo">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin malignant melanoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin normal">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin seborrhoeic keratosis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="skin wart">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="small intestine adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="small intestine carcinoid-endocrine tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="small intestine carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="small intestine inflammatory fibroid polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue angiosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue desmoid tumour-fibromatosis">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue epithelioid sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue fibrosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue gastrointestinal stromal tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="soft tissue gist tumourlet(hyalinizing stromal tumour;minute gastric sclerosing stromal tumour;gross icc hyperplasia)">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue haemangioblastoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue kaposi sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue leiomyoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue leiomyosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue liposarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="soft tissue malignant fibrous histiocytoma-pleomorphic sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue malignant peripheral nerve sheath tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue myxoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue neurofibroma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue rhabdoid tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue rhabdomyosarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue schwannoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="soft tissue synovial sarcoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach adenoma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach dysplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach gastritis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach inflammatory fibroid polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="stomach metaplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="testis germ cell tumour">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="thymus thymic carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="thymus thymoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="thyroid adenoma-nodule-goitre">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="thyroid carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="thyroid chronic thyroiditis">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="thyroid neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="upper aerodigestive tract carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="upper aerodigestive tract dysplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour
			name="upper aerodigestive tract leukoplakia-hyperplakia-erythroplakia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="upper aerodigestive tract nasal polyp">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="urinary tract carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="urinary tract hyperplasia">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="urinary tract neoplasm">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="urinary tract papilloma">
			<characteristics>
				<malignant>false</malignant>
			</characteristics>
		</tumour>
		<tumour name="vagina carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
		<tumour name="vulva carcinoma">
			<characteristics>
				<malignant>true</malignant>
			</characteristics>
		</tumour>
	</tumours>
	<genes>
		<gene name="ABL1">
			<chromosome>14</chromosome>
			<start>133589268</start>
			<stop>133763062</stop>
			<geneSize>173795</geneSize>
			<characteristics>
				<fullName>c-abl oncogene 1, non-receptor tyrosine kinase</fullName>
				<somaticTumorTypes>CML, ALL, T-ALL</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>The Abl family of non-receptor tyrosine kinases
					includes c-Abl (Abelson tyrosine kinase) and Arg (Abl2) subtypes.
					c-Abl is localized at several subcellular sites including the
					nucleus, cytoplasm, mitochondria and endoplasmic reticulum, where
					it interacts with a large variety of cellular proteins including
					signaling adaptors, kinases, phosphatases, cell cycle regulators,
					transcription factors and cytoskeletal proteins. Due to its diverse
					range of targets, c-Abl has been implicated in many cellular
					processes including regulation of cell growth and survival,
					oxidative stress and DNA-damage responses, and actin dynamics and
					cell migration. The Abl family have significant structural homology
					to the Src tyrosine kinase family, but have a unique long
					carboxy-terminal extension that contains protein-protein
					interaction sites and acts as the binding site for targets such as
					ATM, p53 and pRb. c-Abl is medically important as there is a causal
					link between the Abl-Bcr fusion protein (caused by a t(9,22)
					translocation) and development of chronic myeloid leukemia.
				</description>
			</characteristics>
		</gene>
		<gene name="AKT1">
			<chromosome>14</chromosome>
			<start>105235686</start>
			<stop>105262080</stop>
			<geneSize>26395</geneSize>
			<characteristics>
				<fullName>v-akt murine thymoma viral oncogene homolog 1</fullName>
				<somaticTumorTypes>breast, colorectal, ovarian, NSCLC
				</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Akt (Protein kinase B, PKB) is a serine/threonine
					kinase that plays a key in regulating cell survival, insulin
					signaling, angiogenesis and tumor formation. Akt is a downstream
					mediator of the PI 3-K pathway, resulting in the recruitment of Akt
					to the plasma membrane via the PH (plexstrin homology domain) of
					Akt. Akt is fully activated by phosphorylation at two key sites:
					Ser308 (phosphorylated by PDK1) and Thr478 (phosphorylated by mTOR
					and DNA-PK). Akt can then phosphorylated a wide range of substrates
					including transcription factors (e.g. FOXO1), kinases (GSK-3,
					Raf-1, ASK, Chk1) and other proteins with important signaling roles
					(e.g. Bad, MDM2). There are three isoforms of Akt; Akt 1, 2 and 3
					(also known as PKBalpha, beta and gamma).</description>
			</characteristics>
		</gene>
		<gene name="AKT2">
			<chromosome>19</chromosome>
			<start>40736224</start>
			<stop>40791302</stop>
			<geneSize>55079</geneSize>
			<characteristics>
				<fullName>v-akt murine thymoma viral oncogene homolog 2</fullName>
				<somaticTumorTypes>ovarian, pancreatic</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Akt (Protein kinase B, PKB) is a serine/threonine
					kinase that plays a key in regulating cell survival, insulin
					signaling, angiogenesis and tumor formation. Akt is a downstream
					mediator of the PI 3-K pathway, resulting in the recruitment of Akt
					to the plasma membrane via the PH (plexstrin homology domain) of
					Akt. Akt is fully activated by phosphorylation at two key sites:
					Ser308 (phosphorylated by PDK1) and Thr478 (phosphorylated by mTOR
					and DNA-PK). Akt can then phosphorylated a wide range of substrates
					including transcription factors (e.g. FOXO1), kinases (GSK-3,
					Raf-1, ASK, Chk1) and other proteins with important signaling roles
					(e.g. Bad, MDM2). There are three isoforms of Akt; Akt 1, 2 and 3
					(also known as PKBalpha, beta and gamma).</description>
			</characteristics>
		</gene>
		<gene name="BRAF">
			<chromosome>7</chromosome>
			<start>140424943</start>
			<stop>140624564</stop>
			<geneSize>199622</geneSize>
			<characteristics>
				<fullName>v-raf murine sarcoma viral oncogene homolog B1</fullName>
				<somaticTumorTypes>melanoma, colorectal, papillary thyroid,
					borderline ov, Non small-cell lung cancer (NSCLC),
					cholangiocarcinoma, pilocytic astrocytoma</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Raf kinases, a family of three serine/threonine
					kinases, are part of the ras-MAPK signaling cascade and
					phosphorylate MEK. Upon growth factor stimulation, Raf-1 (or c-Raf)
					is activated by GTP-bound Ras and recruited to the cell membrane.
					This activation process is tightly regulated by a number of factors
					including phosphatases (e.g. PP1, PP2A, PP5), kinases (e.g. Src,
					ERK, Akt, PKC) and proteins that bind directly to Raf-1 (e.g. RKIP,
					14-3-3zeta, KSR, Hsp90). Raf-1 is also thought to be able to
					dimerize with wild type B-Raf in a Ras-dependent process. B-raf is
					commonly mutated and thereby activated in many human cancers, the
					most frequent mutation being the V600E mutation of the kinase
					domain. Whilst wt b-Raf and Raf-1 are strongly activated by growth
					factor signals via Ras and Src, a-Raf is only modestly activated
					and has low basal activity. All three isoforms of Raf are
					considered to be oncogenic.</description>
			</characteristics>
		</gene>
		<gene name="CDK4">
			<chromosome>12</chromosome>
			<start>58142003</start>
			<stop>58146164</stop>
			<geneSize>4162</geneSize>
			<characteristics>
				<fullName>cyclin-dependent kinase 4</fullName>
				<somaticTumorTypes></somaticTumorTypes>
				<germlineTumorTypes>melanoma</germlineTumorTypes>
				<cancerSyndrome>Familial malignant melanoma</cancerSyndrome>
				<description>Cdks (cyclin-dependent kinases) are heteromeric
					serine/threonine kinases that control progression through the cell
					cycle in concert with their regulatory subunits, the cyclins.
					Although there are 12 different cdk genes, only 5 have been shown
					to directly drive the cell cycle (Cdk1, -2, -3, -4, and -6).
					Following extracellular mitogenic stimuli, cyclin D gene expression
					is upregulated. Cdk4 forms a complex with cyclin D and
					phosphorylates Rb protein, leading to liberation of the
					transcription factor E2F. E2F induces transcription of genes
					including cyclins A and E, DNA polymerase and thymidine kinase.
					Cdk4-cyclin E complexes form and initiate G1/S transition.
					Subsequently, Cdk1-cyclin B complexes form and induce G2/M phase
					transition. Cdk1-cyclin B activation induces the breakdown of the
					nuclear envelope and the initiation of mitosis. Cdks are
					constitutively expressed and are regulated by several kinases and
					phosphastases, including Wee1, CDK-activating kinase and Cdc25
					phosphatase. In addition, cyclin expression is induced by molecular
					signals at specific points of the cell cycle, leading to activation
					of Cdks. Tight control of Cdks is essential as misregulation can
					induce unscheduled proliferation, and genomic and chromosomal
					instability. Cdk4 has been shown to be mutated in some types of
					cancer, whilst a chromosomal rearrangement can lead to Cdk6
					overexpression in lymphoma, leukemia and melanoma. Cdks are
					currently under investigation as potential targets for
					antineoplastic therapy, but as Cdks are essential for driving each
					cell cycle phase, therapeutic strategies that block Cdk activity
					are unlikely to selectively target tumor cells.</description>
			</characteristics>
		</gene>
		<gene name="EGFR">
			<chromosome>7</chromosome>
			<start>55086714</start>
			<stop>55324313</stop>
			<geneSize>237600</geneSize>
			<characteristics>
				<fullName>epidermal growth factor receptor</fullName>
				<somaticTumorTypes>glioma, NSCLC</somaticTumorTypes>
				<germlineTumorTypes>NSCLC</germlineTumorTypes>
				<cancerSyndrome>Familial lung cancer</cancerSyndrome>
				<description>The epidermal growth factor receptor (EGFR) is a
					receptor tyrosine kinase of the ErbB family. Four members of the
					ErbB family have been identified; EGFR (ErbB1, HER1), ErbB2 (HER2),
					ErbB3 (HER3) and ErbB4 (HER4). EGFR signaling is initiated by
					ligand binding to the extracellular ligand binding domain. This
					initiates receptor homo-/hetero-dimerization and
					autophosphorylation by the intracellular kinase domain, resulting
					in receptor activation. Following activation, phosphorylation of
					cytoplasmic substrates occurs and a signaling cascade is initiated
					that drives many cellular responses, including changes in gene
					expression, cytoskeletal rearrangement, anti-apoptosis and
					increased cell proliferation. Ligand independent activation can
					occur as a result of activating mutations in the tyrosine kinase
					coding region within the EGFR gene. Common activating mutations in
					exon 19 and exon 21 of the EGFR gene are validated predictive
					biomarkers for benefit to EGFR targeted tyrosine kinase inhibitors
					kinase inhibitors erlotinib and gefitinib in lung cancer.
					Additional mutations in exon 20 can cause structural changes to the
					EGFR protein and result in resistance to EGFR targeted kinase
					inhibitors. Downstream activating mutations in KRAS have been shown
					to predict for lack of benefit to EGFR targeted therapies in
					colorectal cancer.</description>
			</characteristics>
		</gene>
		<gene name="ERBB2">
			<chromosome>17</chromosome>
			<start>37844393</start>
			<stop>37884915</stop>
			<geneSize>40523</geneSize>
			<characteristics>
				<fullName>v-erb-b2 erythroblastic leukemia viral oncogene homolog 2,
					neuro/glioblastoma derived oncogene homolog (avian)</fullName>
				<somaticTumorTypes>breast, ovarian, other tumour types, NSCLC,
					gastric</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>The epidermal growth factor receptor (EGFR) is a
					receptor tyrosine kinase of the ErbB family. Four members of the
					ErbB family have been identified; EGFR (ErbB1, HER1), ErbB2 (HER2),
					ErbB3 (HER3) and ErbB4 (HER4). EGFR signaling is initiated by
					ligand binding to the extracellular ligand binding domain. This
					initiates receptor homo-/hetero-dimerization and
					autophosphorylation by the intracellular kinase domain, resulting
					in receptor activation. Following activation, phosphorylation of
					cytoplasmic substrates occurs and a signaling cascade is initiated
					that drives many cellular responses, including changes in gene
					expression, cytoskeletal rearrangement, anti-apoptosis and
					increased cell proliferation.</description>
			</characteristics>
		</gene>
		<gene name="FGFR1">
			<chromosome>8</chromosome>
			<start>38268656</start>
			<stop>38326352</stop>
			<geneSize>57697</geneSize>
			<characteristics>
				<fullName>fibroblast growth factor receptor 1</fullName>
				<somaticTumorTypes>MPD, NHL</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Fibroblast growth factors (FGFs) (FGF1 - 10 and 16 -
					23) are mitogenic signaling molecules that have roles in
					angiogenesis, wound healing, cell migration, neural outgrowth and
					embryonic development. FGFs bind heparan sulfate glycosaminoglycans
					(HSGAGs), which facilitates dimerization (activation) of FGF
					receptors (FGFRs). FGFRs are transmembrane catalytic receptors that
					have intracellular tyrosine kinase activity. There are four human
					genes encoding FGFRs, which produce seven different receptors
					(FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b, FGFR3c and FGFR4) due to
					alternative splicing events occurring both in the extracellular and
					intracellular regions. The alternative splice isoforms are
					generally tissue specific: the b isoform is expressed in epithelial
					tissue, whereas the c isoform is expressed in mesenchymal tissue.
					HSGAG-FGF-FGFR binding initiates FGFR dimerization, enabling the
					cytoplasmic kinase domains to transphosphorylate tyrosine residues
					and become activated. HSGAGs also function to stabilize FGF-FGFR
					binding and prevent FGF degradation. FGFRs couple to the PLCgamma,
					MAPK and PI3-K/Akt intracellular signaling cascades and there is
					evidence of cross talk with the Notch signaling pathway. In
					addition, some activated FGF-FGFR complexes are endocytosed and
					function directly in the cytosol and/or nucleus of the cell.
					Mutations in FGFR genes are the cause of several human
					developmental disorders characterized by skeletal abnormalities
					such as achondroplasia, and upregulation of FGFR expression may
					lead to cell transformation and cancer.</description>
			</characteristics>
		</gene>
		<gene name="FGFR3">
			<chromosome>4</chromosome>
			<start>1795034</start>
			<stop>1810599</stop>
			<geneSize>15566</geneSize>
			<characteristics>
				<fullName>fibroblast growth factor receptor 3</fullName>
				<somaticTumorTypes>bladder, MM, T-cell lymphoma</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Fibroblast growth factors (FGFs) (FGF1 - 10 and 16 -
					23) are mitogenic signaling molecules that have roles in
					angiogenesis, wound healing, cell migration, neural outgrowth and
					embryonic development. FGFs bind heparan sulfate glycosaminoglycans
					(HSGAGs), which facilitates dimerization (activation) of FGF
					receptors (FGFRs). FGFRs are transmembrane catalytic receptors that
					have intracellular tyrosine kinase activity. There are four human
					genes encoding FGFRs, which produce seven different receptors
					(FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b, FGFR3c and FGFR4) due to
					alternative splicing events occurring both in the extracellular and
					intracellular regions. The alternative splice isoforms are
					generally tissue specific: the b isoform is expressed in epithelial
					tissue, whereas the c isoform is expressed in mesenchymal tissue.
					HSGAG-FGF-FGFR binding initiates FGFR dimerization, enabling the
					cytoplasmic kinase domains to transphosphorylate tyrosine residues
					and become activated. HSGAGs also function to stabilize FGF-FGFR
					binding and prevent FGF degradation. FGFRs couple to the PLCgamma,
					MAPK and PI3-K/Akt intracellular signaling cascades and there is
					evidence of cross talk with the Notch signaling pathway. In
					addition, some activated FGF-FGFR complexes are endocytosed and
					function directly in the cytosol and/or nucleus of the cell.
					Mutations in FGFR genes are the cause of several human
					developmental disorders characterized by skeletal abnormalities
					such as achondroplasia, and upregulation of FGFR expression may
					lead to cell transformation and cancer.</description>
			</characteristics>
		</gene>
		<gene name="FLT3">
			<chromosome>13</chromosome>
			<start>28577411</start>
			<stop>28674729</stop>
			<geneSize>97319</geneSize>
			<characteristics>
				<fullName>fms-related tyrosine kinase 3</fullName>
				<somaticTumorTypes>AML, ALL</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>This gene encodes a class III receptor tyrosine kinase
					that regulates hematopoiesis. The receptor consists of an
					extracellular domain composed of five immunoglobulin-like domains,
					one transmembrane region, and a cytoplasmic kinase domain split
					into two parts by a kinase-insert domain. The receptor is activated
					by binding of the fms-related tyrosine kinase 3 ligand to the
					extracellular domain, which induces homodimer formation in the
					plasma membrane leading to autophosphorylation of the receptor. The
					activated receptor kinase subsequently phosphorylates and activates
					multiple cytoplasmic effector molecules in pathways involved in
					apoptosis, proliferation, and differentiation of hematopoietic
					cells in bone marrow. Mutations that result in the constitutive
					activation of this receptor result in acute myeloid leukemia and
					acute lymphoblastic leukemia. (provided by RefSeq)</description>
			</characteristics>
		</gene>
		<gene name="HRAS">
			<chromosome>11</chromosome>
			<start>532242</start>
			<stop>537287</stop>
			<geneSize>5046</geneSize>
			<characteristics>
				<fullName>v-Ha-ras Harvey rat sarcoma viral oncogene homolog
				</fullName>
				<somaticTumorTypes>infrequent sarcomas, rare other types
				</somaticTumorTypes>
				<germlineTumorTypes>rhadomyosarcoma, ganglioneuroblastoma, bladder
				</germlineTumorTypes>
				<cancerSyndrome>Costello syndrome</cancerSyndrome>
				<description>This gene belongs to the Ras oncogene family, whose
					members are related to the transforming genes of mammalian sarcoma
					retroviruses. The products encoded by these genes function in
					signal transduction pathways. These proteins can bind GTP and GDP,
					and they have intrinsic GTPase activity. This protein undergoes a
					continuous cycle of de- and re-palmitoylation, which regulates its
					rapid exchange between the plasma membrane and the Golgi apparatus.
					Mutations in this gene cause Costello syndrome, a disease
					characterized by increased growth at the prenatal stage, growth
					deficiency at the postnatal stage, predisposition to tumor
					formation, mental retardation, skin and musculoskeletal
					abnormalities, distinctive facial appearance and cardiovascular
					abnormalities. Defects in this gene are implicated in a variety of
					cancers, including bladder cancer, follicular thyroid cancer, and
					oral squamous cell carcinoma. Multiple transcript variants, which
					encode different isoforms, have been identified for this gene.
					(provided by RefSeq)</description>
			</characteristics>
		</gene>
		<gene name="JAK2">
			<chromosome>9</chromosome>
			<start>4985033</start>
			<stop>5128183</stop>
			<geneSize>143151</geneSize>
			<characteristics>
				<fullName>Janus kinase 2</fullName>
				<somaticTumorTypes>ALL, AML, MPD, CML</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>JAKs (or Janus kinases) are a family of tyrosine
					kinases that associated with cytokine receptors. Upon receptor
					activation JAKs phosphorylate the transcription factors known as
					STATs and initiate the JAK-STAT signaling pathway. Four JAK family
					members have been identified (JAK1, JAK2, JAK3 and Tyk2), which
					share a similar protein domain structure: a kinase domain, a
					regulatory pseudo -kinase domain, a SH2 domain and a FERM domain.
					The FERM domain of JAK family members mediates the association of
					JAK with other enzymes and cytokine receptors. The JAK Tyk2
					associates with the IFN-1, IL-6, 10, 12, and 23 cytokine receptor
					families. JAK1 mediates signals from IFN-alpha, beta, gamma and
					IL-2, 6 receptors. JAK2 transduces signals from the single chain
					and IL-3 cytokine receptor families, and from the IFN-gamma
					receptors. JAK3 associates with the IL-2 receptor gamma-chain.
				</description>
			</characteristics>
		</gene>
		<gene name="KIT">
			<chromosome>4</chromosome>
			<start>55524085</start>
			<stop>55606881</stop>
			<geneSize>82797</geneSize>
			<characteristics>
				<fullName>v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene
					homolog</fullName>
				<somaticTumorTypes>GIST, AML, TGCT, mastocytosis, mucosal melanoma
				</somaticTumorTypes>
				<germlineTumorTypes>GIST, epithelioma</germlineTumorTypes>
				<cancerSyndrome>Familial gastrointestinal stromal tumour
				</cancerSyndrome>
				<description>This gene encodes the human homolog of the
					proto-oncogene c-kit. C-kit was first identified as the cellular
					homolog of the feline sarcoma viral oncogene v-kit. This protein is
					a type 3 transmembrane receptor for MGF (mast cell growth factor,
					also known as stem cell factor). Mutations in this gene are
					associated with gastrointestinal stromal tumors, mast cell disease,
					acute myelogenous lukemia, and piebaldism. Multiple transcript
					variants encoding different isoforms have been found for this gene.
					(provided by RefSeq)</description>
			</characteristics>
		</gene>
		<gene name="KRAS">
			<chromosome>12</chromosome>
			<start>25358180</start>
			<stop>25403854</stop>
			<geneSize>45675</geneSize>
			<characteristics>
				<fullName>v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
				</fullName>
				<somaticTumorTypes>pancreatic, colorectal, lung, thyroid, AML,
					others</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>This gene, a Kirsten ras oncogene homolog from the
					mammalian ras gene family, encodes a protein that is a member of
					the small GTPase superfamily. A single amino acid substitution is
					responsible for an activating mutation. The transforming protein
					that results is implicated in various malignancies, including lung
					adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas
					and colorectal carcinoma. Alternative splicing leads to variants
					encoding two isoforms that differ in the C-terminal region.
					(provided by RefSeq)</description>
			</characteristics>
		</gene>
		<gene name="MET">
			<chromosome>7</chromosome>
			<start>116312248</start>
			<stop>116438440</stop>
			<geneSize>126193</geneSize>
			<characteristics>
				<fullName>met proto-oncogene (hepatocyte growth factor receptor)
				</fullName>
				<somaticTumorTypes>papillary renal, head-neck squamous cell
				</somaticTumorTypes>
				<germlineTumorTypes>papillary renal</germlineTumorTypes>
				<cancerSyndrome>Familial Papillary Renal Cancer</cancerSyndrome>
				<description>MET (Mesenchymal epithelial transition factor), also
					known as hepatocyte growth factor receptor (HGFR) is a
					proto-oncogenic receptor tyrosine kinase. The endogenous ligand for
					MET is hepatocyte growth factor/scatter factor (HGF), a
					disulfide-linked heterodimeric molecule produced predominantly by
					mesenchymal cells. In the adult, MET expression is limited to stem
					and progenitor cells and is necessary for wound healing and
					hepatocyte regeneration. In the embryo, MET receptors are expressed
					on cells of epithelial origin. They are essential for invasive
					growth and mediate epithelial-mesenchymal transition (EMT).
					Abberant activation of the HGF/MET pathway leads to a variety of
					cancers. MET mutation is associated with a poor prognosis as it can
					trigger tumor growth, angiogenesis and metastasis.</description>
			</characteristics>
		</gene>
		<gene name="NRAS">
			<chromosome>1</chromosome>
			<start>115247078</start>
			<stop>115259515</stop>
			<geneSize>12438</geneSize>
			<characteristics>
				<fullName>neuroblastoma RAS viral (v-ras) oncogene homolog
				</fullName>
				<somaticTumorTypes>melanoma, MM, AML, thyroid</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>This is an N-ras oncogene encoding a membrane protein
					that shuttles between the Golgi apparatus and the plasma membrane.
					This shuttling is regulated through palmitoylation and
					depalmitoylation by the ZDHHC9-GOLGA7 complex. The encoded protein,
					which has intrinsic GTPase activity, is activated to a GTP-bound
					form by a GTPase activating protein and inactivated to a GDP-bound
					form by a guanine nucleotide-exchange factor. Defects in this gene
					are a cause of juvenile myelomonocytic leukemia (JMML). (provided
					by RefSeq)</description>
			</characteristics>
		</gene>
		<gene name="PDGFRA">
			<chromosome>4</chromosome>
			<start>55095264</start>
			<stop>55164414</stop>
			<geneSize>69151</geneSize>
			<characteristics>
				<fullName>platelet-derived growth factor receptor, alpha polypeptide
				</fullName>
				<somaticTumorTypes>GIST, idiopathic hypereosinophilic syndrome
				</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>Platelet-derived growth factor receptors (PDGFRs) are
					catalytic receptors that have intracellular tyrosine kinase
					activity. They have roles in the regulation of many biological
					processes including embryonic development, angiogenesis, cell
					proliferation and differentiation, and contribute to the
					pathophysiology of some diseases, including cancer. There are two
					isoforms of the PDGFR receptor; PDGFRalpha and PDGFRbeta, which can
					form homo- or heterodimers. The endogenous PDGFR ligands are
					PDGF-A, -B, -C and -D, which induce receptor dimerization and
					transphosphorylation at specific tyrosine residues upon binding.
					This activates the intracellular kinase activity, initiating
					intracellular signaling through the MAPK, PI 3-K and PKCgamma
					pathways.</description>
			</characteristics>
		</gene>
		<gene name="PIK3CA">
			<chromosome>3</chromosome>
			<start>178865902</start>
			<stop>178957881</stop>
			<geneSize>91980</geneSize>
			<characteristics>
				<fullName>phosphoinositide-3-kinase, catalytic, alpha polypeptide
				</fullName>
				<somaticTumorTypes>colorectal, gastric, gliobastoma, breast
				</somaticTumorTypes>
				<germlineTumorTypes></germlineTumorTypes>
				<cancerSyndrome></cancerSyndrome>
				<description>PI 3-Kinases (phosphoinositide 3-kinases, PI3Ks) are
					family of lipid kinases capable of phosphorylating the 3'OH of the
					inositol ring of phosphoinositides. They are responsible for
					coordinating a diverse range of cell functions including
					proliferation, cell survival, degranulation, vesicular trafficking
					and cell migration. The PI 3-kinases are grouped into three
					distinct classes. Class I PI 3-kinases are heteromeric consisting
					of a regulatory subunit and a 110 kDA catalytic subunits (3 forms
					in class 1A : alpha-, beta- and delta- and one in class 1B :
					gamma-). PI 3-kinases p110 alpha- and beta- are ubiquitously
					expressed whilst p110 delta- expression is associated with
					leukocytes. Activating mutations in the p110alpha- subunit have
					recently been discovered in certain types of cancer cell. Class II
					PI 3-kinases are large homomeric enzymes (C2alpha-, beta- and
					gamma-) that are sensitive to wortmannin (although less sensitive
					than Class 1 PI 3-kinases) but are resistant to LY 292002. Class
					III contains just one member, hVps34p, which is thought to play an
					important role in both protein sorting and nutrient sensing in
					concert with the mTOR pathway.</description>
			</characteristics>
		</gene>
		<gene name="RET">
			<chromosome>10</chromosome>
			<start>43572475</start>
			<stop>43625799</stop>
			<geneSize>53325</geneSize>
			<characteristics>
				<fullName>ret proto-oncogene</fullName>
				<somaticTumorTypes>medullary thyroid, papillary thyroid,
					pheochromocytoma</somaticTumorTypes>
				<germlineTumorTypes>medullary thyroid, papillary thyroid,
					pheochromocytoma</germlineTumorTypes>
				<cancerSyndrome>Multiple endocrine neoplasia 2A/2B</cancerSyndrome>
				<description>This gene, a member of the cadherin superfamily,
					encodes one of the receptor tyrosine kinases, which are
					cell-surface molecules that transduce signals for cell growth and
					differentiation. This gene plays a crucial role in neural crest
					development, and it can undergo oncogenic activation in vivo and in
					vitro by cytogenetic rearrangement. Mutations in this gene are
					associated with the disorders multiple endocrine neoplasia, type
					IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease,
					and medullary thyroid carcinoma. Two transcript variants encoding
					different isoforms have been found for this gene. Additional
					transcript variants have been described but their biological
					validity has not been confirmed. (provided by RefSeq)</description>
			</characteristics>
		</gene>
	</genes>
	<mutations>
		<mutation chromosome="9" gene="ABL1" start="133738349" stop="133738349"
			mutation="G250E" refAllele="G" varAllele="A">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:10:30.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical data and modelling taking into
						account in vitro sensitivity and preclinical considerations
						predict that the G250E ABL mutation renders the clone resistant to
						imatinib but that sensitivity to dasatinib and nilotinib might be
						preserved.
						Another in vitro study suggests that this mutation renders the neoplastic
						clone insensitive to imatinib and nilotinib but that sensitivity
						to dasatinib might be preserved.
					</significanceComment>
					<significanceReference>pmid:20194843, pmid:15930265
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 60 patients patients had the
						G250E ABL mutation. 56/60 patients experienced a Complete
						Hematologic Response (CHR), 29/60 experienced a Major Cytogenetic
						Response (MCyR) and 20/60 experienced a Complete Cytogenetic
						Response (CCR).
						In a phase II trial of patients intolerant or resistant to imatinib
						treated with nilotinib, 5 patients had the G250E mutation at study
						entry. Of those, 3/5 had a CCyR and 2/5 had a Major Molecular
						response
					</significanceComment>
					<significanceReference>pmid:19652056, pmid:19779040
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib, nilotinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:19075254</actionReference>
					<actionComment>This mutation may confer resistance to imatinib
						therapy in Chronic Myeloid Leukemia (CML) and Philadelphia
						Positive Acute Lymphoblastic Leukemia </actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748290" stop="133748290"
			mutation="F317L" refAllele="C" varAllele="G">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-05 16:09:55.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>In vitro studies have shown that CML cell
						lines harboring the F317L ABL mutation are more sensitive to
						nilotinib than to dasatinib and imatinib</significanceComment>
					<significanceReference>pmid:18191450</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of patients treated with
						dasatinib for CML who were resistant or intolerant to frontline
						imatinib, only 2/14 patients achieved a major cytogenetic
						response. Preliminary results with nilotinib are more encouraging.
					</significanceComment>
					<significanceReference>pmid:19779040, pmid:19652056
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>Preclinical studies have shown this mutation
						to arise in patients developing resistance to imatinib and
						dasatinib therapy and thus probably confers resistance to these
						agents. </significanceComment>
					<significanceReference>pmid:19589924, pmid:17339191, pmid:18818391
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib, dasatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18818391, pmid:18191450</actionReference>
					<actionComment>This mutation may confer resistance to imatinib and
						dasatinib therapy in Chronic Myeloid Leukemia (CML) and
						Philadelphia Positive Acute Lymphoblastic Leukemia </actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748391" stop="133748391"
			mutation="M351T" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:11:03.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II/III trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 54 patients patients had the
						M351T ABL mutation. 51/54 patients experienced a Complete
						Hematologic Response (CHR), 28/54 experienced a Major Cytogenetic
						Response (MCyR) and 25/54 experienced a Complete Cytogenetic
						Response (CCR).
					</significanceComment>
					<significanceReference>pmid:19779040</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical data based on in vitro sensitivity
						suggests that this mutation might render the neoplastic clone more
						sensitive to bosutinib, dasatinib and nilotinib than to imatinib
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:15930265
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib, nilotinib, bosutinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:15930265</actionReference>
					<actionComment>This mutation may confer resistance to imatinib
						therapy in Chronic Myeloid Leukemia (CML) and Philadelphia
						Positive Acute Lymphoblastic Leukemia.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748403" stop="133748403"
			mutation="E355G" refAllele="A" varAllele="G">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-01-04 10:46:22.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies based on in vitro
						sensitivity suggest that CML harboring this mutation may respond
						better to dasatinb than to imatinib and nilotinib.
					</significanceComment>
					<significanceReference>pmid:19567878</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib, dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:20702476</actionReference>
					<actionComment>This mutation may confer resistance to imatinib
						therapy in Chronic Myeloid Leukemia (CML) and Philadelphia
						Positive Acute Lymphoblastic Leukemia</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748414" stop="133748414"
			mutation="F359V" refAllele="T" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:10:15.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies have suggested that this
						mutation renders the neoplastic clone resistant to imatinib and
						nilotinib but maintains sensitivity to dasatinib.
					</significanceComment>
					<significanceReference>pmid:15930265, pmid:19075254
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 27 patients patients had the
						F359V ABL mutation. 25/27 patients experienced a Complete
						Hematologic Response (CHR), 17/27 experienced a Major Cytogenetic
						Response (MCyR) and 14/27 experienced a Complete Cytogenetic
						Response (CCR).
						In a phase II trial of patients intolerant or resistant to imatinib
						treated with nilotinib, 10 patients had the F359C/V mutation at
						study entry. Of those, 3/10 had a CHR, 1/10 had a MCyR and 0/10
						had a CCR
					</significanceComment>
					<significanceReference>pmid:19779040, pmid:19652056
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib, nilotinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:20194843</actionReference>
					<actionComment>This mutation may confer resistance to imatinib and
						nilotinib therapy in Chronic Myeloid Leukemia (CML) and
						Philadelphia Positive Acute Lymphoblastic Leukemia.
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-01-04 11:05:18.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133750356" stop="133750356"
			mutation="H396R" refAllele="A" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:10:47.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>In vitro sensitivity assays, show that this
						mutation may render the neoplastic clone resistant to imatinib
						therapy while preserving sensitivity to dasatinib and nilotinib
						therapy</significanceComment>
					<significanceReference>pmid:15930265, pmid:20194843
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II/III trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 33 patients patients had the
						H396R ABL mutation. 30/33 patients experienced a Complete
						Hematologic Response (CHR), 17/33 experienced a Major Cytogenetic
						Response (MCyR) and 13/33 experienced a Complete Cytogenetic
						Response (CCR).</significanceComment>
					<significanceReference>pmid:19779040</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib, nilotinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15930265, pmid:1975254</actionReference>
					<actionComment>This mutation may confer resistance to imatinib
						therapy in Chronic Myeloid Leukemia (CML) and Philadelphia
						Positive Acute Lymphoblastic Leukemia.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738356" stop="133738356"
			mutation="Q252H" refAllele="G" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:22:22.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical data suggests that this mutation
						does not render the Chronic Myeloid Leukemia clone insensitive to
						imatinib therapy and that in fact this mutation might make the
						clone more sensitive to imatinib than to dasatinib and nilotinib
					</significanceComment>
					<significanceReference>pmid:20194843, pmid:19075254
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15930265, pmid:17189410</actionReference>
					<actionComment>The functional consequence of this mutation is
						poorly studied and there is insufficient data to draw conclusions
						as to whether it confers resistance or sensitivity to specific
						tyrosine kinase inhibitors</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738357" stop="133738357"
			mutation="Y253H" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 17:33:26.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical data based on in vitro sensitivity
						suggests that CML clone harboring this mutation may be more
						resistant to imatinib and nilotinib than to dasatinib
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:15930265
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II/III trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 23 patients patients had the
						Y253H ABL mutation. 20/23 patients experienced a Complete
						Hematologic Response (CHR), 15/23 experienced a Major Cytogenetic
						Response (MCyR) and 14/23 experienced a Complete Cytogenetic
						Response (CCR).
						In a phase II trial of CML patients intolerant or resistant to
						imatinib therapy in first line treated with nilotinib, 0/6
						evaluable patients experienced a CHR to imatinib and 1/8 evaluable
						patients experienced a MCyR to nilotinib.
					</significanceComment>
					<significanceReference>pmid:19652056, pmid:19779040
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib, nilotinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:20194843</actionReference>
					<actionComment>This mutation probably confers resistance to
						imatinib and nilotinib therapy in Chronic Myelogenous Leukemia
						(CML) and Philadelphia positive acute lymphoblastic lekamia.
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738358" stop="133738358"
			mutation="Y253F" refAllele="A" varAllele="T">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 17:36:25.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical data based on in vitro sensitivity
						suggests that CML clone harboring this mutation may be more
						resistant to imatinib and nilotinib than to dasatinib
						Moreover, resistance to imatinib and nilotinib has been infered from
						clinical observations with the closely related Y253H mutation that
						is more common that have shown CML harboring the Y253H mutation to
						be resistant to imatinib and nilotinib therapy.
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:15930265, pmid:19652056,
						pmid:19779040</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib, Nilotinib</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:20194843</actionReference>
					<actionComment>This mutation probably confers resistance to
						imatinib and nilotinib therapy in Chronic Myelogenous Leukemia
						(CML) and Philadelphia positive acute lymphoblastic lekamia.
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738363" stop="133738363"
			mutation="E255K" refAllele="G" varAllele="A">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-07-12 09:19:23.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>A pooled analysis of three phase II/III
						studies of dasatinib in patients refractory or intolerant to
						frontline imatinib for CML showed that of patients harboring the
						E255K mutation at study initiation, 14/16 patients had a complete
						hematologic response, 9/16 achieved a majory cytogenetic response
						and 6/16 achieved a complete cytogenetic response.
					</significanceComment>
					<significanceReference>pmid:19779040</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies based on in vitro
						sensitivity suggest that CML harboring this mutation may respond
						better to dasatinib and nilotinib than to imatinib.
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:20194843
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>A phase II study of nilotinib in patients with
						resistance or intolerance to frontline imatinib therapy for CML
						showed that of patients harboring the E255K or E255V mutation at
						study initiation, 5/7 experienced a complete hematologic response,
						3/7 had a major cytogenetic response and 1/7 had a major molecular
						response. Hovever 6/7 patients progressed on nilotinib therapy.
						Four patients not initially harboring the mutation developped the
						E255K/V mutation and became nilotinib resistant
					</significanceComment>
					<significanceReference>pmid:19652056</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib, dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:14745431, pmid:20607847, pmid:15510211,
						pmid:17189410</actionReference>
					<actionComment>This mutation is neither inactivating nor activating
						but might confer resistance to imatinib therapy in Chronic
						Myelogenous Leukemia (CML) and in Philadelphia positive Acute
						Lymphoblastic Leukemia</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-11-24 11:29:20.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>PGh0bWwgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGh0bWwiPgo8aGVhZD4KPHRpdGxlPk11dGF0aW9uIHJlcG9ydCBmb3IgQUJMMSBFMjU1SzwvdGl0bGU+Cgo8L2hlYWQ+Cjxib2R5PgoJPHA+CglTdGF0dXM6IAoJCgk8c3BhbiBjbGFzcz0ic3RhdHVzY29tcGxldGUiPkNPTVBMRVRFPC9zcGFuPgoJCgkKCWFuZCBjb25maXJtZWQKCQoJJiN4MjAxNDsgCgkKCUxhc3Qgc2F2ZWQgYnk6IFZpbmNlbnQgQ2FzdG9uZ3VheSBvbiAwNy8xMi8yMDExIDA5OjE5IEFNCgkKCTwvcD4KCSAgCgk8aHIgLz4KCTxoMz5GcmVxdWVuY3kgb2YgRTI1NUsgbXV0YXRpb24gaW4gQUJMMSBpbiB0aGUgdG9wIHR1bW91ciB0eXBlczwvaDM+CgkKCTx0YWJsZT4KCTx0aGVhZD4KCQk8dHI+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjMwIj48L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIyMjAiPlR1bW91cjwvdGg+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjgwIj5GcmVxdWVuY3k8L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIxMDAiPlNhbXBsZXM8L3RoPgoJCTwvdHI+Cgk8L3RoZWFkPgoJPHRib2R5PgoJCQoJCQoJCQk8dHI+CgkJCQk8dGQ+MS48L3RkPgoJCQkJPHRkPmhhZW1hdG9wb2lldGljIGFuZCBseW1waG9pZCB0aXNzdWUgaGFlbWF0b3BvaWV0aWMgbmVvcGxhc208L3RkPgoJCQkJPHRkPjMuMTE4NCU8L3RkPgoJCQkJPHRkPig1OS8xODkyIHNhbXBsZXMpPC90ZD4KCQkJCQoJCQk8L3RyPgoJCQoJCQoJPC90Ym9keT4KCTwvdGFibGU+CgkKCTxociAvPgoJPGgzPkFCTDEgY2hhcmFjdGVyaXN0aWNzPC9oMz4KCQoJPGg0PkZ1bGwgbmFtZTogYy1hYmwgb25jb2dlbmUgMSwgbm9uLXJlY2VwdG9yIHR5cm9zaW5lIGtpbmFzZTwvaDQ+CgkKCTxwPlRoZSBBYmwgZmFtaWx5IG9mIG5vbi1yZWNlcHRvciB0eXJvc2luZSBraW5hc2VzIGluY2x1ZGVzIGMtQWJsIChBYmVsc29uIHR5cm9zaW5lIGtpbmFzZSkgYW5kIEFyZyAoQWJsMikgc3VidHlwZXMuIGMtQWJsIGlzIGxvY2FsaXplZCBhdCBzZXZlcmFsIHN1YmNlbGx1bGFyIHNpdGVzIGluY2x1ZGluZyB0aGUgbnVjbGV1cywgY3l0b3BsYXNtLCBtaXRvY2hvbmRyaWEgYW5kIGVuZG9wbGFzbWljIHJldGljdWx1bSwgd2hlcmUgaXQgaW50ZXJhY3RzIHdpdGggYSBsYXJnZSB2YXJpZXR5IG9mIGNlbGx1bGFyIHByb3RlaW5zIGluY2x1ZGluZyBzaWduYWxpbmcgYWRhcHRvcnMsIGtpbmFzZXMsIHBob3NwaGF0YXNlcywgY2VsbCBjeWNsZSByZWd1bGF0b3JzLCB0cmFuc2NyaXB0aW9uIGZhY3RvcnMgYW5kIGN5dG9za2VsZXRhbCBwcm90ZWlucy4gRHVlIHRvIGl0cyBkaXZlcnNlIHJhbmdlIG9mIHRhcmdldHMsIGMtQWJsIGhhcyBiZWVuIGltcGxpY2F0ZWQgaW4gbWFueSBjZWxsdWxhciBwcm9jZXNzZXMgaW5jbHVkaW5nIHJlZ3VsYXRpb24gb2YgY2VsbCBncm93dGggYW5kIHN1cnZpdmFsLCBveGlkYXRpdmUgc3RyZXNzIGFuZCBETkEtZGFtYWdlIHJlc3BvbnNlcywgYW5kIGFjdGluIGR5bmFtaWNzIGFuZCBjZWxsIG1pZ3JhdGlvbi4gVGhlIEFibCBmYW1pbHkgaGF2ZSBzaWduaWZpY2FudCBzdHJ1Y3R1cmFsIGhvbW9sb2d5IHRvIHRoZSBTcmMgdHlyb3NpbmUga2luYXNlIGZhbWlseSwgYnV0IGhhdmUgYSB1bmlxdWUgbG9uZyBjYXJib3h5LXRlcm1pbmFsIGV4dGVuc2lvbiB0aGF0IGNvbnRhaW5zIHByb3RlaW4tcHJvdGVpbiBpbnRlcmFjdGlvbiBzaXRlcyBhbmQgYWN0cyBhcyB0aGUgYmluZGluZyBzaXRlIGZvciB0YXJnZXRzIHN1Y2ggYXMgQVRNLCBwNTMgYW5kIHBSYi4gYy1BYmwgaXMgbWVkaWNhbGx5IGltcG9ydGFudCBhcyB0aGVyZSBpcyBhIGNhdXNhbCBsaW5rIGJldHdlZW4gdGhlIEFibC1CY3IgZnVzaW9uIHByb3RlaW4gKGNhdXNlZCBieSBhIHQoOSwyMikgdHJhbnNsb2NhdGlvbikgYW5kIGRldmVsb3BtZW50IG9mIGNocm9uaWMgbXllbG9pZCBsZXVrZW1pYS48L3A+CgkgICAgICAgICAgICAgICAKCTxociAvPgoJPGgzPkFCTDEgRTI1NUsgY2hhcmFjdGVyaXN0aWNzPC9oMz4KCSAgCQoJPHA+VGhlIGZ1bmN0aW9uYWwgY29uc2VxdWVuY2Ugb2YgdGhpcyBtdXRhdGlvbiBpczogPGI+b3RoZXI8L2I+LgoJICAgUmVmZXJlbmNlIChQTUlEKTogcG1pZDo8YSBocmVmPSdodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE0NzQ1NDMxJz4xNDc0NTQzMTwvYT4sIHBtaWQ6PGEgaHJlZj0naHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMDYwNzg0Nyc+MjA2MDc4NDc8L2E+LCBwbWlkOjxhIGhyZWY9J2h0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTU1MTAyMTEnPjE1NTEwMjExPC9hPiwgcG1pZDo8YSBocmVmPSdodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE3MTg5NDEwJz4xNzE4OTQxMDwvYT48L3A+CgkKCQoJCgkJCgkJPHA+VGhpcyBtdXRhdGlvbiBpcyBuZWl0aGVyIGluYWN0aXZhdGluZyBub3IgYWN0aXZhdGluZyBidXQgbWlnaHQgY29uZmVyIHJlc2lzdGFuY2UgdG8gaW1hdGluaWIgdGhlcmFweSBpbiBDaHJvbmljIE15ZWxvZ2Vub3VzIExldWtlbWlhIChDTUwpIGFuZCBpbiBQaGlsYWRlbHBoaWEgcG9zaXRpdmUgQWN1dGUgTHltcGhvYmxhc3RpYyBMZXVrZW1pYTwvcD4KCQkKCQoJCgkJCQkJCgk8aHIgLz4KCTxoMz5DbGluaWNhbCBhbmQgUHJlY2xpbmljYWwgU3R1ZGllczwvaDM+CgkKCQoJCgkKCSAgCQoJCgk8aDQ+MS4gaGFlbWF0b3BvaWV0aWMgYW5kIGx5bXBob2lkIHRpc3N1ZSBoYWVtYXRvcG9pZXRpYyBuZW9wbGFzbQoJCgktIDMuMTE4NCUKCTwvaDQ+CgkKCQoJCgkJCgkJCTxwPkluIHRoaXMgdHVtb3VyIHR5cGUsIHRoZSBjbGluaWNhbCBzaWduaWZpY2FuY2Ugb2YgdGhpcyBtdXRhdGlvbiBoYXMgYmVlbiBleGFtaW5lZCBieSA8Yj5wcmVjbGluaWNhbDwvYj4gc3R1ZGllcy48L3A+CgkJCQoJCQkJPHA+UHJlY2xpbmljYWwgc3R1ZGllcyBiYXNlZCBvbiBpbiB2aXRybyBzZW5zaXRpdml0eSBzdWdnZXN0IHRoYXQgQ01MIGhhcmJvcmluZyB0aGlzIG11dGF0aW9uIG1heSByZXNwb25kIGJldHRlciB0byBkYXNhdGluaWIgYW5kIG5pbG90aW5pYiB0aGFuIHRvIGltYXRpbmliLjwvcD4KCQkJCTxwPlJlZmVyZW5jZTogcG1pZDo8YSBocmVmPSdodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5MDc1MjU0Jz4xOTA3NTI1NDwvYT4sIHBtaWQ6PGEgaHJlZj0naHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMDE5NDg0Myc+MjAxOTQ4NDM8L2E+IC0gZXZpZGVuY2UgVkQ8L3A+CgkJCQoJCQoJCQk8cD5JbiB0aGlzIHR1bW91ciB0eXBlLCB0aGUgY2xpbmljYWwgc2lnbmlmaWNhbmNlIG9mIHRoaXMgbXV0YXRpb24gaGFzIGJlZW4gZXhhbWluZWQgYnkgPGI+cHJvc3BlY3RpdmU8L2I+IGNsaW5pY2FsIHRyaWFscy48L3A+CgkJCQoJCQkJPHA+QSBwb29sZWQgYW5hbHlzaXMgb2YgdGhyZWUgcGhhc2UgSUkvSUlJIHN0dWRpZXMgb2YgZGFzYXRpbmliIGluIHBhdGllbnRzIHJlZnJhY3Rvcnkgb3IgaW50b2xlcmFudCB0byBmcm9udGxpbmUgaW1hdGluaWIgZm9yIENNTCBzaG93ZWQgdGhhdCBvZiBwYXRpZW50cyBoYXJib3JpbmcgdGhlIEUyNTVLIG11dGF0aW9uIGF0IHN0dWR5IGluaXRpYXRpb24sIDE0LzE2IHBhdGllbnRzIGhhZCBhIGNvbXBsZXRlIGhlbWF0b2xvZ2ljIHJlc3BvbnNlLCA5LzE2IGFjaGlldmVkIGEgbWFqb3J5IGN5dG9nZW5ldGljIHJlc3BvbnNlIGFuZCA2LzE2IGFjaGlldmVkIGEgY29tcGxldGUgY3l0b2dlbmV0aWMgcmVzcG9uc2UuPC9wPgoJCQkJPHA+UmVmZXJlbmNlOiBwbWlkOjxhIGhyZWY9J2h0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTk3NzkwNDAnPjE5Nzc5MDQwPC9hPiAtIGV2aWRlbmNlIElJQjwvcD4KCQkJCgkJCgkJCTxwPkluIHRoaXMgdHVtb3VyIHR5cGUsIHRoZSBjbGluaWNhbCBzaWduaWZpY2FuY2Ugb2YgdGhpcyBtdXRhdGlvbiBoYXMgYmVlbiBleGFtaW5lZCBieSA8Yj5wcm9zcGVjdGl2ZTwvYj4gY2xpbmljYWwgdHJpYWxzLjwvcD4KCQkJCgkJCQk8cD5BIHBoYXNlIElJIHN0dWR5IG9mIG5pbG90aW5pYiBpbiBwYXRpZW50cyB3aXRoIHJlc2lzdGFuY2Ugb3IgaW50b2xlcmFuY2UgdG8gZnJvbnRsaW5lIGltYXRpbmliIHRoZXJhcHkgZm9yIENNTCBzaG93ZWQgdGhhdCBvZiBwYXRpZW50cyBoYXJib3JpbmcgdGhlIEUyNTVLIG9yIEUyNTVWIG11dGF0aW9uIGF0IHN0dWR5IGluaXRpYXRpb24sIDUvNyBleHBlcmllbmNlZCBhIGNvbXBsZXRlIGhlbWF0b2xvZ2ljIHJlc3BvbnNlLCAzLzcgaGFkIGEgbWFqb3IgY3l0b2dlbmV0aWMgcmVzcG9uc2UgYW5kIDEvNyBoYWQgYSBtYWpvciBtb2xlY3VsYXIgcmVzcG9uc2UuIEhvdmV2ZXIgNi83IHBhdGllbnRzIHByb2dyZXNzZWQgb24gbmlsb3RpbmliIHRoZXJhcHkuIEZvdXIgcGF0aWVudHMgbm90IGluaXRpYWxseSBoYXJib3JpbmcgdGhlIG11dGF0aW9uIGRldmVsb3BwZWQgdGhlIEUyNTVLL1YgbXV0YXRpb24gYW5kIGJlY2FtZSBuaWxvdGluaWIgcmVzaXN0YW50PC9wPgoJCQkJPHA+UmVmZXJlbmNlOiBwbWlkOjxhIGhyZWY9J2h0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTk2NTIwNTYnPjE5NjUyMDU2PC9hPiAtIGV2aWRlbmNlIElJQjwvcD4KCQkJCgkJCgkKCQkKCQoJICAJCgk8aHIgLz4KCTxoMz5BdmFpbGFiaWxpdHkgb2YgSW52ZXN0aWdhdGlvbmFsIEFnZW50czwvaDM+CgkgIAkKCQoJCgk8aHIgLz4KCTxoMz5TZW5zaXRpdml0eSBhbmQgUmVzaXN0YW5jZSBDb25mZXJyZWQgYnkgTXV0YXRpb248L2gzPgoJCgkKCQk8cD5UaGlzIG11dGF0aW9uIDxiPm1heTwvYj4gY29uZmVyIDxiPnJlc2lzdGFuY2U8L2I+IHRvOiBJbWF0aW5pYjwvcD4KCQoJCTxwPlRoaXMgbXV0YXRpb24gPGI+bWF5PC9iPiBjb25mZXIgPGI+c2Vuc2l0aXZpdHk8L2I+IHRvOiBOaWxvdGluaWIsIGRhc2F0aW5pYjwvcD4KCQoJCgk8aHIgLz4KCTxoMz5SZXBvcnQgSGlzdG9yeTwvaDM+CgkgIAkKCQoJCTx0YWJsZT4KCQkJPHRoZWFkPgoJCQkJPHRyPgoJCQkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjEyMCI+RGF0ZTwvdGg+CgkJCQkJPHRoIGFsaWduPSJsZWZ0IiB3aWR0aD0iMTAwIj5Db25maXJtZWQgYnk8L3RoPgoJCQkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjIyMCI+Q29tbWVudDwvdGg+CgkJCQk8L3RyPgoJCQk8L3RoZWFkPgoJCQk8dGJvZHk+CgkgIAkJCQoJICAJCQkJPHRyPgoJIAkJCQkJPHRkPjExLzI0LzIwMTEgMTE6MjkgQU08L3RkPgoJICAJCQkJCTx0ZD5KYW5ldCBEYW5jZXk8L3RkPgoJICAJCQkJCTx0ZD48L3RkPgoJIAkJCQk8L3RyPgoJICAJCQkKCSAJCTwvdGJvZHk+CgkJPC90YWJsZT4KCQo8L2JvZHk+CjwvaHRtbD4K
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738364" stop="133738364"
			mutation="E255V" refAllele="A" varAllele="T">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-05-10 15:34:23.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies based on in vitro
						sensitivity suggest that CML harboring this mutation may respond
						better to dasatinib and nilotinib than to imatinib
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:20194843
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>prospective</type>
					<significanceComment>A pooled analysis of three phase II studies of
						dasatinib in patients refractory or intolerant to frontline
						imatinib showed that for patients with the E255V mutation at
						initiation, 9/11 patients achieved a complete hematologic
						response, 4/11 achieved a major cytogenetic response and 4/11
						achieved a complete cytogenetic response</significanceComment>
					<significanceReference>pmid:19779040</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>A pooled analysis of three phase II studies of
						dasatinib in patients refractory or intolerant to frontline
						imatinib showed that for patients with the E255V mutation at
						initiation, 9/11 patients achieved a complete hematologic
						response, 4/11 achieved a major cytogenetic response and 4/11
						achieved a complete cytogenetic response</significanceComment>
					<significanceReference>pmid:19779040</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>A phase II study of nilotinib in patients with
						resistance or intolerance to frontline imatinib in CML showed that
						5/7 patients with the E255K/V mutation had a complete hematologic
						response, 3/7 had a major cytogenetic reponse and 1/7 had a major
						molecular response. However 6/7 patients eventually progressed on
						nilotinib therapy. Four patients on this trial not initally
						harboring the E255K/V mutation developped it and became resistant
						to nilotinib while on treatment</significanceComment>
					<significanceReference>pmid:19652056</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies based on in vitro
						sensitivity suggest that CML harboring this mutation may respond
						better to dasatinib and nilotinib than to imatinib
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:20194843
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>prospective</type>
					<significanceComment>A phase II study of nilotinib in patients with
						resistance or intolerance to frontline imatinib in CML showed that
						5/7 patients with the E255K/V mutation had a complete hematologic
						response, 3/7 had a major cytogenetic reponse and 1/7 had a major
						molecular response. However 6/7 patients eventually progressed on
						nilotinib therapy. Four patients on this trial not initally
						harboring the E255K/V mutation developped it and became resistant
						to nilotinib while on treatment</significanceComment>
					<significanceReference>pmid:19652056</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib, Dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:14745431, pmid:20607847, pmid:15510211,
						pmid:17189410</actionReference>
					<actionComment>This mutation may confer resistance to imatinib
						therapy in Chronic Myeloid Leukemia (CML) and Philadelphia
						Positive Acute Lymphoblastic Leukemia</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133747520" stop="133747520"
			mutation="D276G" refAllele="A" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-07-25 12:24:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>Myelogenous Leukemia harboring this mutation
						may respond better to dasatinib and nilotinib than to imatinib
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:20194843
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation might confer resistance to
						imatinib therapy in Chronic Myelogenous Leukemia.
					</significanceComment>
					<significanceReference>pmid:14745431, pmid:20607847, pmid:15510211
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib, dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:14745431, pmid:20607847, pmid:15510211
					</actionReference>
					<actionComment>This mutation is neither activating nor inactivating
						but may cause resistance to imatinib therapy.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748270" stop="133748270"
			mutation="F311L" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:09:23.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>There is limitted preclinical data to indicate
						that Chronic Myelogenous Leukemia harboring the F311L mutation of
						ABL1 might be more sensitive to dasatinib and nilotinib than to
						imatinib</significanceComment>
					<significanceReference>pmid:15930265</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Nilotinib, dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17189410, pmid:15930265</actionReference>
					<actionComment>There is limited data to indicate that this mutation
						may confer resistance to imatinib therapy in Chronic Myeloid
						Leukemia (CML) and Philadelphia Positive Acute Lymphoblastic
						Leukemia</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133748283" stop="133748283"
			mutation="T315I" refAllele="C" varAllele="T">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 16:49:28.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>In vitro sensitivity data suggests that
						Chronic Myeloid Leukemia clones harboring this mutation are highly
						resistant to imatinib, bosutinib, nilotinib and imatinib.
					</significanceComment>
					<significanceReference>pmid:19075254, pmid:15930265
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>In a pooled analysis of phase II/III trials of
						patients intolerant or resistant to first line imatinib
						subsequently treated with dasatinib, 21 patients patients had the
						T315I ABL mutation. Only 6/21 patients experienced a Complete
						Hematologic Response (CHR)and 0 patient experienced a Complete
						Cytogenetic Response (CCR). Moreover 25/1043 patients overall had
						identification of a new T315I mutation at moment of progression on
						dasatinib therapy.
						In a phase II study of nilotinib in patients intolerant or resistant
						to imatinib therapy, 0/5 patients with a T315I mutation had a
						sustained hematologic response to nilotinib.
					</significanceComment>
					<significanceReference>pmid:19652056, pmid:19779040
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib, nilotinib, dasatinib, bosutinib</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>DCC-2036 (Large spectrum ABL inhibitor), ponatinib (Large
						spectrum ABL inhibitor), omacetaxine mepesuccinate (apoptosis
						inducer and angiogenesis inhibitor),  </agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:19075254, pmid:17189410</actionReference>
					<actionComment>This mutation is documented in Chronic Myeloid
						Leukemia and Philadelphia positive Acute Lymphoblastic Leukemia.
						It confers resistance to imatinib and probably other ABL kinase
						inhibitors (bosutinib, dasatinib, nilotinib)</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="19" gene="AKT2" start="40742220" stop="40742220"
			mutation="S302G" refAllele="T" varAllele="C">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-06-08 22:14:20.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18392055, pmid:19491896</actionReference>
					<actionComment>No known activating mutations of AKT2 exist
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="19" gene="AKT2" start="40741860" stop="40741860"
			mutation="R371H" refAllele="C" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-06-08 22:14:32.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18392055, pmid:19491896</actionReference>
					<actionComment>No known activating mutations of AKT2 exist
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481418" stop="140481418"
			mutation="G464R" refAllele="C" varAllele="G">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:27:03.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15046639</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453150" stop="140453150"
			mutation="F595L" refAllele="A" varAllele="C">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:02:32.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Although BRAF and KRAS mutations are usually
						mutually exclusive, the F595L mutations has been found to co-exist
						with KRAS mutations</significanceComment>
					<significanceReference>pmid:12068308</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12781369</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453149" stop="140453149"
			mutation="G596R" refAllele="C" varAllele="G">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 10:50:48.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>MEK and CRAF inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>inactivating</action>
					<actionReference>pmid:15035987</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453145" stop="140453145"
			mutation="L597Q" refAllele="A" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:18:03.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17525723</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453145" stop="140453145"
			mutation="L597R" refAllele="A" varAllele="C">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:23:31.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19624854</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453145" stop="140453146"
			mutation="L597S" refAllele="AG" varAllele="GA">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:36:46.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15195137</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453146" stop="140453146"
			mutation="L597V" refAllele="G" varAllele="C">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:42:00.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19010912, pmid:17525723</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453139" stop="140453139"
			mutation="T599I" refAllele="G" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:43:14.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitiors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19624854</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453136" stop="140453136"
			mutation="V600E" refAllele="A" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-05-05 14:30:31.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Molecular characterization of 41 breast cancer
						cell lines demonstrated that BRAF mutations occur in basal-like
						breast subtype</significanceComment>
					<significanceReference>pmid:19593635</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>NS malignant melanoma</tumourType>
					<type>prospective</type>
					<significanceComment>A phase I trial of BRAF inhibitor PLX4032 in
						BRAF V600E metastatic melanoma demonstrated improved response
						rates and progression free survival compared to historical data.
						Results from a phase III study are not yet published.
					</significanceComment>
					<significanceReference>pmid:20818844</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies have demonstrated that
						BRAF V600E mutant metastatic colorectal cancer is associated with
						inferior progression free and overall survival compared to BRAF
						wildtype, when treated with cetuximab and chemotherapy. There is
						debate as to whether BRAF V600E mutations are also associated with
						poorer response rates to EGFR targeted therapy.
					</significanceComment>
					<significanceReference>pmid:19571295, pmid:20619739
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies have demonstrated that
						BRAF V600E mutant papillary thyroid cancer is associated with
						poorer outcomes. </significanceComment>
					<significanceReference>pmid:18682506</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>PLX4032</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18631381, pmid:12198537</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453136" stop="140453137"
			mutation="V600K" refAllele="AC" varAllele="TT">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 09:18:28.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>NS malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>V600K mutations are the second most common
						mutation of BRAF. There has been one report of a V600K mutation
						responding to BRAF inhbitor, PLX4032. The pivotal phase I study of
						PLX4032 did not include V600K mutations.  </significanceComment>
					<significanceReference>pmid:20630094, pmid:20818844
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12447372, pmid:15948115</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453137" stop="140453137"
			mutation="V600L" refAllele="C" varAllele="G">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:03:10.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19404918, pmid:15948115</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453136" stop="140453137"
			mutation="V600R" refAllele="AC" varAllele="CT">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:03:16.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17699719</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453132" stop="140453132"
			mutation="K601N" refAllele="T" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 11:43:51.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical study demonstrated cell lines
						habouring a K601N mutation was highly sensitive to MEK inhibition
						with AS703026
					</significanceComment>
					<significanceReference>pmid:20331454</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20331454</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140453134" stop="140453134"
			mutation="K601E" refAllele="T" varAllele="C">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-19 11:23:00.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation, although rare, has been
						identified in MSS colorectal cancer, but not MSI.
					</significanceComment>
					<significanceReference>pmid:14668801</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Retrospective studies have demosntrated that
						the K601E mutation is associated with the follicular variant of
						papillary thyroid cancer.</significanceComment>
					<significanceReference>pmid:16021577, pmid:15902486
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical study of PLX4032 demonstrated
						moderate inhibition of proliferation in cell lines expressing
						K601E mutations</significanceComment>
					<significanceReference>pmid:20551065</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15035987</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481417" stop="140481417"
			mutation="G464E" refAllele="C" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 15:09:40.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15150094</actionReference>
					<actionComment>G464E mutations have no impact on BRAF kinase
						activity and did not increase MEK/ERK signaling.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481417" stop="140481417"
			mutation="G464V" refAllele="C" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:12:57.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapy</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12068308</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481412" stop="140481412"
			mutation="G466R" refAllele="C" varAllele="G">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:03:48.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A preclinical study demonstrated that cells
						habouring G466R mutations had decreased BRAF activity, but
						displayed increased ERK phosphorylation. This study confirmed that
						the presence of a BRAF mutation was associated with poorer
						survival in the metastatic setting</significanceComment>
					<significanceReference>pmid:15046639</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>inactivating</action>
					<actionReference>pmid:15046639</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481405" stop="140481405"
			mutation="F468C" refAllele="A" varAllele="C">
			<lastEditedBy>Stuart Watt</lastEditedBy>
			<lastUpdated>2011-11-02 11:05:05.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Although BRAF mutations are typically mutually
						exclusive with KRAS mutations, F468C mutations have been
						demonstrated to co-exist with KRAS mutations.
					</significanceComment>
					<significanceReference>pmid:15150094</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15150094</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481402" stop="140481402"
			mutation="G469A" refAllele="C" varAllele="G">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:02:26.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study of 697 patients
						identified 18 BRAF mutations of which 7 were G469A. This study
						demonstrated no difference in survival between BRAF mutants and
						wildtypes.</significanceComment>
					<significanceReference>pmid:21483012</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapy</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15035987</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481402" stop="140481402"
			mutation="G469E" refAllele="C" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 10:30:48.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>A study of melanoma cell lines has suggested
						that inactivating braf mutations such as G469E cause MEK/ERK
						activation through CRAF and that inhibiting CRAF by sorafenib can
						induce apoptosis in these cells.</significanceComment>
					<significanceReference>pmid:18794803</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>MEK and CRAF inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>inactivating</action>
					<actionReference>pmid:15035987, pmid:18794803</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481403" stop="140481403"
			mutation="G469R" refAllele="C" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:02:50.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16647948</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481401" stop="140481403"
			mutation="G469S" refAllele="TCC" varAllele="GCT">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:33:04.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12873990</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481402" stop="140481402"
			mutation="G469V" refAllele="C" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-04-19 14:59:39.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>A preclinical study of PLX4032 demonstrated
						that BRAF inhibition had little effect on MEK/ERK phosphorylation
						in cell lines habouring G469V mutations.</significanceComment>
					<significanceReference>pmid:20551065</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF and MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR targeted therapies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>BRAF and MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15948115</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55211080" stop="55211080"
			mutation="R108K" refAllele="G" varAllele="A">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 20:12:05.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>central nervous system glioma</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation is located in the extracellular
						domain and was suggested to increase tumourigenicity and increase
						sensitivity to small molecular EGFR KIs</significanceComment>
					<significanceReference>pmid:17177598</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17177598</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249005" stop="55249005"
			mutation="S768I" refAllele="G" varAllele="T">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 16:59:51.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Mutation shown to be refractory to sustained
						tyrosine phsophorylation.</significanceComment>
					<significanceReference>pmid:16205628</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Identified in a study correlating smoking
						history to mutation</significanceComment>
					<significanceReference>pmid:20150372</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>oesophagus carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Identified in cell line in analysis of
						biomarkers of gefitinib response</significanceComment>
					<significanceReference>pmid:20443891</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16205628</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249011" stop="55249011"
			mutation="V769_D770insASV" refAllele="A" varAllele="CCAGCGTGG">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 21:57:42.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Identified as potential predictor of response
						to erlotinib</significanceComment>
					<significanceReference>pmid:16043828</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>erlotinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16043828</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249010" stop="55249010"
			mutation="V769_D770insCV" refAllele="-" varAllele="TGCGTG">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 22:10:46.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutation correlates to never smoking status
					</significanceComment>
					<significanceReference>pmid:15741570</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15741570</actionReference>
					<actionComment>Unknown. This occurs within the tyrosine kinase
						domain</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249010" stop="55249015"
			mutation="D770_N771&gt;AGG" refAllele="GACAAC" varAllele="GCNGGNGGN">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 14:26:37.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies confirm that
						representative examples of Exon 20 mutations are transforming, and
						confer relative resistance to first generation EGFR TKIs (ie.
						erlotinib, gefitinib). Tumors with these mutations may be
						sensitive to irreversible EGFR TKIs (ie BIBW2992).
					</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to EGFR tyrosine kinase inhibitors (eg. gefitinib, erlotinib.).
						Specific insertions are rare and the available studies typically
						consider these mutatations as a group.</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Irreversible EGFR TKIs ie BIBW2992 and others</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249012" stop="55249012"
			mutation="D770_N771insG" refAllele="C" varAllele="G">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 14:36:32.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to first generation EGFR tyrosine kinase inhibitors (eg.
						gefitinib, erlotinib.). Specific insertions are rare and the
						available studies typically consider these mutations as a group.
					</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies confirm that
						representative examples of Exon 20 mutations are transforming, and
						confer relative resistance to first generation EGFR TKIs (ie.
						erlotinib, gefitinib). Tumors with these mutations may be
						sensitive to irreversible EGFR TKIs (ie BIBW2992).
					</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Irreversible EGFR TKIs ie BIBW2992 and others</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249017" stop="55249017"
			mutation="N771_P772&gt;SVDNR" refAllele="C" varAllele="GCGT">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 19:46:04.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Implicated in the colonization of brain
						metastases</significanceComment>
					<significanceReference>pmid:20604919</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutation linked to risk of nonsmoking related
						adenocarcinoma</significanceComment>
					<significanceReference>pmid:16052218</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16052218</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249017" stop="55249017"
			mutation="P772_H773insV" refAllele="C" varAllele="GGT">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-06-16 10:21:39.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation occurs in exon 20 and has been
						shown to predict lack of response to EGFR TKI.
					</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249019" stop="55249019"
			mutation="H773&gt;NPY" refAllele="C" varAllele="AACCCCT">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:36:30.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>There is no specific information for this rare
						mutant, however Preclinical studies confirm that representative
						examples of Exon 20 mutations are transforming, and confer
						relative resistance to first generation EGFR TKIs (ie. erlotinib,
						gefitinib). Tumors with these mutations may be sensitive to
						irreversible EGFR TKIs (ie BIBW2992).</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>There is no specific information for this rare
						mutant, however Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to EGFR tyrosine kinase inhibitors (eg. gefitinib, erlotinib.).
						Specific insertions are rare and the available studies typically
						consider these mutations as a group.</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Second/third generation, irreversible EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249022" stop="55249022"
			mutation="H773_V774insH" refAllele="-" varAllele="CAC">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:36:12.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to EGFR tyrosine kinase inhibitors (eg. gefitinib, erlotinib.).
						Specific insertions are rare and the available studies typically
						consider these mutations as a group.</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies confirm that
						representative examples of Exon 20 mutations are transforming, and
						confer relative resistance to first generation EGFR TKIs (ie.
						erlotinib, gefitinib). Tumors with these mutations may be
						sensitive to irreversible EGFR TKIs (ie BIBW2992).
					</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Second/third generation, irreversible EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249022" stop="55249022"
			mutation="H773_V774insNPH" refAllele="-" varAllele="ACCCCCAC">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:29:43.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies confirm that
						representative examples of Exon 20 mutations are transforming, and
						confer relative resistance to first generation EGFR TKIs (ie.
						erlotinib, gefitinib). Tumors with these mutations may be
						sensitive to irreversible EGFR TKIs (ie BIBW2992).
					</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to EGFR tyrosine kinase inhibitors (eg. gefitinib, erlotinib.).
						Specific insertions are rare and the available studies typically
						consider these mutations as a group.</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Second/third generation, irreversible EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249022" stop="55249022"
			mutation="H773_V774insPH" refAllele="-" varAllele="CCCCAC">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:27:35.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies confirm that
						representative examples of Exon 20 mutations are transforming, and
						confer relative resistance to first generation EGFR TKIs (ie.
						erlotinib, gefitinib). Tumors with these mutations may be
						sensitive to irreversible EGFR TKIs (ie BIBW2992).
					</significanceComment>
					<significanceReference>pmid:16187797, pmid:18408761
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Exon 20 Insertion mutations, of which this
						mutation is an example, have been associated with poor responses
						to EGFR tyrosine kinase inhibitors (eg. gefitinib, erlotinib.).
						Specific insertions are rare and the available studies typically
						consider these mutatations as a group.</significanceComment>
					<significanceReference>pmid:18676761</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>second generation/irreversible EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Second/third generation, irreversible EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16187797</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249024" stop="55249024"
			mutation="V774_C775insHV" refAllele="-" varAllele="CCACGT">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 22:13:51.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation was shown to not be
						independently predictive of outcome in patients who underwent
						surgical resection</significanceComment>
					<significanceReference>pmid:19096302</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15741570</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55221743" stop="55221743"
			mutation="T263P" refAllele="A" varAllele="C">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 20:26:16.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>central nervous system glioma</tumourType>
					<type>preclinical</type>
					<significanceComment>In GBM cell lines, extracellular missense
						mutations were shown as a mechanism of oncogenic EGFR activation
					</significanceComment>
					<significanceReference>pmid:7177598</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:7177598</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249071" stop="55249071"
			mutation="T790M" refAllele="C" varAllele="T">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 17:34:42.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>In prospective rebiopsy trial in patients with
						acquired EGFR TKI resistance, Among patients with acquired
						resistance to EGFR TKIs, presence of T790M confered a relatively
						favorable prognosis and more indolent progression
					</significanceComment>
					<significanceReference>pmid:21135146, pmid:20887192
					</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MET inhibitor + panHER inhibition in efforts to overcome
						coexisting mechanisms of resistance</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18981003, pmid:20887192</actionReference>
					<actionComment>Confers acquired resistance to EGFR TKI
					</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-10-27 12:07:58.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55259515" stop="55259515"
			mutation="L858R" refAllele="T" varAllele="G">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 14:50:21.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>peritoneum mesothelioma</tumourType>
					<type>retrospective</type>
					<significanceComment>Suggested as a predictor of resectability.
					</significanceComment>
					<significanceReference>pmid:18998063</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>This mutation is predictive of response to
						EGFR TKI and prognosis.</significanceComment>
					<significanceReference>pmid:16785471</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Present in thyroid papillary carcinoma with no
						comment of predictive or prognostic validity.
					</significanceComment>
					<significanceReference>pmid:19253367</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15329413</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-10-28 18:59:42.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-10-28 18:58:06.0</date>
					<userName>dancey</userName>
					<name>dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovQ3JlYXRvciAoQXBhY2hlIEZPUCBWZXJzaW9uIDEuMCkKL1Byb2R1Y2VyIChBcGFjaGUgRk9QIFZlcnNpb24gMS4wKQovQ3JlYXRpb25EYXRlIChEOjIwMTExMDI4MTg1ODA3LTA0JzAwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwKICAvTiAzCiAgL0xlbmd0aCAxMSAwIFIKICAvRmlsdGVyIC9GbGF0ZURlY29kZQo+PgpzdHJlYW0KeJydlndUU9kWh8+9N71QkhCKlNBraFICSA29SJEuKjEJEErAkAAiNkRUcERRkaYIMijggKNDkbEiioUBUbHrBBlE1HFwFBuWSWStGd+8ee/Nm98f935rn73P3Wfvfda6AJD8gwXCTFgJgAyhWBTh58WIjYtnYAcBDPAAA2wA4HCzs0IW+EYCmQJ82IxsmRP4F726DiD5+yrTP4zBAP+flLlZIjEAUJiM5/L42VwZF8k4PVecJbdPyZi2NE3OMErOIlmCMlaTc/IsW3z2mWUPOfMyhDwZy3PO4mXw5Nwn4405Er6MkWAZF+cI+LkyviZjg3RJhkDGb+SxGXxONgAoktwu5nNTZGwtY5IoMoIt43kA4EjJX/DSL1jMzxPLD8XOzFouEiSniBkmXFOGjZMTi+HPz03ni8XMMA43jSPiMdiZGVkc4XIAZs/8WRR5bRmyIjvYODk4MG0tbb4o1H9d/JuS93aWXoR/7hlEH/jD9ld+mQ0AsKZltdn6h21pFQBd6wFQu/2HzWAvAIqyvnUOfXEeunxeUsTiLGcrq9zcXEsBn2spL+jv+p8Of0NffM9Svt3v5WF485M4knQxQ143bmZ6pkTEyM7icPkM5p+H+B8H/nUeFhH8JL6IL5RFRMumTCBMlrVbyBOIBZlChkD4n5r4D8P+pNm5lona+BHQllgCpSEaQH4eACgqESAJe2Qr0O99C8ZHA/nNi9GZmJ37z4L+fVe4TP7IFiR/jmNHRDK4ElHO7Jr8WgI0IABFQAPqQBvoAxPABLbAEbgAD+ADAkEoiARxYDHgghSQAUQgFxSAtaAYlIKtYCeoBnWgETSDNnAYdIFj4DQ4By6By2AE3AFSMA6egCnwCsxAEISFyBAVUod0IEPIHLKFWJAb5AMFQxFQHJQIJUNCSAIVQOugUqgcqobqoWboW+godBq6AA1Dt6BRaBL6FXoHIzAJpsFasBFsBbNgTzgIjoQXwcnwMjgfLoK3wJVwA3wQ7oRPw5fgEVgKP4GnEYAQETqiizARFsJGQpF4JAkRIauQEqQCaUDakB6kH7mKSJGnyFsUBkVFMVBMlAvKHxWF4qKWoVahNqOqUQdQnag+1FXUKGoK9RFNRmuizdHO6AB0LDoZnYsuRlegm9Ad6LPoEfQ4+hUGg6FjjDGOGH9MHCYVswKzGbMb0445hRnGjGGmsVisOtYc64oNxXKwYmwxtgp7EHsSewU7jn2DI+J0cLY4X1w8TogrxFXgWnAncFdwE7gZvBLeEO+MD8Xz8MvxZfhGfA9+CD+OnyEoE4wJroRIQiphLaGS0EY4S7hLeEEkEvWITsRwooC4hlhJPEQ8TxwlviVRSGYkNimBJCFtIe0nnSLdIr0gk8lGZA9yPFlM3kJuJp8h3ye/UaAqWCoEKPAUVivUKHQqXFF4pohXNFT0VFysmK9YoXhEcUjxqRJeyUiJrcRRWqVUo3RU6YbStDJV2UY5VDlDebNyi/IF5UcULMWI4kPhUYoo+yhnKGNUhKpPZVO51HXURupZ6jgNQzOmBdBSaaW0b2iDtCkVioqdSrRKnkqNynEVKR2hG9ED6On0Mvph+nX6O1UtVU9Vvuom1TbVK6qv1eaoeajx1UrU2tVG1N6pM9R91NPUt6l3qd/TQGmYaYRr5Grs0Tir8XQObY7LHO6ckjmH59zWhDXNNCM0V2ju0xzQnNbS1vLTytKq0jqj9VSbru2hnaq9Q/uE9qQOVcdNR6CzQ+ekzmOGCsOTkc6oZPQxpnQ1df11Jbr1uoO6M3rGelF6hXrtevf0Cfos/ST9Hfq9+lMGOgYhBgUGrQa3DfGGLMMUw12G/YavjYyNYow2GHUZPTJWMw4wzjduNb5rQjZxN1lm0mByzRRjyjJNM91tetkMNrM3SzGrMRsyh80dzAXmu82HLdAWThZCiwaLG0wS05OZw2xljlrSLYMtCy27LJ9ZGVjFW22z6rf6aG1vnW7daH3HhmITaFNo02Pzq62ZLde2xvbaXPJc37mr53bPfW5nbse322N3055qH2K/wb7X/oODo4PIoc1h0tHAMdGx1vEGi8YKY21mnXdCO3k5rXY65vTW2cFZ7HzY+RcXpkuaS4vLo3nG8/jzGueNueq5clzrXaVuDLdEt71uUnddd457g/sDD30PnkeTx4SnqWeq50HPZ17WXiKvDq/XbGf2SvYpb8Tbz7vEe9CH4hPlU+1z31fPN9m31XfKz95vhd8pf7R/kP82/xsBWgHcgOaAqUDHwJWBfUGkoAVB1UEPgs2CRcE9IXBIYMj2kLvzDecL53eFgtCA0O2h98KMw5aFfR+OCQ8Lrwl/GGETURDRv4C6YMmClgWvIr0iyyLvRJlESaJ6oxWjE6Kbo1/HeMeUx0hjrWJXxl6K04gTxHXHY+Oj45vipxf6LNy5cDzBPqE44foi40V5iy4s1licvvj4EsUlnCVHEtGJMYktie85oZwGzvTSgKW1S6e4bO4u7hOeB28Hb5Lvyi/nTyS5JpUnPUp2Td6ePJninlKR8lTAFlQLnqf6p9alvk4LTduf9ik9Jr09A5eRmHFUSBGmCfsytTPzMoezzLOKs6TLnJftXDYlChI1ZUPZi7K7xTTZz9SAxESyXjKa45ZTk/MmNzr3SJ5ynjBvYLnZ8k3LJ/J9879egVrBXdFboFuwtmB0pefK+lXQqqWrelfrry5aPb7Gb82BtYS1aWt/KLQuLC98uS5mXU+RVtGaorH1futbixWKRcU3NrhsqNuI2ijYOLhp7qaqTR9LeCUXS61LK0rfb+ZuvviVzVeVX33akrRlsMyhbM9WzFbh1uvb3LcdKFcuzy8f2x6yvXMHY0fJjpc7l+y8UGFXUbeLsEuyS1oZXNldZVC1tep9dUr1SI1XTXutZu2m2te7ebuv7PHY01anVVda926vYO/Ner/6zgajhop9mH05+x42Rjf2f836urlJo6m06cN+4X7pgYgDfc2Ozc0tmi1lrXCrpHXyYMLBy994f9Pdxmyrb6e3lx4ChySHHn+b+O31w0GHe4+wjrR9Z/hdbQe1o6QT6lzeOdWV0iXtjusePhp4tLfHpafje8vv9x/TPVZzXOV42QnCiaITn07mn5w+lXXq6enk02O9S3rvnIk9c60vvG/wbNDZ8+d8z53p9+w/ed71/LELzheOXmRd7LrkcKlzwH6g4wf7HzoGHQY7hxyHui87Xe4Znjd84or7ldNXva+euxZw7dLI/JHh61HXb95IuCG9ybv56Fb6ree3c27P3FlzF3235J7SvYr7mvcbfjT9sV3qID0+6j068GDBgztj3LEnP2X/9H686CH5YcWEzkTzI9tHxyZ9Jy8/Xvh4/EnWk5mnxT8r/1z7zOTZd794/DIwFTs1/lz0/NOvm1+ov9j/0u5l73TY9P1XGa9mXpe8UX9z4C3rbf+7mHcTM7nvse8rP5h+6PkY9PHup4xPn34D94Tz+wplbmRzdHJlYW0KZW5kb2JqCjYgMCBvYmoKWy9JQ0NCYXNlZCA1IDAgUl0KZW5kb2JqCjcgMCBvYmoKPDwKICAvVHlwZSAvTWV0YWRhdGEKICAvU3VidHlwZSAvWE1MCiAgL0xlbmd0aCAxMiAwIFIKPj4Kc3RyZWFtCjw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+Cgo8eDp4bXBtZXRhIHhtbG5zOng9ImFkb2JlOm5zOm1ldGEvIj4KPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4KPHJkZjpEZXNjcmlwdGlvbiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iIHJkZjphYm91dD0iIj4KPGRjOmRhdGU+MjAxMS0xMC0yOFQxODo1ODowNy0wNDowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAxLjA8L3BkZjpQcm9kdWNlcj4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiByZGY6YWJvdXQ9IiI+Cjx4bXA6Q3JlYXRlRGF0ZT4yMDExLTEwLTI4VDE4OjU4OjA3LTA0OjAwPC94bXA6Q3JlYXRlRGF0ZT4KPHhtcDpDcmVhdG9yVG9vbD5BcGFjaGUgRk9QIFZlcnNpb24gMS4wPC94bXA6Q3JlYXRvclRvb2w+Cjx4bXA6TWV0YWRhdGFEYXRlPjIwMTEtMTAtMjhUMTg6NTg6MDctMDQ6MDA8L3htcDpNZXRhZGF0YURhdGU+CjwvcmRmOkRlc2NyaXB0aW9uPgo8L3JkZjpSREY+CjwveDp4bXBtZXRhPgo8P3hwYWNrZXQgZW5kPSJyIj8+CgoKZW5kc3RyZWFtCmVuZG9iagoxMCAwIG9iago8PCAvTGVuZ3RoIDEzIDAgUiAvRmlsdGVyIC9GbGF0ZURlY29kZSA+PgpzdHJlYW0KeJztVstu2zAQvOsr9pgANbukSEnMsU3iomjQ2DHQQ5CDY8upAUtqVBVF/r6k9SAl08+6DxiBIYhcLmeWHHLkZ48Cql9Pv0LJYJJ4z1WMQsjUS0UQnrx3I+/tNQWKMJqZSZQLEkVcSi4ocE6EEIjoUxglcH9286MYF/MshWH8LcsLmGU5fIpENIR5Clf96+H5A4w+elcjb6BYBxazYIzU7IN2RSHbUhOCzzqF3I6fYjiHHg8Ig7OStclnARGSSilRrM5knWSVQAVTCdxfTTYU2WwtnQrKMECkId9OJ1SCL1RtG9m6C1Kp3I9UpnBQmGn9OI3zcRFPrbpT02aRaX+eFNljnL+xRpFS0xsXpo3BhYguMDCR25uW0C0xW1r6QFlHS4qEBXoHQlnWX52lD/PvRZa/NMAGFolQW0CioDzMPd3XT1ICLkBKHWka6tFNNXOxnL+Ar/DFS1VVfe/+QYWmKvjT69EKxZp1t1xPE6jGqE+QVZhq95mBdwKvm26BlyG1ALTGsYVeNd2lo4Xh4GiN61tdjVb71exgvT+4Ax12y9VUlciSBB2VJWFUX8GoEvlSHUvnmaG4QV5s6bq3wNjW4YQlPkhQs8cHSfo+S2fzPFFu8/jilJbtIi0TWL65kUi199B2iWBJa5ASg67e9SLLcavX7FXN62SsYDUoX5XDjq3V3ObaLrqL5n9QPUnitHAKrkH9gPjRityv93YXa16u8+iq0h1U1R//HsWe+otAo/Jrv8GtXzX+l968i57TcTqJN7myW8LfMGHeVXHFhkvUoxmxRXtaVtx1VB4ReQqXre6Iyu6a5oGXkO5ps+LYNisOt9kQKN1qs6cpPDo6J+e/l9v816ntX7Pf2gKPZr+Cgdt+bcJdpN/Tl62vyR93Zf37BT6w7rgKZW5kc3RyZWFtCmVuZG9iago4IDAgb2JqCjw8CiAgL1Jlc291cmNlcyAzIDAgUgogIC9UeXBlIC9QYWdlCiAgL01lZGlhQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvQ3JvcEJveCBbMCAwIDU5NC43MiA3OTJdCiAgL0JsZWVkQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvVHJpbUJveCBbMCAwIDU5NC43MiA3OTJdCiAgL1BhcmVudCAxIDAgUgogIC9Db250ZW50cyAxMCAwIFIKPj4KCmVuZG9iagoxMSAwIG9iagoyNTk2CmVuZG9iagoxMiAwIG9iago3OTMKZW5kb2JqCjEzIDAgb2JqCjY3NwplbmRvYmoKMTUgMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNTMyOTQxMykKL1MgL1VSSSA+PgplbmRvYmoKMTYgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgNDA5LjE1NSA1OTUuMDAxIDQ3NS4zMiA2MDMuODggXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMTUgMCBSCi9IIC9JCgo+PgplbmRvYmoKMTggMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMTY3MDQ1NSkKL1MgL1VSSSA+PgplbmRvYmoKMTkgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMTU0LjY3NCA0MzkuNjQxIDIyMC44MzkgNDQ4LjUyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDE4IDAgUgovSCAvSQoKPj4KZW5kb2JqCjIwIDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjA1NzM5MjYpCi9TIC9VUkkgPj4KZW5kb2JqCjIxIDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDIyOC44NDMgNDM5LjY0MSAyOTUuMDA4IDQ0OC41MiBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSAyMCAwIFIKL0ggL0kKCj4+CmVuZG9iagoyMiAwIG9iago8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIxOTY5NTAwKQovUyAvVVJJID4+CmVuZG9iagoyMyAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAzMDMuMDEyIDQzOS42NDEgMzY5LjE3NyA0NDguNTIgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMjIgMCBSCi9IIC9JCgo+PgplbmRvYmoKMjQgMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMDk0Mjk2MikKL1MgL1VSSSA+PgplbmRvYmoKMjUgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMTU0LjY3NCAzNDMuNjQxIDIyMC44MzkgMzUyLjUyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDI0IDAgUgovSCAvSQoKPj4KZW5kb2JqCjI2IDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg5OTgwNjMpCi9TIC9VUkkgPj4KZW5kb2JqCjI3IDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDIyOC44NDMgMzQzLjY0MSAyOTUuMDA4IDM1Mi41MiBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSAyNiAwIFIKL0ggL0kKCj4+CmVuZG9iagoyOCAwIG9iago8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5MjUzMzY3KQovUyAvVVJJID4+CmVuZG9iagoyOSAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNTQuNjc0IDI0Ny42NDEgMjIwLjgzOSAyNTYuNTIgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMjggMCBSCi9IIC9JCgo+PgplbmRvYmoKMzAgMCBvYmoKPDwgL0xlbmd0aCAzMSAwIFIgL0ZpbHRlciAvRmxhdGVEZWNvZGUgPj4Kc3RyZWFtCnicxVpLc9s4Er77V+CyVU6VxeBNwrdsxkl5d6fGsbUzh/EcaAqSWCORCkk543+/DZISHwAoK07Nlg8W20D3xw/9hPz1giAMPzPzK1QUJduLr62MoJDCL5BgtLr45/zi/SeCCEbzZbeJcBFEEVeKC4I4D4QQGGNG0HyLfr/8eV/FVZpn6F7v8qJCy7xA/4lEdI/SDN18/nT/7g80/9fFzfziC1j90rMsKA0O1r8MEYX0BCaMGB0BuYtXGr1DMy4Dii4bq8f1VAZCEaUUFvZOMloMC4igsIAze3FnIl96zYFQhRJjEnJbAx0tFrCACcA2aW38QrCUM6mU5HJq22ed6SKu9KKHO+s+06j7/EtS5U+6uOr9FRPSPcVV9xnLaxFdY9lJ7n4eHPTgMAdnyRCho7MkOKDSMBCqBv+nQn/d6yx5QUBy403bg5+1bmV+V2uNqnyHqv023xeoetnp8oiiw4AR5QGTYz+jvJO3yFQgB9Ai8ARmzlEoFAWUGA+KWozz2qjzpekrVBMBzq/gzLCt+vj6Tu0Mn9YugFERgcYotLQ/xNvdpkfUlwFVzAT7UTOxNGNLH0GBmwX+Hco2+2yFkrhI0izfxl52vwMlCRjH2Mvo+RofLxlm7D2VIYRg2ZD6+M5DKw8DfpZ26mf1bF07XaRVnun9Fm11mUPYbNIpds8HG2COIy+3Z+t7vCTvuTpJqoiCppy9WjHzs3q+smr9UuTp4hXuer5uEqhIEC+j5yt8vIzec8w8nMKWMAp4ZGoI2iKo9JCd4KEv3oAYH8WqE+PB0xr9dpFd/P4HiBeA9htk/s+tfuXWrw5bH2osTuODPRE+ickjtsGBZ36uTVK3SWqbtGB2f9zWVQP7uDkP1axe5SRNjUmbWSj6B4fPPi8ciAEVtWBMgr+ew2tiUzehv6i9r67YTSH/uI6LOKkgJZVVmrRlyO3DhLIAdIAecPmm6ELFX+6zxHQC8QYleVY2pVKbTqFap2WvUSjRQbldIEFpgEPon0QkHHY+gIVnUJOt/PgoND48DDF2KUDX0BAvdVFDe4Tu6Panx3fXLaAmjotVr+VkIfSc0GNHYeTQttumi2siGFWcsGPgHjepeksUYeigkJQBkcJ4CfQAPEIFMNY4CIEaVzfB0dCbevKBi0Lr08nx8NEX5WYRd9o4yh0B5EcWnkbmk5+OdcssdZh1gA27XbPRavwmbK02N4HhmMCZC4vwYnnVCZowH9DSSkaETHbzUJxgZoTRBLe15+MmzdIE4jXOFuiu0Mnh+aHaL1Jd+sMUtJmkI0gTqG1pRMMuEbW93T+mcgnMMoEwXErKGj23WZMwetPDVT1SHOGV6SpLl/DRmV8O1qidGWCkYwzokow7DK/jEj1pnSH9V7xNM5jNnl7Q3f0vD3c3H+e3v96MRj3ATiAhGP4FbRPCEWJVpPGmvJ58c8ahFwAAQtJDFu2/R54k+6JE31J4PYMJRJRcoW/rNFkjyF/5QpdoF8NsX1Og0Z9pFpcaLYD6NAvQfJx1d4VepCaBavtNOIw9DN6Ey5YM0FnocmcSee0euyLf5NlK159W8KfSaF0WWqNyXzxDVoaXzpsRsIL+qwQCD4jSbJ0+QacLb7PSyxTSd/pklNowRAjzEZwMJ7KBoYtNXq8PEPhFvFik5m2uRkee5EWhNzBON3ShZfwMrhM/bXSNNgM0ZWBbg0LKjAeoQzk8pzTADAoTBhRd6VBUFwZKZIi5EMfCcNgCzgeVnnJ/XejdsFgDKo+CiMGEygV1WEZXXsREyCDiDGPKXDsbzFiETFF5xNxtegtoakonDiFSJDkPNGUEii54JuOunS3RSirRGyK7TW8CraCOm0aCKOECffOcLoyzXKPbD1Opkipo6xQ191bHuQx5Zj/UjGyTKZNRHMh6iBDkb02ZtmFnyry/mU8kTWau8SDVRJFg5ydNJtgoQzzsVytdmps0wBIfklxeoCaD6aSKn9JNWr3YCYCF/MckAFtRG0yKUyWpIwGwUPyQBGBbfm0C8GAm5nYKS+ZKAG8APUgADtC9WPr1p6lgYkqMgokFyJr4UTOnT4YReND/J4xsw98RRpxG4zAypbZsOrfJGOJcjWLozgRKVjV3tw2Vu3iXbjZx8dIjta6tWQ7ldrs1y4GArqdAEHJtsYX5EUE/kC6cUcdD/GOizlbUeLCigjEZOqKOh+SHRJ1t2eXA9WW3+dYhgpwFrg/z4GB06MkHEwmPeCfHw0fffGd0hR4b4WGzNTL5kYnTyHzy0/OdZZY6zDrAim7XbLQavwnbrFnmJpCPCZy5sDAvlledoJnmBrS0khEhvtlOYBEILE3P04b0h+c43bSVzwTqbfYMVTJdxe0VzYcVRPDkLY+gYRAR811TeJxPYBZo9G5MVz/UGNcaJ5IgEUAlNVkQaomtHUp1DoPGqvlmzOTTepiY//t24q4HplDJaFNWbJVoHT+bgSjZm3wFaVUvTfJOXiZQMuj6zG0agTThUPnf7M8s/5YNI1xwcDdI6CEZOk9PPvBJwUknx8NHX4SbRdRp4yh3BI0fGT2NzCc/HeGWWeow6wBLu12z0Wr8JmytNjeBdEzgzIUFe7G86gRNPA9oaSUjQrwRLmmguFARO35fqLMSpuFnE+BmQr/XMOVWdWfyMc+gohZNH3H4T4DJWDeJZtASQKxDSYwL01KA9rhYmCySGMFqD6UOOiKYtqt1XMH8X3fg1kxuMEzlA4bNSBU2Rm0EZfd+fuiMN1fuTbRaOsyVxAQAyQJGCaznjr2DqwyrixFKQl0gKqSyXX/isgMdrzKGuUNigBXW/2YwcMuefODtkuBOjoePvtxhFhGXjU7uCEcvMkJOI/PJT+cOyyx1mLXBdn+t43WwGr8JW6vNTSAZEzhzYOkfJf6OEzSZYkBLIxkTYn7+B7lsWxAKZW5kc3RyZWFtCmVuZG9iagoxNyAwIG9iagpbCjE2IDAgUgoxOSAwIFIKMjEgMCBSCjIzIDAgUgoyNSAwIFIKMjcgMCBSCjI5IDAgUgpdCmVuZG9iagoxNCAwIG9iago8PAogIC9SZXNvdXJjZXMgMyAwIFIKICAvVHlwZSAvUGFnZQogIC9NZWRpYUJveCBbMCAwIDU5NC43MiA3OTJdCiAgL0Nyb3BCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9CbGVlZEJveCBbMCAwIDU5NC43MiA3OTJdCiAgL1RyaW1Cb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9QYXJlbnQgMSAwIFIKICAvQW5ub3RzIDE3IDAgUgogIC9Db250ZW50cyAzMCAwIFIKPj4KCmVuZG9iagozMSAwIG9iagoyMTgyCmVuZG9iagozMiAwIG9iago8PAogIC9UeXBlIC9Gb250CiAgL1N1YnR5cGUgL1R5cGUxCiAgL0Jhc2VGb250IC9IZWx2ZXRpY2EKICAvRW5jb2RpbmcgL1dpbkFuc2lFbmNvZGluZwo+PgoKZW5kb2JqCjMzIDAgb2JqCjw8CiAgL1R5cGUgL0ZvbnQKICAvU3VidHlwZSAvVHlwZTEKICAvQmFzZUZvbnQgL0hlbHZldGljYS1Cb2xkCiAgL0VuY29kaW5nIC9XaW5BbnNpRW5jb2RpbmcKPj4KCmVuZG9iagozNCAwIG9iago8PAogIC9UeXBlIC9Gb250CiAgL1N1YnR5cGUgL1R5cGUxCiAgL0Jhc2VGb250IC9IZWx2ZXRpY2EtT2JsaXF1ZQogIC9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nCj4+CgplbmRvYmoKMSAwIG9iago8PCAvVHlwZSAvUGFnZXMKL0NvdW50IDIKL0tpZHMgWzE0IDAgUiA4IDAgUiBdID4+CmVuZG9iagoyIDAgb2JqCjw8CiAgL1R5cGUgL0NhdGFsb2cKICAvUGFnZXMgMSAwIFIKICAvTWV0YWRhdGEgNyAwIFIKICAvTGFuZyAoZW4tVVMpCiAgL1BhZ2VMYWJlbHMgOSAwIFIKPj4KCmVuZG9iagozIDAgb2JqCjw8Ci9Gb250IDw8CiAgL0YxIDMyIDAgUgogIC9GMyAzMyAwIFIKICAvRjIgMzQgMCBSCj4+Ci9Qcm9jU2V0IFsgL1BERiAvSW1hZ2VCIC9JbWFnZUMgL1RleHQgXQovQ29sb3JTcGFjZSA8PAogIC9EZWZhdWx0UkdCIDYgMCBSCj4+Cj4+CmVuZG9iago5IDAgb2JqCjw8IC9OdW1zIFswIDw8IC9QICgxKSA+PgogMSA8PCAvUCAoMikgPj4KXSA+PgoKZW5kb2JqCnhyZWYKMCAzNQowMDAwMDAwMDAwIDY1NTM1IGYgCjAwMDAwMDkyMDQgMDAwMDAgbiAKMDAwMDAwOTI2OSAwMDAwMCBuIAowMDAwMDA5Mzc3IDAwMDAwIG4gCjAwMDAwMDAwMTUgMDAwMDAgbiAKMDAwMDAwMDE0NSAwMDAwMCBuIAowMDAwMDAyODI3IDAwMDAwIG4gCjAwMDAwMDI4NjAgMDAwMDAgbiAKMDAwMDAwNDQ5NiAwMDAwMCBuIAowMDAwMDA5NTI3IDAwMDAwIG4gCjAwMDAwMDM3NDMgMDAwMDAgbiAKMDAwMDAwNDcwMCAwMDAwMCBuIAowMDAwMDA0NzIxIDAwMDAwIG4gCjAwMDAwMDQ3NDEgMDAwMDAgbiAKMDAwMDAwODYyNyAwMDAwMCBuIAowMDAwMDA0NzYxIDAwMDAwIG4gCjAwMDAwMDQ4NDIgMDAwMDAgbiAKMDAwMDAwODU1OCAwMDAwMCBuIAowMDAwMDA0OTgwIDAwMDAwIG4gCjAwMDAwMDUwNjEgMDAwMDAgbiAKMDAwMDAwNTIwMCAwMDAwMCBuIAowMDAwMDA1MjgxIDAwMDAwIG4gCjAwMDAwMDU0MjAgMDAwMDAgbiAKMDAwMDAwNTUwMSAwMDAwMCBuIAowMDAwMDA1NjQwIDAwMDAwIG4gCjAwMDAwMDU3MjEgMDAwMDAgbiAKMDAwMDAwNTg2MCAwMDAwMCBuIAowMDAwMDA1OTQxIDAwMDAwIG4gCjAwMDAwMDYwODAgMDAwMDAgbiAKMDAwMDAwNjE2MSAwMDAwMCBuIAowMDAwMDA2MzAwIDAwMDAwIG4gCjAwMDAwMDg4NDkgMDAwMDAgbiAKMDAwMDAwODg3MCAwMDAwMCBuIAowMDAwMDA4OTc3IDAwMDAwIG4gCjAwMDAwMDkwODkgMDAwMDAgbiAKdHJhaWxlcgo8PAovU2l6ZSAzNQovUm9vdCAyIDAgUgovSW5mbyA0IDAgUgovSUQgWzw4RjQ1MTExNzgwMzIzNUM4MDAyNjY0MTI1QkE4MDJDQz4gPDhGNDUxMTE3ODAzMjM1QzgwMDI2NjQxMjVCQTgwMkNDPl0KPj4Kc3RhcnR4cmVmCjk1ODkKJSVFT0YK
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-10-27 11:58:06.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55259524" stop="55259524"
			mutation="L861Q" refAllele="T" varAllele="A">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 17:33:06.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>EGFR mutation status associated with
						resistance to EGFR TKI erlotinib or gefininib
					</significanceComment>
					<significanceReference>pmid:19671843, pmid:20887192
					</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19147750, pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55221822" stop="55221822"
			mutation="A289V" refAllele="C" varAllele="T">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 13:18:52.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>central nervous system glioma</tumourType>
					<type>preclinical</type>
					<significanceComment>A Preclinical study confirmed EGFR A289V as an
						activating mutation, increasing basal EGFR activity. Transfection
						of this mutant into fibroblasts resulted in transformation and
						tumorigenesis in a xenograft model. Sensitivity of the EGFR A289V
						mutant to the small molecule inhibitor erlotinib was demonstrated
						in an in vitro model system.</significanceComment>
					<significanceReference>pmid:17177598</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>central nervous system glioma</tumourType>
					<type>retrospective</type>
					<significanceComment>Small, retrospective studies (underpowered)
						have not demonstrated an association between EGFR A289V and either
						survival or response to EGFR tyrosine kinase inhibitors. Few if
						any individuals with EGFR A289V mutations were included
					</significanceComment>
					<significanceReference>pmid:19571295, pmid:20619739
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs based on preclinical data</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR inhibitors, EGFR monoclonal antibodies, downstream
						targets of activated EGFR</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17177598, pmid:19284481</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55233043" stop="55233043"
			mutation="G598V" refAllele="G" varAllele="T">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 10:43:51.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>central nervous system glioma</tumourType>
					<type>preclinical</type>
					<significanceComment>This EGFR activating extracellular domain
						mutant is transforming in preclinical studies, and mutants exhibit
						sensitivity to the EGFR TKI erlotinib in vitro.
					</significanceComment>
					<significanceReference>pmid:17177598</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs based on preclinical data</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs, inhibitors of downstream targets</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17177598</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241677" stop="55241679"
			mutation="E709H" refAllele="GAA" varAllele="CAT">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:54:20.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>Second/third generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18372921</actionReference>
					<actionComment>Tumors containing this mutation in the cosmic
						database also contain other activating EGFR mutations. No
						definitive information regarding the functional consequence of the
						E709H mutation could be identified. It is possible that it could
						confer reduced sensitivity to first generation EGFR TKIs, as the
						E709A mutation appears to do.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241677" stop="55241677"
			mutation="E709K" refAllele="G" varAllele="A">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:54:02.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>Second/third generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18372921</actionReference>
					<actionComment>Lung cancers containing this mutation in the cosmic
						database also contain other activating EGFR mutations. No
						definitive information regarding the functional consequence of the
						this mutation could be identified. It is possible that in lung
						cancer, it could confer reduced sensitivity to first generation
						EGFR TKIs, as the E709A mutation appears to do.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241678" stop="55241678"
			mutation="E709A" refAllele="A" varAllele="C">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 15:36:03.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation, when it occurs in combination
						with G719C appears to confer relative resistance/intermediate
						sensitivity to first generation EGFR TKIs. </significanceComment>
					<significanceReference>pmid:19671738</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>First generation EGFR TKIs eg erlotinib, gefitinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Irreversible EGFR TKIs, inhibitors of downstream pathways
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18372921</actionReference>
					<actionComment>This mutation typically occurs in combination with a
						second, activating EGFR mutation (G719C).</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241678" stop="55241678"
			mutation="E709G" refAllele="A" varAllele="G">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:53:19.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>Second/third generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18372921</actionReference>
					<actionComment>Tumors containing this mutation in the cosmic
						database also contain the L858R mutation. No definitive
						information regarding the functional consequence of the E709G
						mutation could be identified. It is possible that it could confer
						reduced sensitivity to first generation EGFR TKIs, as the E709A
						mutation appears to do.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241678" stop="55241678"
			mutation="E709V" refAllele="A" varAllele="T">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:53:31.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>Second/third generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18372921</actionReference>
					<actionComment>Tumors containing this mutation in the cosmic
						database also contain other activating EGFR mutations. No
						definitive information regarding the functional consequence of the
						this mutation could be identified. It is possible that it could
						confer reduced sensitivity to first generation EGFR TKIs, as the
						E709A mutation appears to do.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241707" stop="55241707"
			mutation="G719C" refAllele="G" varAllele="T">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:20:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>While less common than sensitizing exon 19 and
						exon 21 EGFR mutations, this activating substitution mutation in
						Exon 18 has been shown to confer sensitivity to the EGFR TKIs
						erlotinib/gefitinib in multiple studies.

						In addition, this mutation may be associated with response to the
						investigational pan-her inhibitor neratinib.
					</significanceComment>
					<significanceReference>pmid:20887192, pmid:15710947, pmid:20479403
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs (erlotinib, gefitinib)</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>neratinib (PMID 20479403)</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs, second/third generation TKIs, pan-her inhibitors
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241707" stop="55241707"
			mutation="G719S" refAllele="G" varAllele="A">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-27 11:19:09.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>While less common than sensitizing exon 19 and
						exon 21 EGFR mutations, this activating substitution mutation in
						Exon 18 has been shown to confer sensitivity to the EGFR TKIs
						erlotinib/gefitinib in multiple studies.

						In addition, this mutation may be associated with response to the
						investigational pan-her inhibitor neratinib.
					</significanceComment>
					<significanceReference>pmid:20887192, pmid:15710947, pmid:20479403
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs (erlotinib, gefitinib)</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>neratinib (PMID 20479403)</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs, second/third generation TKIs, pan-her inhibitors
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55241708" stop="55241708"
			mutation="G719A" refAllele="G" varAllele="C">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-27 11:18:34.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>While less common than sensitizing exon 19 and
						exon 21 EGFR mutations, this activating substitution mutation in
						Exon 18 has been shown to confer sensitivity to the EGFR TKIs
						erlotinib/gefitinib in multiple studies.

						In addition, this mutation may be associated with response to the
						investigational pan-her inhibitor neratinib.
					</significanceComment>
					<significanceReference>pmid:20887192, pmid:15710947, pmid:20479403
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs (erlotinib, gefitinib)</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>neratinib (PMID 20479403)</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs, second/third generation TKIs, pan-her inhibitors
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249001" stop="55249006"
			mutation="M766_A767insAI" refAllele="GCCAGC" varAllele="GCCATA">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 19:35:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Low number of CA repeats in intron 1 of
						epidermal growth factor receptor is associated with gefitinib
						responsiveness in non-small-cell lung cancer patients independent
						of epidermal growth factor receptor mutation</significanceComment>
					<significanceReference>pmid:17429313</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>erlotinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16043828</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242478" stop="55242478"
			mutation="A750P" refAllele="G" varAllele="C">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 13:19:01.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>In a retrospective study, 2 patients whose
						tumors harbored this mutation responded to treatment with EFGR
						tyrosine kinase inhibitors; however, in both cases an EGFR exon 19
						deletion (p.L747_E749del), known to confer sensitivity to EGFR
						inhibitors was also present.</significanceComment>
					<significanceReference>pmid:15118125</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>EGFR inhibitors and downstream targets</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15118125</actionReference>
					<actionComment>Mutation occurs in tyrosine kinase domain, but no
						data on functional consequence available.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242466" stop="55242480"
			mutation="E746_A750del" refAllele="GAATTAAGAGAAGCA" varAllele="-">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-26 13:24:07.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Multiple large studies have demonstrated that
						EGFR exon 19 deletions, including E746_A750del is predictive for
						response to EGFR tyrosine kinase inhibitors including erlotinib
						and gefitinib</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A marked response to the EGFR tyrosine kinase
						inhibitor gefitinib was observed in a patient with
						E746_A750del-mutated papillary thyroid cancer
					</significanceComment>
					<significanceReference>pmid:19253367</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242466" stop="55242483"
			mutation="E746_T751del" refAllele="GAATTAAGAGAAGCAACA" varAllele="-">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-26 16:17:51.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>E746_T751del is an Exon 19 deletion. Multiple
						large studies have demonstrated that EGFR exon 19 deletions are
						predictive for response to EGFR tyrosine kinase inhibitors
						including erlotinib and gefitinib.</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors (erlotinib, gefitinib)
					</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242469" stop="55242477"
			mutation="L747_E749del" refAllele="TTAAGAGAA" varAllele="-">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-28 01:02:34.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Multiple large studies have demonstrated that
						EGFR exon 19 deletions, such as E747_A749del, are predictive for
						response to EGFR tyrosine kinase inhibitors including erlotinib
						and gefitinib</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKIs</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-11-02 19:47:51.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242469" stop="55242486"
			mutation="L747_S752del" refAllele="TTAAGAGAAGCAACATCT" varAllele="-">
			<lastEditedBy>D Cescon</lastEditedBy>
			<lastUpdated>2011-04-28 01:05:04.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Multiple large studies have demonstrated that
						EGFR exon 19 deletions, such as L747_S752del, are predictive for
						response to EGFR tyrosine kinase inhibitors including erlotinib
						and gefitinib</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>First generation EGFR TKIs (erlotinib, gefitinib)</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242469" stop="55242480"
			mutation="L747_T751del" refAllele="TTAAGAGAAGCA" varAllele="-">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 14:46:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>This is an exon 19 mutation occuring in the
						tyrosine kinase domain. Assessed in multiple prospective trials
						shown to be predictive of response to EGFR TK inhibition.
					</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>first generation EGFR TKIs</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242481" stop="55242481"
			mutation="T751A" refAllele="A" varAllele="G">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 17:04:16.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>This mutation occurs within exon 19 within the
						tyrosine kinase domain. Mutations occurring in this region have
						been predictive of EGFR TKI response.</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242482" stop="55242482"
			mutation="T751I" refAllele="C" varAllele="T">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 21:50:02.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation was identified in a study of
						mutations present in cell line. No predictive or prognostic value
						assessed</significanceComment>
					<significanceReference>pmid:7088437</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation was identified in a study of
						heterogenicity between primary and metastases, no predictive or
						prognostic value assessed</significanceComment>
					<significanceReference>pmid:20811949</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>second generation EGFR TKIs</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:20811949</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242481" stop="55242481"
			mutation="T751P" refAllele="A" varAllele="C">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-05-13 17:02:54.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>This mutation occurs within exon 19 within the
						tyrosine kinase domain. Mutations occurring in this region have
						been predictive of EGFR TKI response.</significanceComment>
					<significanceReference>pmid:20887192</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20887192</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55242484" stop="55242507"
			mutation="S752_I759del" refAllele="TCTCCGAAAGCCAACAAGGAAATC"
			varAllele="-">
			<lastEditedBy>SR</lastEditedBy>
			<lastUpdated>2011-04-27 22:18:46.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Presence of mutation association with
						increased EGFR TKI response</significanceComment>
					<significanceReference>pmid:17285735</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>second generation EGFR TKI</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17285735</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37880219" stop="37880221"
			mutation="L755P" refAllele="TTG" varAllele="CCA">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-06-14 16:03:12.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>Anti-Her2 directed therapy</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15457249</actionReference>
					<actionComment>The localisation in the kinase domain of this
						mutation suggests that it is an activating mutation. This,
						however, has not been proven</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37880997" stop="37880997"
			mutation="G776&gt;LC" refAllele="G" varAllele="CTTT">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-25 11:40:03.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A case report in a patient with non-small cell
						lung cancer and this mutation demonstrated that the presence of
						this mutation may confer sensitivity to HER2 targeted therapy
					</significanceComment>
					<significanceReference>pmid:16775247</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>HER2 targeted agents</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>HER2 targeted agents</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16775247</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37880997" stop="37880997"
			mutation="G776S" refAllele="G" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-25 11:38:24.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>HER2 targeted agents</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>HER2 targeted agents</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18039657</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37880998" stop="37880998"
			mutation="G776&gt;VC" refAllele="-" varAllele="TTT">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-06-14 15:40:46.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>ERBB2 (Her2) mutation G776VC has been found in
						4 of 671 unselected patients in whom ERBB2 was sequenced. Although
						this mutation itself has been poorly studied, there is more data
						on ERBB2 G776YMVA believed to be biologically similar. In vitro
						studies have shown that cell lines harboring G776YMVA have a
						proliferative phenotype and are resistant to apoptosis. Moreover,
						G776YMVA has stronger catalytic activity than WT ERBB2. Finally
						experiments in cell line have shown that cell lines harboring
						G776YMVA are insensitive to tyrosine kinase inhibitors but that
						growth is inhibited by Her2 directed therapy. The same is believed
						to be true for G776VC although no data has been published.
					</significanceComment>
					<significanceReference>pmid:16843263, pmid:15753357
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Her2 directed targeted therapy</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16843263</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37880997" stop="37880997"
			mutation="A775_G776insYVMA" refAllele="-" varAllele="TACGTGATGGCT">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-05-19 10:03:28.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>A preclinical study identified ERBB2
						A775_G776insYVMA as an activating mutation that confers
						sensitivity to HER-2 targeted therapies (lapatinib, trastuzumab,
						CI-1033) but insensitivity to EGFR TKIs (erlotinib, gefitinib).
					</significanceComment>
					<significanceReference>pmid:16843263, pmid:19122144
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>HER2 targeted therapies</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>HER2 targeted therapies</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16843263, pmid:19122144</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37881011" stop="37881011"
			mutation="P780_Y781insGSP" refAllele="-" varAllele="GGCTCCCCA">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-06-20 07:55:56.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16638863</actionReference>
					<actionComment>There's only one report published re this mutation.
						It pertains to a retrospective series (n&lt;100) of patients with
						NSCLC. Three subjects who carried this mutation did not respond to
						gefitinib, but info re its functional consequence could not be
						ascertained. COSMIC database did not provide either a
						clarification about this</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-06-20 07:47:53.0</date>
					<userName>Ivan Diaz-Padilla</userName>
					<name>Ivan Diaz-Padilla</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovQ3JlYXRvciAoQXBhY2hlIEZPUCBWZXJzaW9uIDEuMCkKL1Byb2R1Y2VyIChBcGFjaGUgRk9QIFZlcnNpb24gMS4wKQovQ3JlYXRpb25EYXRlIChEOjIwMTEwNjIwMDc0NzU0LTA0JzAwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwKICAvTiAzCiAgL0xlbmd0aCAxMSAwIFIKICAvRmlsdGVyIC9GbGF0ZURlY29kZQo+PgpzdHJlYW0KeJydlndUU9kWh8+9N71QkhCKlNBraFICSA29SJEuKjEJEErAkAAiNkRUcERRkaYIMijggKNDkbEiioUBUbHrBBlE1HFwFBuWSWStGd+8ee/Nm98f935rn73P3Wfvfda6AJD8gwXCTFgJgAyhWBTh58WIjYtnYAcBDPAAA2wA4HCzs0IW+EYCmQJ82IxsmRP4F726DiD5+yrTP4zBAP+flLlZIjEAUJiM5/L42VwZF8k4PVecJbdPyZi2NE3OMErOIlmCMlaTc/IsW3z2mWUPOfMyhDwZy3PO4mXw5Nwn4405Er6MkWAZF+cI+LkyviZjg3RJhkDGb+SxGXxONgAoktwu5nNTZGwtY5IoMoIt43kA4EjJX/DSL1jMzxPLD8XOzFouEiSniBkmXFOGjZMTi+HPz03ni8XMMA43jSPiMdiZGVkc4XIAZs/8WRR5bRmyIjvYODk4MG0tbb4o1H9d/JuS93aWXoR/7hlEH/jD9ld+mQ0AsKZltdn6h21pFQBd6wFQu/2HzWAvAIqyvnUOfXEeunxeUsTiLGcrq9zcXEsBn2spL+jv+p8Of0NffM9Svt3v5WF485M4knQxQ143bmZ6pkTEyM7icPkM5p+H+B8H/nUeFhH8JL6IL5RFRMumTCBMlrVbyBOIBZlChkD4n5r4D8P+pNm5lona+BHQllgCpSEaQH4eACgqESAJe2Qr0O99C8ZHA/nNi9GZmJ37z4L+fVe4TP7IFiR/jmNHRDK4ElHO7Jr8WgI0IABFQAPqQBvoAxPABLbAEbgAD+ADAkEoiARxYDHgghSQAUQgFxSAtaAYlIKtYCeoBnWgETSDNnAYdIFj4DQ4By6By2AE3AFSMA6egCnwCsxAEISFyBAVUod0IEPIHLKFWJAb5AMFQxFQHJQIJUNCSAIVQOugUqgcqobqoWboW+godBq6AA1Dt6BRaBL6FXoHIzAJpsFasBFsBbNgTzgIjoQXwcnwMjgfLoK3wJVwA3wQ7oRPw5fgEVgKP4GnEYAQETqiizARFsJGQpF4JAkRIauQEqQCaUDakB6kH7mKSJGnyFsUBkVFMVBMlAvKHxWF4qKWoVahNqOqUQdQnag+1FXUKGoK9RFNRmuizdHO6AB0LDoZnYsuRlegm9Ad6LPoEfQ4+hUGg6FjjDGOGH9MHCYVswKzGbMb0445hRnGjGGmsVisOtYc64oNxXKwYmwxtgp7EHsSewU7jn2DI+J0cLY4X1w8TogrxFXgWnAncFdwE7gZvBLeEO+MD8Xz8MvxZfhGfA9+CD+OnyEoE4wJroRIQiphLaGS0EY4S7hLeEEkEvWITsRwooC4hlhJPEQ8TxwlviVRSGYkNimBJCFtIe0nnSLdIr0gk8lGZA9yPFlM3kJuJp8h3ye/UaAqWCoEKPAUVivUKHQqXFF4pohXNFT0VFysmK9YoXhEcUjxqRJeyUiJrcRRWqVUo3RU6YbStDJV2UY5VDlDebNyi/IF5UcULMWI4kPhUYoo+yhnKGNUhKpPZVO51HXURupZ6jgNQzOmBdBSaaW0b2iDtCkVioqdSrRKnkqNynEVKR2hG9ED6On0Mvph+nX6O1UtVU9Vvuom1TbVK6qv1eaoeajx1UrU2tVG1N6pM9R91NPUt6l3qd/TQGmYaYRr5Grs0Tir8XQObY7LHO6ckjmH59zWhDXNNCM0V2ju0xzQnNbS1vLTytKq0jqj9VSbru2hnaq9Q/uE9qQOVcdNR6CzQ+ekzmOGCsOTkc6oZPQxpnQ1df11Jbr1uoO6M3rGelF6hXrtevf0Cfos/ST9Hfq9+lMGOgYhBgUGrQa3DfGGLMMUw12G/YavjYyNYow2GHUZPTJWMw4wzjduNb5rQjZxN1lm0mByzRRjyjJNM91tetkMNrM3SzGrMRsyh80dzAXmu82HLdAWThZCiwaLG0wS05OZw2xljlrSLYMtCy27LJ9ZGVjFW22z6rf6aG1vnW7daH3HhmITaFNo02Pzq62ZLde2xvbaXPJc37mr53bPfW5nbse322N3055qH2K/wb7X/oODo4PIoc1h0tHAMdGx1vEGi8YKY21mnXdCO3k5rXY65vTW2cFZ7HzY+RcXpkuaS4vLo3nG8/jzGueNueq5clzrXaVuDLdEt71uUnddd457g/sDD30PnkeTx4SnqWeq50HPZ17WXiKvDq/XbGf2SvYpb8Tbz7vEe9CH4hPlU+1z31fPN9m31XfKz95vhd8pf7R/kP82/xsBWgHcgOaAqUDHwJWBfUGkoAVB1UEPgs2CRcE9IXBIYMj2kLvzDecL53eFgtCA0O2h98KMw5aFfR+OCQ8Lrwl/GGETURDRv4C6YMmClgWvIr0iyyLvRJlESaJ6oxWjE6Kbo1/HeMeUx0hjrWJXxl6K04gTxHXHY+Oj45vipxf6LNy5cDzBPqE44foi40V5iy4s1licvvj4EsUlnCVHEtGJMYktie85oZwGzvTSgKW1S6e4bO4u7hOeB28Hb5Lvyi/nTyS5JpUnPUp2Td6ePJninlKR8lTAFlQLnqf6p9alvk4LTduf9ik9Jr09A5eRmHFUSBGmCfsytTPzMoezzLOKs6TLnJftXDYlChI1ZUPZi7K7xTTZz9SAxESyXjKa45ZTk/MmNzr3SJ5ynjBvYLnZ8k3LJ/J9879egVrBXdFboFuwtmB0pefK+lXQqqWrelfrry5aPb7Gb82BtYS1aWt/KLQuLC98uS5mXU+RVtGaorH1futbixWKRcU3NrhsqNuI2ijYOLhp7qaqTR9LeCUXS61LK0rfb+ZuvviVzVeVX33akrRlsMyhbM9WzFbh1uvb3LcdKFcuzy8f2x6yvXMHY0fJjpc7l+y8UGFXUbeLsEuyS1oZXNldZVC1tep9dUr1SI1XTXutZu2m2te7ebuv7PHY01anVVda926vYO/Ner/6zgajhop9mH05+x42Rjf2f836urlJo6m06cN+4X7pgYgDfc2Ozc0tmi1lrXCrpHXyYMLBy994f9Pdxmyrb6e3lx4ChySHHn+b+O31w0GHe4+wjrR9Z/hdbQe1o6QT6lzeOdWV0iXtjusePhp4tLfHpafje8vv9x/TPVZzXOV42QnCiaITn07mn5w+lXXq6enk02O9S3rvnIk9c60vvG/wbNDZ8+d8z53p9+w/ed71/LELzheOXmRd7LrkcKlzwH6g4wf7HzoGHQY7hxyHui87Xe4Znjd84or7ldNXva+euxZw7dLI/JHh61HXb95IuCG9ybv56Fb6ree3c27P3FlzF3235J7SvYr7mvcbfjT9sV3qID0+6j068GDBgztj3LEnP2X/9H686CH5YcWEzkTzI9tHxyZ9Jy8/Xvh4/EnWk5mnxT8r/1z7zOTZd794/DIwFTs1/lz0/NOvm1+ov9j/0u5l73TY9P1XGa9mXpe8UX9z4C3rbf+7mHcTM7nvse8rP5h+6PkY9PHup4xPn34D94Tz+wplbmRzdHJlYW0KZW5kb2JqCjYgMCBvYmoKWy9JQ0NCYXNlZCA1IDAgUl0KZW5kb2JqCjcgMCBvYmoKPDwKICAvVHlwZSAvTWV0YWRhdGEKICAvU3VidHlwZSAvWE1MCiAgL0xlbmd0aCAxMiAwIFIKPj4Kc3RyZWFtCjw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+Cgo8eDp4bXBtZXRhIHhtbG5zOng9ImFkb2JlOm5zOm1ldGEvIj4KPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4KPHJkZjpEZXNjcmlwdGlvbiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iIHJkZjphYm91dD0iIj4KPGRjOmRhdGU+MjAxMS0wNi0yMFQwNzo0Nzo1NC0wNDowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAxLjA8L3BkZjpQcm9kdWNlcj4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiByZGY6YWJvdXQ9IiI+Cjx4bXA6Q3JlYXRlRGF0ZT4yMDExLTA2LTIwVDA3OjQ3OjU0LTA0OjAwPC94bXA6Q3JlYXRlRGF0ZT4KPHhtcDpDcmVhdG9yVG9vbD5BcGFjaGUgRk9QIFZlcnNpb24gMS4wPC94bXA6Q3JlYXRvclRvb2w+Cjx4bXA6TWV0YWRhdGFEYXRlPjIwMTEtMDYtMjBUMDc6NDc6NTQtMDQ6MDA8L3htcDpNZXRhZGF0YURhdGU+CjwvcmRmOkRlc2NyaXB0aW9uPgo8L3JkZjpSREY+CjwveDp4bXBtZXRhPgo8P3hwYWNrZXQgZW5kPSJyIj8+CgoKZW5kc3RyZWFtCmVuZG9iagoxMCAwIG9iago8PCAvTGVuZ3RoIDEzIDAgUiAvRmlsdGVyIC9GbGF0ZURlY29kZSA+PgpzdHJlYW0KeJzdWVtv2zYUfvev4MuABKhYXnXJW+9LgQ5JE2AYmmJQHSURYMupLGfIfv0OJUoiKdJ24g1YiyCIdER+59N3LiSV7zOKCPxE6k+SMTRfzr5rG0UJgz9gIeh29vpy9vI9RZSgy5txEqUSE5ZlWZqkSAgspSSEcIoul+jL0adNkzflqkKfi/tV3aCbVY3OkpT8+UeS0rJaf7g4Q2WF3n1+/Zodf0WXH2fvLmfnQODcICEZwz2Rc5tcwnbQI4gzh9NZflugYxRJghN01HkdxrMYxzyG16F8OpM6g2EAzWBwGk/Hjh5WN0FvIsGUUvAm6W5vkuEY3peQNNvmzn0hIXEWxzBSsG3TPhRVUedNcW0Qr8Zr0Hm4/ripihfmI0rHu7wZr0lyIpITyUfLq09WlK1IWoHkiDInkJRgFksQK8k68u/r4vumqOaPCCR2s2rZZ16fXuqiuStQs7pHzWa52tSoebwv1gOhkQ4B1TCP3XxjYrRrkhmOLZYpZAQHsanMUIpZG9tU071snXrfn+0BDXWWsAxiR6bQgxJedE52o0N4mEwBMU0m6Bf58n5hCHVuScUlTtMBmU6QyQSPIuxXQTwDbLGpbtE8r+dltVrmQXWfDkwwSVMaFPTpgFdH4qWQPEPrTs+rYwtcBUFiwWFGhpZISIrbajfNCzCTwRyPZmLd3aHfZ9Xsy1cwXwPdv6CsPmj8zI+f9VMvWi5e5/acZCengHlKDgugp7CZ3yWbupzSTMY5kT2WHMAqakd5RYtd0aIpCxlisU+8CJaWFJ3BESHULJMEx6rrE5502df1QLdLvrnL63zeFHW5bsq5LnF/OmcZzrp3Z7qfQTO92VRz1WXzBZqvqnXXhQrVj5u7cm004TXqsae9B0AxSWAdlamcuonCpBjhmEFTzDzT0AnsOW6KuuVzdXT26fTt1fGJ0ezbvQvDaaJWFDu2ht1KGEr5aCf2bajm1CDu9THYPekcZiZ2MwvZd1fexC3zuPWQFeOsyBlNDuKm0fwCClfAyMeFBbnsFUFVdJYs2uIIEty0wDpBCRQiS/WW682irMo5FExeXaOzupj39xfN5ros1uE6ATRV/hTen8lYr6UY2Ssg6tatX7aVMk1SLDmsTUmcdjCnVVewxsboRbtbGtity9uqvIFLb3333ti0RmHbylXHirnwOD7ZxpORDHYldFxCPRWN3j2U18rk1DaDQwNVDVDYaWPYrWxkjI92Yt+GalthxQEfcT95Ui5hZmI3s5B9d21P3DKPWw9ZMc6KnNHkIG5RN8wvIHcFjHxcWJDLXhFUlWzJoi2OIKHaZnDc5ane7bf5+eohLxf5t3JRNu2h5LR6KGBhvc31Gvnqtqiarassi+EAmlE4UhJdIb+t4ORiw+QtDMrrAuWdx0XhZH8C0OqsEDvCjnY7XikZ7cS+DWY/DKI+H6Pdl1AhZindzSxk3yP7XbfM43ZKdnzaZZw5mhzETaP5BaSugJGHixlK8owItrluytJZXEFC2c8JxSmT6sSot5gXRbUum/JBJb9a3D4Xa9hWtgvGm1UFnbsurtG3R9R/FLJTlsMBNwMBKLfVMOyWyJzGo53Yt6GUVYOE18dg92RBmFmym1nIvjtlJ26Zx62HbDLOipzR5CBuGs0vYOIKGPm4yCCXvSKoEtSSRVscQYIpy1NMhYS9CBk2FO1nyV8hT1f1o+9TkMJX7ym6D6OtQ/W77CAX6uQhjQv4VZcwtd1gDq+i+BuvE1GNYszqdBsM+hlsUQnTmAxLNsJ7gUPTDfDO1O9k9XNioetLP3ViYHh8WM/VFlw/1XoNCvb6kD3cEZeuEWbPUdX58vI2bwrvhxzoslviS6zAPjnCxA7ETxzjZ0V01PhZMVUrSlkv2xXF/9Vvr9gySbq/YowRXD8huC2CEdsRaTmiSzK8ZffcuBvE6v16PWpYBSqm8TBtwaCbvnZH3efm/xD25RI2v/5v0SrescAsnsT7B6zc/kbq3jlcPrOi6RN7du+3e/t/IdjSCrb3E6MTbPWfpYjEEYMR+l9J29r4Txp64rn5odr5PqE+fcgr9LbM/47O8utysQj8J2dboA9o4cKN9aSJd6hdG++b6QFt3HBrVobbyE2H++TBEzu8sSr9x3nQ/fwDW7vdvwplbmRzdHJlYW0KZW5kb2JqCjggMCBvYmoKPDwKICAvUmVzb3VyY2VzIDMgMCBSCiAgL1R5cGUgL1BhZ2UKICAvTWVkaWFCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9Dcm9wQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvQmxlZWRCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9UcmltQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvUGFyZW50IDEgMCBSCiAgL0NvbnRlbnRzIDEwIDAgUgo+PgoKZW5kb2JqCjExIDAgb2JqCjI1OTYKZW5kb2JqCjEyIDAgb2JqCjc5MwplbmRvYmoKMTMgMCBvYmoKMTYwMAplbmRvYmoKMTQgMCBvYmoKPDwKICAvVHlwZSAvRm9udAogIC9TdWJ0eXBlIC9UeXBlMQogIC9CYXNlRm9udCAvSGVsdmV0aWNhCiAgL0VuY29kaW5nIC9XaW5BbnNpRW5jb2RpbmcKPj4KCmVuZG9iagoxNSAwIG9iago8PAogIC9UeXBlIC9Gb250CiAgL1N1YnR5cGUgL1R5cGUxCiAgL0Jhc2VGb250IC9IZWx2ZXRpY2EtQm9sZAogIC9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nCj4+CgplbmRvYmoKMTYgMCBvYmoKPDwKICAvVHlwZSAvRm9udAogIC9TdWJ0eXBlIC9UeXBlMQogIC9CYXNlRm9udCAvSGVsdmV0aWNhLU9ibGlxdWUKICAvRW5jb2RpbmcgL1dpbkFuc2lFbmNvZGluZwo+PgoKZW5kb2JqCjEgMCBvYmoKPDwgL1R5cGUgL1BhZ2VzCi9Db3VudCAxCi9LaWRzIFs4IDAgUiBdID4+CmVuZG9iagoyIDAgb2JqCjw8CiAgL1R5cGUgL0NhdGFsb2cKICAvUGFnZXMgMSAwIFIKICAvTWV0YWRhdGEgNyAwIFIKICAvTGFuZyAoZW4tVVMpCiAgL1BhZ2VMYWJlbHMgOSAwIFIKPj4KCmVuZG9iagozIDAgb2JqCjw8Ci9Gb250IDw8CiAgL0YxIDE0IDAgUgogIC9GMyAxNSAwIFIKICAvRjIgMTYgMCBSCj4+Ci9Qcm9jU2V0IFsgL1BERiAvSW1hZ2VCIC9JbWFnZUMgL1RleHQgXQovQ29sb3JTcGFjZSA8PAogIC9EZWZhdWx0UkdCIDYgMCBSCj4+Cj4+CmVuZG9iago5IDAgb2JqCjw8IC9OdW1zIFswIDw8IC9QICgxKSA+PgpdID4+CgplbmRvYmoKeHJlZgowIDE3CjAwMDAwMDAwMDAgNjU1MzUgZiAKMDAwMDAwNjAxOSAwMDAwMCBuIAowMDAwMDA2MDc3IDAwMDAwIG4gCjAwMDAwMDYxODUgMDAwMDAgbiAKMDAwMDAwMDAxNSAwMDAwMCBuIAowMDAwMDAwMTQ1IDAwMDAwIG4gCjAwMDAwMDI4MjcgMDAwMDAgbiAKMDAwMDAwMjg2MCAwMDAwMCBuIAowMDAwMDA1NDE5IDAwMDAwIG4gCjAwMDAwMDYzMzUgMDAwMDAgbiAKMDAwMDAwMzc0MyAwMDAwMCBuIAowMDAwMDA1NjIzIDAwMDAwIG4gCjAwMDAwMDU2NDQgMDAwMDAgbiAKMDAwMDAwNTY2NCAwMDAwMCBuIAowMDAwMDA1Njg1IDAwMDAwIG4gCjAwMDAwMDU3OTIgMDAwMDAgbiAKMDAwMDAwNTkwNCAwMDAwMCBuIAp0cmFpbGVyCjw8Ci9TaXplIDE3Ci9Sb290IDIgMCBSCi9JbmZvIDQgMCBSCi9JRCBbPEUxQjg1Q0IyOUU1QUQ5MzM4MjExNzY0NjQ0Q0VCMjU1PiA8RTFCODVDQjI5RTVBRDkzMzgyMTE3NjQ2NDRDRUIyNTU+XQo+PgpzdGFydHhyZWYKNjM4MQolJUVPRgo=
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="17" gene="ERBB2" start="37881008" stop="37881008"
			mutation="S779_P780insVGS" refAllele="-" varAllele="CTGTGGGCT">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-06-20 08:03:55.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>case</type>
					<significanceComment>Stephens et al. report in a very interesting
						paper the existence of mutations in HER2 in non-small cell
						carcinoma specimens. These mutations are usually located in the
						kinase domain, thereby potentially influencing receptor
						functionality. These mutations are almost exclusive of
						adenocarcinomas.</significanceComment>
					<significanceReference>pmid:15457249</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>gefitinib/erlotinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Trastuzumab</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>inactivating</action>
					<actionReference>pmid:15457249</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-06-20 08:03:55.0</date>
					<userName>Ivan Diaz-Padilla</userName>
					<name>Ivan Diaz-Padilla</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-20 07:56:27.0</date>
					<userName>Ivan Diaz-Padilla</userName>
					<name>Ivan Diaz-Padilla</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="8" gene="FGFR1" start="38285938" stop="38285938"
			mutation="S125L" refAllele="G" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-05-19 10:05:50.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>FGFR targeted therapies</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR targeted therapies</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15908952</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="8" gene="FGFR1" start="38282209" stop="38282209"
			mutation="P252T" refAllele="G" varAllele="T">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-05-19 10:04:55.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>FGFR targeted therapies</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR targeted therapies</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16140923</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1806089" stop="1806089"
			mutation="G370C" refAllele="G" varAllele="T">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-05-19 10:09:14.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>urinary tract carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation was present in 1 of 286 cases of
						papillary urothelial cell carcinoma and was associated with a more
						favourable disease course</significanceComment>
					<significanceReference>pmid:16877795</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>FGFR targeted therapies</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR targeted therapies</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16877735, pmid:19789314</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1806099" stop="1806099"
			mutation="Y373C" refAllele="A" varAllele="G">
			<lastEditedBy>RICHTER</lastEditedBy>
			<lastUpdated>2011-06-30 09:20:42.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>preclinical</type>
					<significanceComment>R3Mab demonstrates antitumour activity in cell
						lines and mouse models with wild type and mutant FGFR3
					</significanceComment>
					<significanceReference>pmid:2673861</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>urinary tract carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>R3Mab demonstrates antitumour activity in cell
						lines and mouse models with wild type and mutant FGFR3
					</significanceComment>
					<significanceReference>pmid:2673861</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>dexamethasone in multiple myeloma</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:11429702</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1806153" stop="1806153"
			mutation="A391E" refAllele="C" varAllele="A">
			<lastEditedBy>Ben Tran</lastEditedBy>
			<lastUpdated>2011-05-19 10:07:36.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>FGFR targeted therapies</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR targeted therapies</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:19377444, pmid:16877735</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1807889" stop="1807889"
			mutation="K650E" refAllele="A" varAllele="G">
			<lastEditedBy>D. Cescon</lastEditedBy>
			<lastUpdated>2011-06-16 10:18:43.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>bortezemib in myeloma based on preclinical analysis of a
						similar activating mutation PMID: 21273588</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR3 inhibitors (no data availble on ability of agents to
						inhibit this activating mutation)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19855393, pmid:11055896</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1807889" stop="1807889"
			mutation="K650Q" refAllele="A" varAllele="C">
			<lastEditedBy>D. Cescon</lastEditedBy>
			<lastUpdated>2011-06-16 10:16:12.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>bortezemib in myeloma based on preclinical analysis of a
						similar activating mutation PMID: 21273588</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR3 inhibitors (no data availble on ability of agents to
						inhibit this activating mutation)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19855393, pmid:11055896</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1807890" stop="1807890"
			mutation="K650M" refAllele="A" varAllele="T">
			<lastEditedBy>D. Cescon</lastEditedBy>
			<lastUpdated>2011-06-16 10:20:34.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>bortezemib in myeloma based on preclinical analysis of a
						similar activating mutation PMID: 21273588</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR3 inhibitors (no data availble on ability of agents to
						inhibit this activating mutation)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19855393, pmid:11055896</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="FGFR3" start="1807890" stop="1807890"
			mutation="K650T" refAllele="A" varAllele="C">
			<lastEditedBy>D. Cescon</lastEditedBy>
			<lastUpdated>2011-06-16 10:19:34.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>bortezemib in myeloma based on preclinical analysis of a
						similar activating mutation PMID: 21273588</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>FGFR3 inhibitors (no data availble on ability of agents to
						inhibit this activating mutation)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19855393, pmid:11055896</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="13" gene="FLT3" start="28592637" stop="28592639"
			mutation="I836del" refAllele="GAT" varAllele="-">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-29 23:17:36.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>prospective</type>
					<significanceComment>The effect of this mutation in Acute Myeloid
						Leukemia has been studied in several Phase II trials, utilizing
						agents such as Midostaurin, Sorafenib and Lestaurtinib. In these
						trials, clinical benefits (either by means of complete response or
						other marrow examination improvements) were consistently higher in
						FLT-3 mutation patients. </significanceComment>
					<significanceReference>pmid:20733134, pmid:20212254, pmid:16857985
					</significanceReference>
					<significanceEvidence>IIIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Midostaurin, Lestaurtinib, Sorafenib, AC220</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>AC220, PKC412 based therapy, Sorafenib based therapy
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15256420</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="13" gene="FLT3" start="28592642" stop="28592642"
			mutation="D835H" refAllele="C" varAllele="G">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-29 23:30:05.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>prospective</type>
					<significanceComment>The effect of this mutation in Acute Myeloid
						Leukemia has been studied in several Phase II trials, utilizing
						agents such as Sorafenib and Lestaurtinib. In these trials,
						clinical benefits (either by means of complete response or other
						marrow examination improvements) were consistently higher in FLT-3
						mutated patients. </significanceComment>
					<significanceReference>pmid:20212254, pmid:16857985
					</significanceReference>
					<significanceEvidence>IIIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Midostaurin, Lestaurtinib, Sorafenib, AC220</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>AC220, PKC412 based therapy, Sorafenib based therapy
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15256420</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="13" gene="FLT3" start="28592642" stop="28592642"
			mutation="D835Y" refAllele="C" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-29 23:29:31.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>preclinical</type>
					<significanceComment>In one preclinical study, FLT3 mutated mice
						were treated with sorafenib. Compared to non-mutated mice, there
						was a decrease in leukemic burden and an increased survival when
						sorafenib was used.</significanceComment>
					<significanceReference>pmid:18230792</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>The effect of this mutation in Acute Myeloid
						Leukemia has been studied in several Phase II trials, utilizing
						agents such as Sorafenib and Lestaurtinib. In these trials,
						clinical benefits (either by means of complete response or other
						marrow examination improvements) were consistently higher in FLT-3
						mutated patients. </significanceComment>
					<significanceReference>pmid:20212254, pmid:16857985
					</significanceReference>
					<significanceEvidence>IIIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Midostaurin, Lestaurtinib, Sorafenib, AC220</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>AC220, PKC412 based therapy, Sorafenib based therapy
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15256420</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="534288" stop="534288"
			mutation="G12D" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:18:49.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19303097</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="534288" stop="534288"
			mutation="G12V" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:14:49.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>urinary tract neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study did not demonstrate a
						predictive role of HRAS mutation status on recurrence or survival
						in patients with bladder cancer </significanceComment>
					<significanceReference>pmid:21072204</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19303097</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="534286" stop="534286"
			mutation="G13C" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:54:56.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>In a retrospective study the presence of
						various HRAS mutations was found to be associated with a poorer
						prognosis</significanceComment>
					<significanceReference>pmid:12947056</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:3144694</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="534286" stop="534286"
			mutation="G13R" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:28:39.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>urinary tract carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study did not demonstrate a
						predictive role of HRAS mutation status on recurrence or survival
						in patients with bladder cancer </significanceComment>
					<significanceReference>pmid:21072204</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15897885</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="534286" stop="534286"
			mutation="G13S" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:32:38.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:11211612</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="533873" stop="533873"
			mutation="Q61H" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:35:34.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12947056</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="533874" stop="533874"
			mutation="Q61L" refAllele="T" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-14 14:02:47.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This is the most prevalent mutation found in
						BRAF inhibitor induced cutaneous squamous-cell carcinomas and
						keratoacanthomas. </significanceComment>
					<significanceReference>pmid:22256804</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>urinary tract neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study did not demonstrate a
						predictive role of HRAS mutation status on recurrence or survival
						in patients with bladder cancer</significanceComment>
					<significanceReference>pmid:21072204</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>MEK inhibitors,</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15897885</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-03-14 14:03:08.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="533874" stop="533874"
			mutation="Q61P" refAllele="T" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:52:52.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>In a retrospective study the presence of
						various HRAS mutations was found to be associated with a poorer
						prognosis</significanceComment>
					<significanceReference>pmid:12947056</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12947056</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="533874" stop="533874"
			mutation="Q61R" refAllele="T" varAllele="C">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 09:42:02.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>urinary tract neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study did not demonstrate a
						predictive role of HRAS mutation status on recurrence or survival
						in patients with bladder cancer</significanceComment>
					<significanceReference>pmid:21072204</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15897885</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="11" gene="HRAS" start="533875" stop="533875"
			mutation="Q61K" refAllele="G" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-22 10:25:03.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>In a retrospective study the presence of
						various HRAS mutations was found to be associated with a poorer
						prognosis</significanceComment>
					<significanceReference>pmid:12947056</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12947056</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="JAK2" start="5073770" stop="5073770"
			mutation="V617F" refAllele="G" varAllele="T">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-05 18:12:19.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>Infrequent positivity of JAK2 V617F has also
						been reported in myelodysplastic syndrome (in particular in
						association with the 5q deletion and refractory anemia with ringed
						sideroblast), atypical myeloproliferative disorders and acute
						leukemias.</significanceComment>
					<significanceReference>pmid:21120162</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>Early phase I and II trials suggest that JAK2
						inhibitors can be of benefit in patients with myelofibrosis,
						resulting in reduction of splenomegaly and systemic symptoms as
						well as frequent correction of thrombocytosis and leukocytosis.
					</significanceComment>
					<significanceReference>pmid:21220608, pmid:20843246
					</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>The JAK2 V617F has been found in about 90% of
						patients with Polycythemia Vera, 50% of patients with Essential
						Thrombocythemia and 50% of patients with Essential Myelofibrosis.
						When it is present, it has important diagnostic implications and
						as such, has recently been integrated as part of WHO diagnosis
						criteria of BCR-ABL negative myeloproliferative disorders.
					</significanceComment>
					<significanceReference>pmid:15858187, pmid:15837627, pmid:15781101,
						pmid:20191332</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Jak2 inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Jak2 inhibitors</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16304380, pmid:15837627, pmid:15781101,
						pmid:15858187</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55561764" stop="55561764"
			mutation="D52N" refAllele="G" varAllele="A">
			<lastEditedBy>Ivan Diaz-Padill</lastEditedBy>
			<lastUpdated>2011-04-14 11:44:14.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:8555071, pmid:9168438</actionReference>
					<actionComment>Evidence comes from you small retrospective studies.
						Translational relevance of this finding cannot be ascertained
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593609" stop="55593611"
			mutation="V559del" refAllele="GTT" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 10:23:04.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation is also located in exon 11, and
						it can be found in some melanoma subtypes, indicating their
						responsiveness to imatinib</significanceComment>
					<significanceReference>pmid:18980976</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18980976</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593609" stop="55593614"
			mutation="V559_V560del" refAllele="GTTGTT" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-18 09:43:14.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17909012</actionReference>
					<actionComment>There is one case reported in pediatric GIST. With
						that evidence it is really difficult to infer its potential
						functional consequences or clinical relevance.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593612" stop="55593614"
			mutation="V560del" refAllele="GTT" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 16:07:41.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thymus thymic carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been found in two thymic
						carcinomas. preclinical studies carried out suggest that the
						V560del mutant was associated with similar sensitivities to
						imatinib and sunitinib</significanceComment>
					<significanceReference>pmid:19861435</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>preclinical</type>
					<significanceComment>This study investigated the efficacy of
						second-line tyrosine kinase inhibitors, such as sorafenib,
						dasatinib, and nilotinib, against the commonly observed
						imatinib-resistant KIT mutations, such as V560del/V654A
					</significanceComment>
					<significanceReference>pmid:17699867</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19861435</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593585" stop="55593599"
			mutation="P551_V555del" refAllele="CCCATGTATGAAGTA" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 10:01:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>A large retrospective series has identified
						this mutation in pediatric GIST. There's insufficient data as to
						assess its predictive value</significanceComment>
					<significanceReference>pmid:15838387</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18488000</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593591" stop="55593602"
			mutation="Y553_Q556del" refAllele="TATGAAGTACAG" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 13:44:01.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18488000</actionReference>
					<actionComment>It is unknown. Only one curated manuscript from
						Sanger related to the discovery of new mutation in a
						two-institutions case series study</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593642" stop="55593662"
			mutation="Y570_L576del" refAllele="TACATAGACCCAACACAACTT" varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 13:23:04.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:20470368</actionReference>
					<actionComment>There are no sufficient data to ascertain the
						functional consequence of this mutation. The aforementioned
						manuscript is a retrospective study looking at further chromosomic
						imbalances in GIST, which may potentially add prognostic
						information</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593615" stop="55593615"
			mutation="E561K" refAllele="G" varAllele="A">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-15 15:58:14.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:10811105</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593661" stop="55593661"
			mutation="L576P" refAllele="T" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-17 21:12:34.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation is present in anals melanomas,
						and seem to be predict sensitivity to dasatinib
					</significanceComment>
					<significanceReference>pmid:17372901</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This study aims to evaluate the response of
						GIST harbouring KIT L576P, a rare mutation in GIST.It is reported
						a low histologic response to imatinib despite an apparent good
						response by functional imaging.</significanceComment>
					<significanceReference>pmid:19723893</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>testis germ cell tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>This study showed one case of testicular
						seminoma with the aforementioned mutation. Its clinical relevance
						is actually unknown.</significanceComment>
					<significanceReference>pmid:16741525</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>dasatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>dasatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19018266, pmid:21069551</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593689" stop="55593689"
			mutation="P585P" refAllele="C" varAllele="T">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-18 09:26:07.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15643509</actionReference>
					<actionComment>Only three reports in literature link this mutation
						with rare case of uncommon NHL lymphomas in Japanese population
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593669" stop="55593671"
			mutation="D579del" refAllele="GAT" varAllele="-">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-04-18 17:38:04.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>case</type>
					<significanceComment>This mutation resides at the first tyrosine
						kinase catalytic domain of KIT protein and has been reported in
						familial GIST. One patient treated with imatinib had stable
						disease. One patient with thymic carcinoma and this mutation had
						response to sorafenib</significanceComment>
					<significanceReference>pmid:15897563, pmid:20970876
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective study. Mucosal melanoma (n=37).
						16% had KIT mutations. Those subjects who had mutations in exon 11
						correlated with KIT protein expression.</significanceComment>
					<significanceReference>pmid:19018266</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib, sunitinib, sorafenib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib, Nilotinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>unknown</action>
					<actionReference></actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-18 17:38:17.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovVGl0bGUgKE11dGF0aW9uIHJlcG9ydCBmb3IgS0lUIEQ1NzlkZWwpCi9Qcm9kdWNlciAoQXBhY2hlIEZPUCBWZXJzaW9uIDAuOTMpCi9DcmVhdGlvbkRhdGUgKEQ6MjAxMjA0MTgxNzM4MTctMDQnMC00ODAnKQo+PgplbmRvYmoKNSAwIG9iago8PCAvTiAzCi9MZW5ndGggMTEgMCBSCi9GaWx0ZXIgL0ZsYXRlRGVjb2RlIAo+PgpzdHJlYW0KeJydlndUU9kWh8+9N71QkhCKlNBraFICSA29SJEuKjEJEErAkAAiNkRUcERRkaYIMijggKNDkbEiioUBUbHrBBlE1HFwFBuWSWStGd+8ee/Nm98f935rn73P3Wfvfda6AJD8gwXCTFgJgAyhWBTh58WIjYtnYAcBDPAAA2wA4HCzs0IW+EYCmQJ82IxsmRP4F726DiD5+yrTP4zBAP+flLlZIjEAUJiM5/L42VwZF8k4PVecJbdPyZi2NE3OMErOIlmCMlaTc/IsW3z2mWUPOfMyhDwZy3PO4mXw5Nwn4405Er6MkWAZF+cI+LkyviZjg3RJhkDGb+SxGXxONgAoktwu5nNTZGwtY5IoMoIt43kA4EjJX/DSL1jMzxPLD8XOzFouEiSniBkmXFOGjZMTi+HPz03ni8XMMA43jSPiMdiZGVkc4XIAZs/8WRR5bRmyIjvYODk4MG0tbb4o1H9d/JuS93aWXoR/7hlEH/jD9ld+mQ0AsKZltdn6h21pFQBd6wFQu/2HzWAvAIqyvnUOfXEeunxeUsTiLGcrq9zcXEsBn2spL+jv+p8Of0NffM9Svt3v5WF485M4knQxQ143bmZ6pkTEyM7icPkM5p+H+B8H/nUeFhH8JL6IL5RFRMumTCBMlrVbyBOIBZlChkD4n5r4D8P+pNm5lona+BHQllgCpSEaQH4eACgqESAJe2Qr0O99C8ZHA/nNi9GZmJ37z4L+fVe4TP7IFiR/jmNHRDK4ElHO7Jr8WgI0IABFQAPqQBvoAxPABLbAEbgAD+ADAkEoiARxYDHgghSQAUQgFxSAtaAYlIKtYCeoBnWgETSDNnAYdIFj4DQ4By6By2AE3AFSMA6egCnwCsxAEISFyBAVUod0IEPIHLKFWJAb5AMFQxFQHJQIJUNCSAIVQOugUqgcqobqoWboW+godBq6AA1Dt6BRaBL6FXoHIzAJpsFasBFsBbNgTzgIjoQXwcnwMjgfLoK3wJVwA3wQ7oRPw5fgEVgKP4GnEYAQETqiizARFsJGQpF4JAkRIauQEqQCaUDakB6kH7mKSJGnyFsUBkVFMVBMlAvKHxWF4qKWoVahNqOqUQdQnag+1FXUKGoK9RFNRmuizdHO6AB0LDoZnYsuRlegm9Ad6LPoEfQ4+hUGg6FjjDGOGH9MHCYVswKzGbMb0445hRnGjGGmsVisOtYc64oNxXKwYmwxtgp7EHsSewU7jn2DI+J0cLY4X1w8TogrxFXgWnAncFdwE7gZvBLeEO+MD8Xz8MvxZfhGfA9+CD+OnyEoE4wJroRIQiphLaGS0EY4S7hLeEEkEvWITsRwooC4hlhJPEQ8TxwlviVRSGYkNimBJCFtIe0nnSLdIr0gk8lGZA9yPFlM3kJuJp8h3ye/UaAqWCoEKPAUVivUKHQqXFF4pohXNFT0VFysmK9YoXhEcUjxqRJeyUiJrcRRWqVUo3RU6YbStDJV2UY5VDlDebNyi/IF5UcULMWI4kPhUYoo+yhnKGNUhKpPZVO51HXURupZ6jgNQzOmBdBSaaW0b2iDtCkVioqdSrRKnkqNynEVKR2hG9ED6On0Mvph+nX6O1UtVU9Vvuom1TbVK6qv1eaoeajx1UrU2tVG1N6pM9R91NPUt6l3qd/TQGmYaYRr5Grs0Tir8XQObY7LHO6ckjmH59zWhDXNNCM0V2ju0xzQnNbS1vLTytKq0jqj9VSbru2hnaq9Q/uE9qQOVcdNR6CzQ+ekzmOGCsOTkc6oZPQxpnQ1df11Jbr1uoO6M3rGelF6hXrtevf0Cfos/ST9Hfq9+lMGOgYhBgUGrQa3DfGGLMMUw12G/YavjYyNYow2GHUZPTJWMw4wzjduNb5rQjZxN1lm0mByzRRjyjJNM91tetkMNrM3SzGrMRsyh80dzAXmu82HLdAWThZCiwaLG0wS05OZw2xljlrSLYMtCy27LJ9ZGVjFW22z6rf6aG1vnW7daH3HhmITaFNo02Pzq62ZLde2xvbaXPJc37mr53bPfW5nbse322N3055qH2K/wb7X/oODo4PIoc1h0tHAMdGx1vEGi8YKY21mnXdCO3k5rXY65vTW2cFZ7HzY+RcXpkuaS4vLo3nG8/jzGueNueq5clzrXaVuDLdEt71uUnddd457g/sDD30PnkeTx4SnqWeq50HPZ17WXiKvDq/XbGf2SvYpb8Tbz7vEe9CH4hPlU+1z31fPN9m31XfKz95vhd8pf7R/kP82/xsBWgHcgOaAqUDHwJWBfUGkoAVB1UEPgs2CRcE9IXBIYMj2kLvzDecL53eFgtCA0O2h98KMw5aFfR+OCQ8Lrwl/GGETURDRv4C6YMmClgWvIr0iyyLvRJlESaJ6oxWjE6Kbo1/HeMeUx0hjrWJXxl6K04gTxHXHY+Oj45vipxf6LNy5cDzBPqE44foi40V5iy4s1licvvj4EsUlnCVHEtGJMYktie85oZwGzvTSgKW1S6e4bO4u7hOeB28Hb5Lvyi/nTyS5JpUnPUp2Td6ePJninlKR8lTAFlQLnqf6p9alvk4LTduf9ik9Jr09A5eRmHFUSBGmCfsytTPzMoezzLOKs6TLnJftXDYlChI1ZUPZi7K7xTTZz9SAxESyXjKa45ZTk/MmNzr3SJ5ynjBvYLnZ8k3LJ/J9879egVrBXdFboFuwtmB0pefK+lXQqqWrelfrry5aPb7Gb82BtYS1aWt/KLQuLC98uS5mXU+RVtGaorH1futbixWKRcU3NrhsqNuI2ijYOLhp7qaqTR9LeCUXS61LK0rfb+ZuvviVzVeVX33akrRlsMyhbM9WzFbh1uvb3LcdKFcuzy8f2x6yvXMHY0fJjpc7l+y8UGFXUbeLsEuyS1oZXNldZVC1tep9dUr1SI1XTXutZu2m2te7ebuv7PHY01anVVda926vYO/Ner/6zgajhop9mH05+x42Rjf2f836urlJo6m06cN+4X7pgYgDfc2Ozc0tmi1lrXCrpHXyYMLBy994f9Pdxmyrb6e3lx4ChySHHn+b+O31w0GHe4+wjrR9Z/hdbQe1o6QT6lzeOdWV0iXtjusePhp4tLfHpafje8vv9x/TPVZzXOV42QnCiaITn07mn5w+lXXq6enk02O9S3rvnIk9c60vvG/wbNDZ8+d8z53p9+w/ed71/LELzheOXmRd7LrkcKlzwH6g4wf7HzoGHQY7hxyHui87Xe4Znjd84or7ldNXva+euxZw7dLI/JHh61HXb95IuCG9ybv56Fb6ree3c27P3FlzF3235J7SvYr7mvcbfjT9sV3qID0+6j068GDBgztj3LEnP2X/9H686CH5YcWEzkTzI9tHxyZ9Jy8/Xvh4/EnWk5mnxT8r/1z7zOTZd794/DIwFTs1/lz0/NOvm1+ov9j/0u5l73TY9P1XGa9mXpe8UX9z4C3rbf+7mHcTM7nvse8rP5h+6PkY9PHup4xPn34D94Tz+wplbmRzdHJlYW0KZW5kb2JqCjYgMCBvYmoKWy9JQ0NCYXNlZCA1IDAgUl0KZW5kb2JqCjcgMCBvYmoKPDwgL1R5cGUgL01ldGFkYXRhCi9TdWJ0eXBlIC9YTUwKL0xlbmd0aCAxMiAwIFIKCj4+CnN0cmVhbQo8P3hwYWNrZXQgYmVnaW49Iu+7vyIgaWQ9Ilc1TTBNcENlaGlIenJlU3pOVGN6a2M5ZCI/PgoKPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyI+CjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6ZGM9Imh0dHA6Ly9wdXJsLm9yZy9kYy9lbGVtZW50cy8xLjEvIiByZGY6YWJvdXQ9IiI+CjxkYzp0aXRsZT5NdXRhdGlvbiByZXBvcnQgZm9yIEtJVCBENTc5ZGVsPC9kYzp0aXRsZT4KPGRjOmRhdGU+MjAxMi0wNC0xOFQxNzozODoxNy0wLTQ6MDA8L2RjOmRhdGU+CjwvcmRmOkRlc2NyaXB0aW9uPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOnBkZj0iaHR0cDovL25zLmFkb2JlLmNvbS9wZGYvMS4zLyIgcmRmOmFib3V0PSIiPgo8cGRmOlBERlZlcnNpb24+MS40PC9wZGY6UERGVmVyc2lvbj4KPHBkZjpQcm9kdWNlcj5BcGFjaGUgRk9QIFZlcnNpb24gMC45MzwvcGRmOlByb2R1Y2VyPgo8L3JkZjpEZXNjcmlwdGlvbj4KPHJkZjpEZXNjcmlwdGlvbiB4bWxuczp4bXA9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8iIHJkZjphYm91dD0iIj4KPHhtcDpDcmVhdGVEYXRlPjIwMTItMDQtMThUMTc6Mzg6MTctMC00OjAwPC94bXA6Q3JlYXRlRGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjwvcmRmOlJERj4KPC94OnhtcG1ldGE+Cjw/eHBhY2tldCBlbmQ9InIiPz4KCgplbmRzdHJlYW0KZW5kb2JqCjEwIDAgb2JqCjw8IC9MZW5ndGggMTMgMCBSCi9GaWx0ZXIgL0ZsYXRlRGVjb2RlIAo+PgpzdHJlYW0KeJyFksFSg0AMhu88RY7todsku1vAo1ZH63Smdbg5HrBdnM4IKOKhb+8C2worU2GAkORPPhII0J4zsrcwZtjlwWdArY8gZPuwnuskmN9JIIQkc0ErII1iIRFRg1JCaw1JDs+T9Xed1oeymMIE7FWZj7Kq3UtWVs56fEictdRhvDfvU3iBZBXcJsG2R4AdQN+lmcUJbDuEDfkXl3xcBMm/lJv0zXQAM6JYYGyPqEM4KzgUkpvIQMlTL80Go4gQaZDmVZ6U2X/tVCxowY3/Yjut7OfLS73GBtlOZ7BLoRfefGwBqbqKT/2t3R++6rI6OpBGHQtfy9alomYIrX6Z1sYHJ/6TdlMW2aHKzd51ej36Ih4T5bkp6jMOjeAosrMMm9W1ElRziuaMxK4R6isZOXuzHiP1KqzSwpzmsUyLnTn2f9gfF02wcwplbmRzdHJlYW0KZW5kb2JqCjkgMCBvYmoKPDwgL1R5cGUgL1BhZ2UKL1BhcmVudCAxIDAgUgovTWVkaWFCb3ggWyAwIDAgNTk1IDc5MiBdCi9UcmltQm94IFsgMCAwIDU5NSA3OTIgXQovQmxlZWRCb3ggWyAwIDAgNTk1IDc5MiBdCi9SZXNvdXJjZXMgMyAwIFIKL0NvbnRlbnRzIDEwIDAgUgo+PgplbmRvYmoKMTEgMCBvYmoKMjU5NgplbmRvYmoKMTIgMCBvYmoKNzI4CmVuZG9iagoxMyAwIG9iagozMjUKZW5kb2JqCjE0IDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDE0NS4wODQ5OSAzMDMuMTczIDE4Ny43ODEgMzEyLjA1MiBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSA8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE1ODk3NTYzKQovUyAvVVJJID4+Ci9IIC9JCgo+PgplbmRvYmoKMTYgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMjE2LjU4NiAzMDMuMTczIDI1OS4yODE5OCAzMTIuMDUyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjA5NzA4NzYpCi9TIC9VUkkgPj4KL0ggL0kKCj4+CmVuZG9iagoxNyAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNDUuMDg0OTkgMTk1LjY1Mjk4IDE4Ny43ODEgMjA0LjUzMTk4IF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTkwMTgyNjYpCi9TIC9VUkkgPj4KL0ggL0kKCj4+CmVuZG9iagoxOCAwIG9iago8PCAvTGVuZ3RoIDE5IDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnic3VlZc+S2EX6fXzEvrpKqVhBAEDy2Kg/OXpHtjXdXqqQqlh8gDkbDLI9ZHtLOv0+DZAMkyJmRnTylXGsBELrR59fdFFtT+O+Kwf/C2Fsn+erbinVnbB168ANO/nq3un7P14yu77bDL4GACUoCTikVa98nQoj1Xb7+7eJj28gmLYvL9cUa/lVqX1bNsNmW1bD6+eZuWL0VYbxR2eX69/XdT6t3d6vPIwloL8D4SHgeQcE+T4UNPSsuc8Wla+5ZKT/JR9ULcMVY3L9trnoh4d7kOrt0rsAvowh0Z5NryO6i3B5l7seEBTSO4wml5z4gfNCSHXtgyVadAUb6xyRwDBARj3k9o1twUlu/Hnzw5tePn355d/du2MpiM6ySstimVa5wf+954bD8Rdbo1lo+mRsPB2T6kywU3ngri0Qdho2JDepfs+jao8zDA/GaR8P600cbEt9WPgQbuFfbA/zP+lUOOtldpnfM7sYko+Pd+p+rYvXb73B7A1Z7XlHirz+sOtoA+U5pA6S9BYObZCDCtS+PScxC7drOxu8r9a1VRWL03roh3+3yacKkuLApYo6ancJVucdVm5ctplVz2Kt6sJuW0o0BTtcBCM49rU8n5N1A7mSAmF0caeOkwpzprcz32UiQpWAMPUIFkAwByciM7+xOXW4xoJq0rls0xiOEYlWmRaPqJi0kGlYf5mbXHFXUeYWSiEbihyU1nZv3F75/LXwfw7fu1b6/dGkh9TgRITOh4S1p69ypvxq/gxbpYyEL1D5XmSxAtyVtHC6U0CjwF7Vxbt5fsGvGRHhEGTcNY59wgKI46NLQ7nQaxtzuxiSj46NpCJci5DuljZD2TBoyBpjAqIlGm0jJTlYyaVSVQqAkpxIFuHBdZ7jN5jbDUCpkrhDlnq6+puiWv8lqc7j6V5t8VVUu0Xk+Fj+VpYUy1q2SzoE9k7QycVoWSfmozMVdmZdZ+XgylZgA4/ggqj/k9C6tMTUsJ8jdcqPwFxZKdq2V1bw2BSx7eV+VTXnlyJhoGxCsJSODPEt8DqqIKRfpRhVNuk1NzZATodzUYYEgPADtol67RGVZm8nqpSL/Obs/jXUaGVQbQJnENMfIUQPwsOR4VMmizlX+AD+X1AsDaCV8SnmvXqUStW9Mo2Rbpo8f3g+rewAEY01tDnR2VT43OySEQC+rVyhfVpfD8mtRPqP8xvJ1o/I5w57H/SXaAXs7pBoVpqWIk9WSvlFEfAr6hr2+sq7LJJWNiYbn1OjwYmCvalR02TKbtFayVsYaSdugkPlBZdrxZYsaZO1XlafSXNbd0EyLGGq9Roeg12KfqgeZwTO5tVXWpICg4yhIqnSP0j3JKgVEx0e77EyLRyPwdqsqZRA/hdpXVjne3kHHNSwflEIvbMvWdG42bhzfzCqP7nwY8X0fywCE+BPkqO3ohsUXtb1V344WBM+DPNXVUQyNmdl2nZnn2+2EanR+vDeDWxHydqgjpD5TFjyfE+bHBiUXRpCTRWIJeb3AJwFIQgNEXoM6bZHoVDFhCq103XdQeGWEVcZDbjOILfrRQuVRKFM+qCVmwrTFkOpHFfBgcIvCOSWxHtdBaCS+h6785u395etjIRBGRNAQm4LRtguBMLTbCdXo/HgIADOKvJ03KVKfC4E4IByVfANlIU2Mf+zQ8wkgePq726bdpCcba2j+WQCIABJx29D2aPW/6Fq7zdXwc9qhLkcm52AWQFk6tC83C1A9Gx1emTumtE8NUUMbCpU7kX8oinemzIzASn2XOdRlF2WOjy6CERFxSqOZbpUCm9V7BQn3pE5YxQeci/Qni3DGotMVKsQcHDkM7ELEpv2o+1hYgFEeUhLo8Y/P2rDc/ShSp7YVk83M7ON2qTmAcraDgamgk3MQuZHZAWAKywaEjinKxjMW6abdiw35RQ/1n27UQvXjkUe67BsGIcNxCz7NUhMuH25u7zANfjUa7MEUtrI1lVou/mkO94r0wYiId+pGPpi6OlT2c6+M+Da7Q24MlkA/mC6NUnqa54gxfaNirHUq0vEOuHivER9JsPuqy0puVaeW+6DPAI31wDEAlEFfnDX2ebpB6O2/+VSPlkHIYdTT9W3GiIkoDkXALWr31F8+INBS4vkRjzjg7ZiNADY8YBEgLkyGJIyoToPRuUbc6ecmuh6JNCGayvTqRTox/WUxEktKeTQOaRQGL1JqwmesVRQSL2J/UKsx0VSoMUor3URZnPzH25Plw+eCxFpAZr8Q9AHzks8ATnkYj/zL5cEXIdFFMwr//8qDq9ufKA8ui6mus8QNokn71EBnny1VCD+KJ5DyZSrZgG7t5mCHiKSsjXkdf99fFH/hoZ3OWPDDDIYs9KPRazvUlgae6vbh3yAF+uF5V445uWoIysjoy0h+bCpU342PGcOIKasK1FhE/GN1Sn3fA5zW8MSCTfXfAzgkTiT+S9R0GbGYssgLzgKM8CaoKTwObHjAHdQcnb8cNV2ZTuDLjQEYtyuHR4kXRDiYjbZZtxV2O6EanR/tyvWtEHk71CFSn+nKhfAJDUQcDvH045NMM/kAjUQz+3R+UzzpdvlRTmarH2GwbU5PaiIURDBh8NVOarJ/znQU6eITcniil2JoTRAQ/55m5bRXMem8KZM2B1IT72qrATI5nBvsuB8Szrge7FzZp4PdzN0AMr7nU9b/gWS07dytP7/gdkI1Oj/ubrgVI2+HOkbqM+4OKJRPj5mYvlVFnQIAWm/bTusLNMrQ7tkof1MWkN7V/OOE/bPjiSAIPABq/ck7PNOhH/VKADmvW/x4xiuXhxNvh+CEKFyi60FRa3Xmaaa/0sSxNrfLox6b8KgM0AYSH5wG9W1JiKZ8fSS867ZIpwdOE+uGYOB7UIxhFXYhONpm3ZbZ7YRqdH40BDUzirydNylS6xD8vPoPKactKwplbmRzdHJlYW0KZW5kb2JqCjE1IDAgb2JqClsKMTQgMCBSCjE2IDAgUgoxNyAwIFIKXQplbmRvYmoKOCAwIG9iago8PCAvVHlwZSAvUGFnZQovUGFyZW50IDEgMCBSCi9NZWRpYUJveCBbIDAgMCA1OTUgNzkyIF0KL1RyaW1Cb3ggWyAwIDAgNTk1IDc5MiBdCi9CbGVlZEJveCBbIDAgMCA1OTUgNzkyIF0KL1Jlc291cmNlcyAzIDAgUgovQ29udGVudHMgMTggMCBSCi9Bbm5vdHMgMTUgMCBSCj4+CmVuZG9iagoxOSAwIG9iagoyMTg3CmVuZG9iagoyMCAwIG9iago8PCAvVHlwZSAvRm9udAovU3VidHlwZSAvVHlwZTEKL05hbWUgL0YxCi9CYXNlRm9udCAvSGVsdmV0aWNhCi9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nID4+CmVuZG9iagoyMSAwIG9iago8PCAvVHlwZSAvRm9udAovU3VidHlwZSAvVHlwZTEKL05hbWUgL0YzCi9CYXNlRm9udCAvSGVsdmV0aWNhLUJvbGQKL0VuY29kaW5nIC9XaW5BbnNpRW5jb2RpbmcgPj4KZW5kb2JqCjEgMCBvYmoKPDwgL1R5cGUgL1BhZ2VzCi9Db3VudCAyCi9LaWRzIFs4IDAgUiA5IDAgUiBdID4+CmVuZG9iagoyIDAgb2JqCjw8IC9UeXBlIC9DYXRhbG9nCi9QYWdlcyAxIDAgUgovTWV0YWRhdGEgNyAwIFIKPj4KZW5kb2JqCjMgMCBvYmoKPDwKL0ZvbnQgPDwKICAvRjEgMjAgMCBSCiAgL0YzIDIxIDAgUgo+PgovUHJvY1NldCBbIC9QREYgL0ltYWdlQiAvSW1hZ2VDIC9UZXh0IF0KL0NvbG9yU3BhY2UgPDwKICAvRGVmYXVsdFJHQiA2IDAgUgo+Pgo+PgplbmRvYmoKeHJlZgowIDIyCjAwMDAwMDAwMDAgNjU1MzUgZiAKMDAwMDAwNzYyNCAwMDAwMCBuIAowMDAwMDA3Njg4IDAwMDAwIG4gCjAwMDAwMDc3NTMgMDAwMDAgbiAKMDAwMDAwMDAxNSAwMDAwMCBuIAowMDAwMDAwMTU2IDAwMDAwIG4gCjAwMDAwMDI4MzMgMDAwMDAgbiAKMDAwMDAwMjg2NiAwMDAwMCBuIAowMDAwMDA3MjA5IDAwMDAwIG4gCjAwMDAwMDQwODEgMDAwMDAgbiAKMDAwMDAwMzY3OSAwMDAwMCBuIAowMDAwMDA0MjM5IDAwMDAwIG4gCjAwMDAwMDQyNjAgMDAwMDAgbiAKMDAwMDAwNDI4MCAwMDAwMCBuIAowMDAwMDA0MzAwIDAwMDAwIG4gCjAwMDAwMDcxNjggMDAwMDAgbiAKMDAwMDAwNDUwMCAwMDAwMCBuIAowMDAwMDA0NzAwIDAwMDAwIG4gCjAwMDAwMDQ5MDQgMDAwMDAgbiAKMDAwMDAwNzM4MiAwMDAwMCBuIAowMDAwMDA3NDAzIDAwMDAwIG4gCjAwMDAwMDc1MTEgMDAwMDAgbiAKdHJhaWxlcgo8PAovU2l6ZSAyMgovUm9vdCAyIDAgUgovSW5mbyA0IDAgUgovSUQgWzxFNzM1REYwOUZEN0Q0Q0QwQTAyMjE0RjE3QjI1ODE2Nj4gPEU3MzVERjA5RkQ3RDRDRDBBMDIyMTRGMTdCMjU4MTY2Pl0KPj4Kc3RhcnR4cmVmCjc4OTAKJSVFT0YK
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55592186" stop="55592186"
			mutation="Y503_F504insAY" refAllele="T" varAllele="GCCTAT">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 13:11:43.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19943934</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55594221" stop="55594221"
			mutation="K642E" refAllele="A" varAllele="G">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-17 20:47:32.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>Analysis of pattern of progression to imatinib
						therapy in GIST reveals the role of secondary mutations, such as
						K642E</significanceComment>
					<significanceReference>pmid:17875769</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies have assessed the
						presence of this mutation in mucosal melanomas, and its potential
						predictive value for response to imatinib</significanceComment>
					<significanceReference>pmid:2037215</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15323137</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55599321" stop="55599321"
			mutation="D816V" refAllele="A" varAllele="T">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-15 15:26:37.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>This phase II study shows the lack of activity
						of imatinib in KIT D816V mutant positive mastocytosis
					</significanceComment>
					<significanceReference>pmid:19193436</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:17587883</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55599320" stop="55599320"
			mutation="D816H" refAllele="G" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-15 12:01:48.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>testis germ cell tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>These findings suggest that activating KIT
						mutations may contribute to tumorigenesis in a subset of
						seminomas, but are not involved in NSGCT.
					</significanceComment>
					<significanceReference>pmid:14695343</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This study shows that secondary mutations in
						KIT may be partly responsible for acquired resitance to imatinib
						in GIST</significanceComment>
					<significanceReference>pmid:17875769</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>Certain KIT mutations (i.e. KIT D816H) may
						constitute an adverse prognostic factor in adult Acute Myeloid
						Leukemia With inv(16) and t(8;21)</significanceComment>
					<significanceReference>pmid:16921041</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This is a retrospective study assessing the
						somatic activation of KIT in distinct subtypes of melanoma
					</significanceComment>
					<significanceReference>pmid:16908931</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib (in GIST)</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Imatinib (in Melanoma)</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16908931</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55599320" stop="55599320"
			mutation="D816Y" refAllele="G" varAllele="T">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-15 14:57:26.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>This specific mutation only relates with
						hematologic malignancies, that's why the other tumor types have
						been deleted. As previously mentioned, this paper higlights the
						prognostic importance of KIT mutations in CBF-AML patients. This
						specific mutations is amongst others in KIT exon 17.
					</significanceComment>
					<significanceReference>pmid:16921041</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16921041</actionReference>
					<actionComment>This specific mutation only relates with hematologic
						malignancies, that's why the other tumor types have been deleted.
						As previously mentioned, this paper higlights the prognostic
						importance of KIT mutations in CBF-AML patients. This specific
						mutations is amongst others in KIT exon 17. I've been unable to
						find out whether this mutation is activating or not
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55599348" stop="55599348"
			mutation="V825A" refAllele="T" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 13:55:32.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been encountered in patients
						with otherwise good prognostic t(8;21) pediatric AML, and it seems
						to confer a poorer outcome</significanceComment>
					<significanceReference>pmid:16291592</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16291592</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55602694" stop="55602694"
			mutation="E839K" refAllele="G" varAllele="A">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-04-15 16:14:18.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue haematopoietic
						neoplasm</tumourType>
					<type>retrospective</type>
					<significanceComment>This study has analyzed kit mutations in
						patients with mastocytosis. Authors report mutations in exon
						position 839 in pediatric population. Clinical sgnificance of this
						are not yet well elucidated</significanceComment>
					<significanceReference>pmid:9990072</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>inactivating</action>
					<actionReference>pmid:9990072</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593588" stop="55593588"
			mutation="M552L" refAllele="A" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-17 21:27:25.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>Several retrospective studies point towards a
						negative prognostic value if this mutation is present in GIST.
						Moreover, other reports have suggested a potential predictive
						value of M552L for poorer responses to imatinib
					</significanceComment>
					<significanceReference>pmid:16697720, pmid:15685537
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16697720</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593636" stop="55593636"
			mutation="Y568D" refAllele="T" varAllele="G">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 13:32:59.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:14694524</actionReference>
					<actionComment>There are no published data re the significance of
						this particular mutation. This paper highlights the distinct
						genetic background of GIST in patients with NF-1 (in Japan)
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593685" stop="55593685"
			mutation="F584S" refAllele="T" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 18:56:43.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:11376557</actionReference>
					<actionComment>Unknown. Very uncommon mut, basically present in
						Japanese population</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593603" stop="55593603"
			mutation="W557G" refAllele="T" varAllele="G">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 15:59:29.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutations in exons 557 and 558 seem to confer
						poorer prognosis to GIST. This paper suggest future trials of
						adjuvant therapy should be stratified by this mutations.
					</significanceComment>
					<significanceReference>pmid:16135486</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16697720</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593603" stop="55593603"
			mutation="W557R" refAllele="T" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 13:42:27.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>testis germ cell tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>This important paper highlights the prognostic
						relevance of mutations (deletions) in codons 557 to 558, with
						regards to relapse-free survival. Authors suggest future trials of
						imatinib in the adjuvant setting may consider stratification for
						these factors.</significanceComment>
					<significanceReference>pmid:16135486</significanceReference>
					<significanceEvidence>IIIC</significanceEvidence>
				</significance>
				<significance>
					<tumourType>genital tract germ cell tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>This study has found this gain-of-function
						mutation in one patient with a testicular seminoma. Any potential
						clinical relevance of this finding needs to be validated.
					</significanceComment>
					<significanceReference>pmid:12824871</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15161681</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593610" stop="55593610"
			mutation="V559A" refAllele="T" varAllele="C">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 10:07:31.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation my be associated with worse
						prognosis but its predicitive value in GIST cannot be ascertained
						based on current published literature</significanceComment>
					<significanceReference>pmid:16697720</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Case reports have shown responses to imatinib
						in melanomas harbouring this mutation</significanceComment>
					<significanceReference>pmid:19812602, pmid:21159146
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16908931</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593610" stop="55593610"
			mutation="V559D" refAllele="T" varAllele="A">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-18 11:54:06.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This study showed sound preclinical evidence
						regarding the activity of sunitinib in imatinib-resistant GISTs.
					</significanceComment>
					<significanceReference>pmid:16046538</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>Sunitinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Sunitinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16294026</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593610" stop="55593610"
			mutation="V559G" refAllele="T" varAllele="G">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 10:17:38.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>eye malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This article suggest that genetic profiling of
						ocular melanomas should be pursued in order to assess if imatinib
						may be a suitable therapeutic option for this disease
					</significanceComment>
					<significanceReference>pmid:21478825</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation seems to be associated with poor
						prognosis.</significanceComment>
					<significanceReference>pmid:16697720, pmid:16685437
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16697720</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593609" stop="55593609"
			mutation="V559I" refAllele="G" varAllele="A">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 10:27:48.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:12721243</actionReference>
					<actionComment>There is available literature to assess the
						functional consequence of this mutation. Only one sample is
						retrieved from Sanger,and the curated article does not address
						this mutation in particular.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593613" stop="55593613"
			mutation="V560D" refAllele="T" varAllele="A">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 16:33:52.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15154005, pmid:18724245</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593613" stop="55593613"
			mutation="V560G" refAllele="T" varAllele="G">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-20 16:16:31.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>soft tissue gastrointestinal stromal tumour
					</tumourType>
					<type>preclinical</type>
					<significanceComment>This preclinical study suggest that V560G may
						confer sensitivity to imatinib. </significanceComment>
					<significanceReference>pmid:12481435</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>Imatinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Imatinib</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:7691885</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593582" stop="55593608"
			mutation="K550_K558del" refAllele="AAACCCATGTATGAAGTACAGTGGAAG"
			varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 19:14:35.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18488000</actionReference>
					<actionComment>There is no sufficient published evidence as to
						ascertain the functional consequence of this mutation
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593582" stop="55593614"
			mutation="K558_V560del" refAllele="AAACCCATGTATGAAGTACAGTGGAAGGTTGTT"
			varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 19:23:35.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:1848800</actionReference>
					<actionComment>The frequency is so low that it is not possible to
						faithfully determine its functional consequences or clinical
						relevance</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55593582" stop="55593620"
			mutation="K558_E562del" refAllele="AAACCCATGTATGAAGTACAGTGGAAGGTTGTTGAGGAG"
			varAllele="-">
			<lastEditedBy>Ivan Diaz-Padilla</lastEditedBy>
			<lastUpdated>2011-04-16 19:17:18.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:1848800</actionReference>
					<actionComment>No sufficient evidence</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398284" stop="25398284"
			mutation="G12A" refAllele="C" varAllele="G">
			<lastEditedBy>anonymous</lastEditedBy>
			<lastUpdated>2011-08-03 10:52:48.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post hoc analysis of clinical trial data
						demonstrate that the presence of mutations in this gene may be
						predictive of lack of response to EGFR tyrosine kinase inhibitors
					</significanceComment>
					<significanceReference>pmid:16043828, pmid:18626007, pmid:20022659
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in KRAS mutant tumors </significanceComment>
					<significanceReference>pmid:18390968</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective and meta-analysis studies
						suggested that KRAS mutations may be negative prognostic factor
					</significanceComment>
					<significanceReference>pmid:15597105</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791, pmid:20978259
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061, pmid:21149634</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-08-03 10:52:48.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovQ3JlYXRvciAoQXBhY2hlIEZPUCBWZXJzaW9uIDEuMCkKL1Byb2R1Y2VyIChBcGFjaGUgRk9QIFZlcnNpb24gMS4wKQovQ3JlYXRpb25EYXRlIChEOjIwMTEwODAzMTA1MjQ5LTA0JzAwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwKICAvTiAzCiAgL0xlbmd0aCAxMSAwIFIKICAvRmlsdGVyIC9GbGF0ZURlY29kZQo+PgpzdHJlYW0KeJydlndUU9kWh8+9N71QkhCKlNBraFICSA29SJEuKjEJEErAkAAiNkRUcERRkaYIMijggKNDkbEiioUBUbHrBBlE1HFwFBuWSWStGd+8ee/Nm98f935rn73P3Wfvfda6AJD8gwXCTFgJgAyhWBTh58WIjYtnYAcBDPAAA2wA4HCzs0IW+EYCmQJ82IxsmRP4F726DiD5+yrTP4zBAP+flLlZIjEAUJiM5/L42VwZF8k4PVecJbdPyZi2NE3OMErOIlmCMlaTc/IsW3z2mWUPOfMyhDwZy3PO4mXw5Nwn4405Er6MkWAZF+cI+LkyviZjg3RJhkDGb+SxGXxONgAoktwu5nNTZGwtY5IoMoIt43kA4EjJX/DSL1jMzxPLD8XOzFouEiSniBkmXFOGjZMTi+HPz03ni8XMMA43jSPiMdiZGVkc4XIAZs/8WRR5bRmyIjvYODk4MG0tbb4o1H9d/JuS93aWXoR/7hlEH/jD9ld+mQ0AsKZltdn6h21pFQBd6wFQu/2HzWAvAIqyvnUOfXEeunxeUsTiLGcrq9zcXEsBn2spL+jv+p8Of0NffM9Svt3v5WF485M4knQxQ143bmZ6pkTEyM7icPkM5p+H+B8H/nUeFhH8JL6IL5RFRMumTCBMlrVbyBOIBZlChkD4n5r4D8P+pNm5lona+BHQllgCpSEaQH4eACgqESAJe2Qr0O99C8ZHA/nNi9GZmJ37z4L+fVe4TP7IFiR/jmNHRDK4ElHO7Jr8WgI0IABFQAPqQBvoAxPABLbAEbgAD+ADAkEoiARxYDHgghSQAUQgFxSAtaAYlIKtYCeoBnWgETSDNnAYdIFj4DQ4By6By2AE3AFSMA6egCnwCsxAEISFyBAVUod0IEPIHLKFWJAb5AMFQxFQHJQIJUNCSAIVQOugUqgcqobqoWboW+godBq6AA1Dt6BRaBL6FXoHIzAJpsFasBFsBbNgTzgIjoQXwcnwMjgfLoK3wJVwA3wQ7oRPw5fgEVgKP4GnEYAQETqiizARFsJGQpF4JAkRIauQEqQCaUDakB6kH7mKSJGnyFsUBkVFMVBMlAvKHxWF4qKWoVahNqOqUQdQnag+1FXUKGoK9RFNRmuizdHO6AB0LDoZnYsuRlegm9Ad6LPoEfQ4+hUGg6FjjDGOGH9MHCYVswKzGbMb0445hRnGjGGmsVisOtYc64oNxXKwYmwxtgp7EHsSewU7jn2DI+J0cLY4X1w8TogrxFXgWnAncFdwE7gZvBLeEO+MD8Xz8MvxZfhGfA9+CD+OnyEoE4wJroRIQiphLaGS0EY4S7hLeEEkEvWITsRwooC4hlhJPEQ8TxwlviVRSGYkNimBJCFtIe0nnSLdIr0gk8lGZA9yPFlM3kJuJp8h3ye/UaAqWCoEKPAUVivUKHQqXFF4pohXNFT0VFysmK9YoXhEcUjxqRJeyUiJrcRRWqVUo3RU6YbStDJV2UY5VDlDebNyi/IF5UcULMWI4kPhUYoo+yhnKGNUhKpPZVO51HXURupZ6jgNQzOmBdBSaaW0b2iDtCkVioqdSrRKnkqNynEVKR2hG9ED6On0Mvph+nX6O1UtVU9Vvuom1TbVK6qv1eaoeajx1UrU2tVG1N6pM9R91NPUt6l3qd/TQGmYaYRr5Grs0Tir8XQObY7LHO6ckjmH59zWhDXNNCM0V2ju0xzQnNbS1vLTytKq0jqj9VSbru2hnaq9Q/uE9qQOVcdNR6CzQ+ekzmOGCsOTkc6oZPQxpnQ1df11Jbr1uoO6M3rGelF6hXrtevf0Cfos/ST9Hfq9+lMGOgYhBgUGrQa3DfGGLMMUw12G/YavjYyNYow2GHUZPTJWMw4wzjduNb5rQjZxN1lm0mByzRRjyjJNM91tetkMNrM3SzGrMRsyh80dzAXmu82HLdAWThZCiwaLG0wS05OZw2xljlrSLYMtCy27LJ9ZGVjFW22z6rf6aG1vnW7daH3HhmITaFNo02Pzq62ZLde2xvbaXPJc37mr53bPfW5nbse322N3055qH2K/wb7X/oODo4PIoc1h0tHAMdGx1vEGi8YKY21mnXdCO3k5rXY65vTW2cFZ7HzY+RcXpkuaS4vLo3nG8/jzGueNueq5clzrXaVuDLdEt71uUnddd457g/sDD30PnkeTx4SnqWeq50HPZ17WXiKvDq/XbGf2SvYpb8Tbz7vEe9CH4hPlU+1z31fPN9m31XfKz95vhd8pf7R/kP82/xsBWgHcgOaAqUDHwJWBfUGkoAVB1UEPgs2CRcE9IXBIYMj2kLvzDecL53eFgtCA0O2h98KMw5aFfR+OCQ8Lrwl/GGETURDRv4C6YMmClgWvIr0iyyLvRJlESaJ6oxWjE6Kbo1/HeMeUx0hjrWJXxl6K04gTxHXHY+Oj45vipxf6LNy5cDzBPqE44foi40V5iy4s1licvvj4EsUlnCVHEtGJMYktie85oZwGzvTSgKW1S6e4bO4u7hOeB28Hb5Lvyi/nTyS5JpUnPUp2Td6ePJninlKR8lTAFlQLnqf6p9alvk4LTduf9ik9Jr09A5eRmHFUSBGmCfsytTPzMoezzLOKs6TLnJftXDYlChI1ZUPZi7K7xTTZz9SAxESyXjKa45ZTk/MmNzr3SJ5ynjBvYLnZ8k3LJ/J9879egVrBXdFboFuwtmB0pefK+lXQqqWrelfrry5aPb7Gb82BtYS1aWt/KLQuLC98uS5mXU+RVtGaorH1futbixWKRcU3NrhsqNuI2ijYOLhp7qaqTR9LeCUXS61LK0rfb+ZuvviVzVeVX33akrRlsMyhbM9WzFbh1uvb3LcdKFcuzy8f2x6yvXMHY0fJjpc7l+y8UGFXUbeLsEuyS1oZXNldZVC1tep9dUr1SI1XTXutZu2m2te7ebuv7PHY01anVVda926vYO/Ner/6zgajhop9mH05+x42Rjf2f836urlJo6m06cN+4X7pgYgDfc2Ozc0tmi1lrXCrpHXyYMLBy994f9Pdxmyrb6e3lx4ChySHHn+b+O31w0GHe4+wjrR9Z/hdbQe1o6QT6lzeOdWV0iXtjusePhp4tLfHpafje8vv9x/TPVZzXOV42QnCiaITn07mn5w+lXXq6enk02O9S3rvnIk9c60vvG/wbNDZ8+d8z53p9+w/ed71/LELzheOXmRd7LrkcKlzwH6g4wf7HzoGHQY7hxyHui87Xe4Znjd84or7ldNXva+euxZw7dLI/JHh61HXb95IuCG9ybv56Fb6ree3c27P3FlzF3235J7SvYr7mvcbfjT9sV3qID0+6j068GDBgztj3LEnP2X/9H686CH5YcWEzkTzI9tHxyZ9Jy8/Xvh4/EnWk5mnxT8r/1z7zOTZd794/DIwFTs1/lz0/NOvm1+ov9j/0u5l73TY9P1XGa9mXpe8UX9z4C3rbf+7mHcTM7nvse8rP5h+6PkY9PHup4xPn34D94Tz+wplbmRzdHJlYW0KZW5kb2JqCjYgMCBvYmoKWy9JQ0NCYXNlZCA1IDAgUl0KZW5kb2JqCjcgMCBvYmoKPDwKICAvVHlwZSAvTWV0YWRhdGEKICAvU3VidHlwZSAvWE1MCiAgL0xlbmd0aCAxMiAwIFIKPj4Kc3RyZWFtCjw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+Cgo8eDp4bXBtZXRhIHhtbG5zOng9ImFkb2JlOm5zOm1ldGEvIj4KPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4KPHJkZjpEZXNjcmlwdGlvbiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iIHJkZjphYm91dD0iIj4KPGRjOmRhdGU+MjAxMS0wOC0wM1QxMDo1Mjo0OS0wNDowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAxLjA8L3BkZjpQcm9kdWNlcj4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiByZGY6YWJvdXQ9IiI+Cjx4bXA6Q3JlYXRlRGF0ZT4yMDExLTA4LTAzVDEwOjUyOjQ5LTA0OjAwPC94bXA6Q3JlYXRlRGF0ZT4KPHhtcDpDcmVhdG9yVG9vbD5BcGFjaGUgRk9QIFZlcnNpb24gMS4wPC94bXA6Q3JlYXRvclRvb2w+Cjx4bXA6TWV0YWRhdGFEYXRlPjIwMTEtMDgtMDNUMTA6NTI6NDktMDQ6MDA8L3htcDpNZXRhZGF0YURhdGU+CjwvcmRmOkRlc2NyaXB0aW9uPgo8L3JkZjpSREY+CjwveDp4bXBtZXRhPgo8P3hwYWNrZXQgZW5kPSJyIj8+CgoKZW5kc3RyZWFtCmVuZG9iagoxMCAwIG9iago8PCAvTGVuZ3RoIDEzIDAgUiAvRmlsdGVyIC9GbGF0ZURlY29kZSA+PgpzdHJlYW0KeJztWNtu2zgQffdX8GWBFKi5vIqU39Jtmu0WybZpij60fVBsxRHWklpJTuG/71AX60bJzmWzbTYIAksjzszhHM4hpW8Tigj8Tc2Pchmah5NvpY0ixeAHLAQtJy/OJ7+/oogSdH5ZO1GhMSXCdaXiSAgspSSEcIrOQ/Tp4GSdeVkQR+jM/xonGbqME3RM2SEKIvTm7PD9sy/o/K/J0fnkHSR910gsGcNV8ndtQIrtgEQQZx0cb72lj56hqXCxRAdF1u145mCHyb4T64yDAVTDAMpVf3AdPb4czCQUJsp4KWd3Osmww6GwmrOxdN3JCECpXBiqLVOq3Y79yE+8zF80gEf1Na8vD9fLdZo9rw2MUFrfeVl9TclMspnQDeeTFsUtGlsscuRip0OjxoxSFyrgFug5RvG1l2zQ3EvmQRSHHiLYpUz+ViQxa6EfhbmYc2aKzoswryOUXQUpytZhvE5QtvnqPweLj+arIArm3gqlwTIKLuEymvsI+MyHh9VarpKxXjIGnHEOiIG4fl6I8eH0zenfH09nY3gdgomEaWsqCr8z/9JPfAPl88Hbk9cvPz+boaPrYGFM20jW+lFYChBJEVVEEhh9hTklvpc2akixEEqM1pAShpmbc8EetIj9xHtWkXKOiVk9XNA7lpFKgalhkitdhJIYpaG3WoGMZX6aBZHfKCfDgrtkvJxKYpZz7D5sNbt59ywmIxK7yqxlyvYuJrT8t4lBQDXWGnwlCpGQFBeBmvYV2Eltd2s7ad9eoY+TaPLpC9gXICPfQT+OixzQbNYcW/sKvc8lyI6g7cXIbmRD9j5ELACkCc8G0jJL2j7Y+mmYE9scTe6ErYxmLWBtrzBNLViaVJJbMEhgr2iVpbB0C1LuFGYRttenAKUjDiFMl81+eO0FK+8iWAXZxrTL6+jaNOoybxdop8OlH2Xp6Jp3OBYgILqS73NoR68Iu/Kh89sBvTzgSCMaFVHMdCJh/eAnR28g5FVwEWRxkj5HL84OXzUMw0CZ1tgh0NGSy35YdOVd+2gRz9chwIPN3r80GjLfjAAV0OxCqmLj6kX8EP0Txd+jTosrBxdbXWf11Pb2olSqtpP27WCLQyw9kENXzv2uGUSmdyMbsu/R4t20zJLWAlbXXtPOaHInbNNimL2AqlvAqQ2LM4hlLwbzhm6WpbR0CjLY4q7GUkjYudxy73rvR2mQBdemw71oAa8YaZBm+f74RxzB9pTAer/YoOodZKzZuVEa2Bi1q+S22xPod/g3MRdesjAyMjeG5Rr2OdiXfdivr+D4m66XS9CCzpY8zzGMKQInMHelCBXUsSBItvMZRs5hd8+PyJIySwiUxWP5HWj0QjuExfno+NUZCuMonq+MwnXeM6Bm8HbBzRpyWXks8qIsuIgXgT8qrFyCpLjgB8ekqtb7nWXgZMyUOQrCOawfJfQ2w2lhmQnKYYMg1OJakjWm3hT6iAk4AzoW/7ReisMQKHBFmOOaclkgjFJFgSruwNwdxizO7d2jrc3cgZ6Dormi3fYNe0tNIE1tJ+3bIW02sfRADl059+RuGJnejWzIvlube2mZJa0FrK69pp3R5E7YpsUwewFVt4BTGxZnEMteDBolbpWltHQKMqTN3JxBGBy/FNHV60H+uedPELA42TQWZPUBwMQX5t2u/OCUJzT/YRFyhVzz/aC+wDK/BNdVHqCaisHfmM6UllEaXkXdtobyGYX3Q1bGZFiyOrw18JB7I3hhKotXPSet6OWlHTppxLDkaD03mlA+Leu1rWBVH7JHOtKF26C5r9xu53vMSy/zrZ93KBnjl7SIvTHDpE3EI+b4VozWNb4Vp+boFCRhfnSycsv24pZJUvyKmiO4vgG5eYQGt3WksI4uyXaWxfPG3bZYVV5rxjKsCSr6fDRtg6Q3c+1m3ZbmZ6A9NG+IVsZzvim8vYoe30+du4865/O8d1ptZ+sureZT/ZToKYFdu/w2PybYTyT/l/K8D6EvzfvgqDDbObyDDosujT0lLqLemxY30j4uNe6JKlOYOU/99kuKqgO6iqieUTHjZExUn0j+9UXVzuGTqP6MospdrPRj6LfqRpaSt728ZR/SG0qtvG+plXeSWmfG6UzKMal9pNQTy83/UITt7D6YCFdCeG8iLBmyi3Az4T7k31CdG3vKv67N5u8HZVyhEwplbmRzdHJlYW0KZW5kb2JqCjggMCBvYmoKPDwKICAvUmVzb3VyY2VzIDMgMCBSCiAgL1R5cGUgL1BhZ2UKICAvTWVkaWFCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9Dcm9wQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvQmxlZWRCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9UcmltQm94IFswIDAgNTk0LjcyIDc5Ml0KICAvUGFyZW50IDEgMCBSCiAgL0NvbnRlbnRzIDEwIDAgUgo+PgoKZW5kb2JqCjExIDAgb2JqCjI1OTYKZW5kb2JqCjEyIDAgb2JqCjc5MwplbmRvYmoKMTMgMCBvYmoKMTYyNwplbmRvYmoKMTUgMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODk0NjA2MSkKL1MgL1VSSSA+PgplbmRvYmoKMTYgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgNDA5LjE1NSA1NzEuOTYxIDQ3NS4zMiA1ODAuODQgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMTUgMCBSCi9IIC9JCgo+PgplbmRvYmoKMTggMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMTE0OTYzNCkKL1MgL1VSSSA+PgplbmRvYmoKMTkgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgNzIuMCA1NjAuNDQxIDEzOC4xNjUgNTY5LjMyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDE4IDAgUgovSCAvSQoKPj4KZW5kb2JqCjIwIDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTgzOTA5NjgpCi9TIC9VUkkgPj4KZW5kb2JqCjIxIDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDE1NC42NzQgNDI4LjEyMSAyMjAuODM5IDQzNy4wIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDIwIDAgUgovSCAvSQoKPj4KZW5kb2JqCjIyIDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjExMTg5NjMpCi9TIC9VUkkgPj4KZW5kb2JqCjIzIDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDE1NC42NzQgMzY0Ljc2MSAyMjAuODM5IDM3My42NCBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSAyMiAwIFIKL0ggL0kKCj4+CmVuZG9iagoyNCAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNTQuNjc0IDI3OC4zNjEgMjIwLjgzOSAyODcuMjQgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMTUgMCBSCi9IIC9JCgo+PgplbmRvYmoKMjUgMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODMxNjc5MSkKL1MgL1VSSSA+PgplbmRvYmoKMjYgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMjI4Ljg0MyAyNzguMzYxIDI5NS4wMDggMjg3LjI0IF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDI1IDAgUgovSCAvSQoKPj4KZW5kb2JqCjI3IDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjA5NzgyNTkpCi9TIC9VUkkgPj4KZW5kb2JqCjI4IDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDMwMy4wMTIgMjc4LjM2MSAzNjkuMTc3IDI4Ny4yNCBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSAyNyAwIFIKL0ggL0kKCj4+CmVuZG9iagoyOSAwIG9iago8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE2MDQzODI4KQovUyAvVVJJID4+CmVuZG9iagozMCAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNTQuNjc0IDE3MC44NDEgMjIwLjgzOSAxNzkuNzIgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgMjkgMCBSCi9IIC9JCgo+PgplbmRvYmoKMzEgMCBvYmoKPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODYyNjAwNykKL1MgL1VSSSA+PgplbmRvYmoKMzIgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMjI4Ljg0MyAxNzAuODQxIDI5NS4wMDggMTc5LjcyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDMxIDAgUgovSCAvSQoKPj4KZW5kb2JqCjMzIDAgb2JqCjw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjAwMjI2NTkpCi9TIC9VUkkgPj4KZW5kb2JqCjM0IDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDMwMy4wMTIgMTcwLjg0MSAzNjkuMTc3IDE3OS43MiBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSAzMyAwIFIKL0ggL0kKCj4+CmVuZG9iagozNSAwIG9iago8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE1NTk3MTA1KQovUyAvVVJJID4+CmVuZG9iagozNiAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNTQuNjc0IDg0LjQ0MSAyMjAuODM5IDkzLjMyIF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDM1IDAgUgovSCAvSQoKPj4KZW5kb2JqCjM3IDAgb2JqCjw8IC9MZW5ndGggMzggMCBSIC9GaWx0ZXIgL0ZsYXRlRGVjb2RlID4+CnN0cmVhbQp4nL1ZS2/jNhC++1fwUiABEobvR27ZNBu47bZ5YXtY96DIiiPUlrySvN3013coydbbsWpgkYMsQpz5+HH4zQzzdUIRgb9z99CWIX81+VqOUaQZPGCEoMXkw9Pk4iNFlKCnl2oSFQZTIqyVmiMhsJSSEMIpelqhLyefNpmXhXGEHoJ1nGToJU7QLWVXKIzQrw9Xj6d/oadfJjdPk3twel9zLBnDW+f3TUCavQOJIM5aOO68RYBO0bmwWKCTwuvue6awYgK+lrI7k7Y+hg+o4dYaSrsfVy7il0F3QmOiOSHUqK4F1vpYMqw4s9YKts9de0UCUGoJs4zeN+02iILEy4J5DXhU/ebVz6vNYpNmZ9UAI0DA7s3Lqt+UXEp2KUxt8qfGPjf2srGVHFHW2kpKMFOwEqttgf5jEnzdBJH/hoDjPJZW2yArg8o9s9cAZfEaZZtVvElQ9rYO0h2ICgIBqjBX7ShjohovgVmsGsgMMMwV7KK0yGBGKUA0JcSn3GnvmtkBpqmE0LewYaRrerf6XuucvG9dAqHSgEUIjbb1R2+1XtaIum9QxSU2ZmeZdiyTjj2KcD8L4n8YW3oJHOIwyoI0C6MA+V7ih1G88gaJHu+DYSDeDnI73uDsRCl2wYyxGqUFu7PTAX5BGMQ4tMP0jra13ESLAygdbZdCdlB8kNHR9mYnVMkLKiwV7xIqDS4S2sHW+TCj443F37zk7QBOx1sm2FImB0kdbxBY1ReQkPi7nGqCxbgdE8Ocjje29iI/Cbz0AFrHG6cwQYtBWscbnJ1IfcEtN+/Saii2apRtOUzreGPpylsuR2nreB8MC27JILvjDc5O+AVlQyHrEimhWLoZGq2QkBTSKiTVxvgSxkk1zqpx0nx9RX9OosmXv2B8Doj/gaLltvDBMOn1sRtfosccUT+C1iz+PrKh8S5E0Nbb3C0bcMt63PaA5dWs89bX5ChspbV+AnmbwPM+LHQQy0E7SLBs0lKOtAgZLE8Zx1pAHchYEZR5AZqXpdevXuL5WZCEcKb8sqjqj2wqFCYS1k2tLEtIqF9fNpHv6lpvifw4SovCL3Blb/YaprWyN0Vb491yD4xCu6GgPzOyx88VePgGZqLFMD4Gs4TW0B/1GECX0Nu9BEkObXZy92n68+z0sgRUnO5kUWufuMZUQrtotOmxtl6F80tqLDCq6O447ybZfIpl1GFRCkMp4EIFKlpoNxJgrN4VtpchYE+5iy3NWd9CzoYww7vUWLq4VCA3FVCQI2EVrzKG+9JAkiDQefXjK4LYZRINy1GtkK/GmydJ02qcNF8HdQls2QEfdju5e9QHkbH3kQ2NH6BLbbesx20PWFbNOm99TY7Cdl581k8gbRN43oeFDGI5aAdzFarTUo60CNnbOluGNYHemasyxq+XYRT6oCdeNEd3SeBv3x+zzTwM0mEZgUYZ2lLi8i8X26sRjAZ7MlR0Uj/tUz3G4YS4E8lBC3KL06iQtlrXfpa38jugabiIwhf42auEW2+sq2GSYc4dcVz0OH6FivI5CCIUfPdWsJA5en5Ddw9/PN7dXD9NP9+07lfctYHGymUIVlrYIcyS0Fuml3sXrgzWLpw41eX9FAAIYPNT2If8YsNDn25+BWJfw+cwixM0D1aQArLissZzoh1mb7sLD0dAlOW0JWkXq7HYWMBqWFk5jVFsw7DSArCqHkOlXkNdZ5XZyeB2CjBt4dgpYo0aLdfuYtEZJkKyHs/o5ls4d0u4RNPph86aOaWtaP1BsdV1PBBbN9e/TX+fXl/9Vmz63oDh7taRU2uMLPNP/fCmxeGtxwhg97Ke2EAr7w3AoDSI0hCCyF2SNSOtGz5ccgxLJFRQdVT4dA1tsyhk/NodQRU+XApMXbZnx4VP13MtfD7/3F2yFpi7A7o73j8qejqORysTN7J1VMZIkyC6Fb6PwbcggckJ5Ix4Ff4LCNa5Wk2n09JiU53y0HPUrJMg7a9YoZyFCEphE1MojnPGsrizEkENliDTlEE1lWO5uf34gMBV7C/zshgCO3yO8+CfnfhBtvkerrznM7T2ohB2agMvs1Onkn68jOHEZK6Udu6SrjMOZLiC0JDjorxrqL+oraIc6kUME1xSPyrKu57R2SBiKhU2gsPR4n0zt8JOlbYV5mrSMaAZ9ExQhUNLoug40IzXxHUANGDShsnqEreadBRoCz2Ia4Jcw9ADupaOPuwroyAIWrmfQRnVuHxFxZ3p3tpJGNo65T9IobqORyuUsBwL2BCj+XiBklSAKMBkJsqO+y5OM/Qa+6AG3vINBMWtrWkSzb3M6+bHtkhtuUiL/yCBpUUARW2RMzvLkKzTvSbBPPTztArWlp7/t3uCg7Vr312qzQUse0vi1FXLf4eRE9I9uVcKF3XAtib6KFXqGipOuCKCG9ZXukmQFiIooUeqUtfzoao0hNkopkA/+lTpCNANVRoFuqFKA6CZuyFS/ap0DOi6KvWA3l8kS+hDmDvLjP5YEek67hWRh5unPTIiNfQE1P0fWrPxOgIRhK3rAZUR25OVwblcB8UBdh3yKsi8852qbMvsdLNYQLu7rXR2RXahHGWBHQULL7ezTuJFFLsbwM4CFIVmHgSEKV7u1wt0dnG3NlGc59dPDA7WUSrQNVScKCmtpkT2qADsVn6fpe1xKtD1XI/NbQmeX93fT/4D3osaoAplbmRzdHJlYW0KZW5kb2JqCjE3IDAgb2JqClsKMTYgMCBSCjE5IDAgUgoyMSAwIFIKMjMgMCBSCjI0IDAgUgoyNiAwIFIKMjggMCBSCjMwIDAgUgozMiAwIFIKMzQgMCBSCjM2IDAgUgpdCmVuZG9iagoxNCAwIG9iago8PAogIC9SZXNvdXJjZXMgMyAwIFIKICAvVHlwZSAvUGFnZQogIC9NZWRpYUJveCBbMCAwIDU5NC43MiA3OTJdCiAgL0Nyb3BCb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9CbGVlZEJveCBbMCAwIDU5NC43MiA3OTJdCiAgL1RyaW1Cb3ggWzAgMCA1OTQuNzIgNzkyXQogIC9QYXJlbnQgMSAwIFIKICAvQW5ub3RzIDE3IDAgUgogIC9Db250ZW50cyAzNyAwIFIKPj4KCmVuZG9iagozOCAwIG9iagoyMDA5CmVuZG9iagozOSAwIG9iago8PAogIC9UeXBlIC9Gb250CiAgL1N1YnR5cGUgL1R5cGUxCiAgL0Jhc2VGb250IC9IZWx2ZXRpY2EKICAvRW5jb2RpbmcgL1dpbkFuc2lFbmNvZGluZwo+PgoKZW5kb2JqCjQwIDAgb2JqCjw8CiAgL1R5cGUgL0ZvbnQKICAvU3VidHlwZSAvVHlwZTEKICAvQmFzZUZvbnQgL0hlbHZldGljYS1Cb2xkCiAgL0VuY29kaW5nIC9XaW5BbnNpRW5jb2RpbmcKPj4KCmVuZG9iago0MSAwIG9iago8PAogIC9UeXBlIC9Gb250CiAgL1N1YnR5cGUgL1R5cGUxCiAgL0Jhc2VGb250IC9IZWx2ZXRpY2EtT2JsaXF1ZQogIC9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nCj4+CgplbmRvYmoKMSAwIG9iago8PCAvVHlwZSAvUGFnZXMKL0NvdW50IDIKL0tpZHMgWzE0IDAgUiA4IDAgUiBdID4+CmVuZG9iagoyIDAgb2JqCjw8CiAgL1R5cGUgL0NhdGFsb2cKICAvUGFnZXMgMSAwIFIKICAvTWV0YWRhdGEgNyAwIFIKICAvTGFuZyAoZW4tVVMpCiAgL1BhZ2VMYWJlbHMgOSAwIFIKPj4KCmVuZG9iagozIDAgb2JqCjw8Ci9Gb250IDw8CiAgL0YxIDM5IDAgUgogIC9GMyA0MCAwIFIKICAvRjIgNDEgMCBSCj4+Ci9Qcm9jU2V0IFsgL1BERiAvSW1hZ2VCIC9JbWFnZUMgL1RleHQgXQovQ29sb3JTcGFjZSA8PAogIC9EZWZhdWx0UkdCIDYgMCBSCj4+Cj4+CmVuZG9iago5IDAgb2JqCjw8IC9OdW1zIFswIDw8IC9QICgxKSA+PgogMSA8PCAvUCAoMikgPj4KXSA+PgoKZW5kb2JqCnhyZWYKMCA0MgowMDAwMDAwMDAwIDY1NTM1IGYgCjAwMDAwMTA4MDMgMDAwMDAgbiAKMDAwMDAxMDg2OCAwMDAwMCBuIAowMDAwMDEwOTc2IDAwMDAwIG4gCjAwMDAwMDAwMTUgMDAwMDAgbiAKMDAwMDAwMDE0NSAwMDAwMCBuIAowMDAwMDAyODI3IDAwMDAwIG4gCjAwMDAwMDI4NjAgMDAwMDAgbiAKMDAwMDAwNTQ0NiAwMDAwMCBuIAowMDAwMDExMTI2IDAwMDAwIG4gCjAwMDAwMDM3NDMgMDAwMDAgbiAKMDAwMDAwNTY1MCAwMDAwMCBuIAowMDAwMDA1NjcxIDAwMDAwIG4gCjAwMDAwMDU2OTEgMDAwMDAgbiAKMDAwMDAxMDIyNiAwMDAwMCBuIAowMDAwMDA1NzEyIDAwMDAwIG4gCjAwMDAwMDU3OTMgMDAwMDAgbiAKMDAwMDAxMDEyOSAwMDAwMCBuIAowMDAwMDA1OTMxIDAwMDAwIG4gCjAwMDAwMDYwMTIgMDAwMDAgbiAKMDAwMDAwNjE0OCAwMDAwMCBuIAowMDAwMDA2MjI5IDAwMDAwIG4gCjAwMDAwMDYzNjcgMDAwMDAgbiAKMDAwMDAwNjQ0OCAwMDAwMCBuIAowMDAwMDA2NTg3IDAwMDAwIG4gCjAwMDAwMDY3MjYgMDAwMDAgbiAKMDAwMDAwNjgwNyAwMDAwMCBuIAowMDAwMDA2OTQ2IDAwMDAwIG4gCjAwMDAwMDcwMjcgMDAwMDAgbiAKMDAwMDAwNzE2NiAwMDAwMCBuIAowMDAwMDA3MjQ3IDAwMDAwIG4gCjAwMDAwMDczODYgMDAwMDAgbiAKMDAwMDAwNzQ2NyAwMDAwMCBuIAowMDAwMDA3NjA2IDAwMDAwIG4gCjAwMDAwMDc2ODcgMDAwMDAgbiAKMDAwMDAwNzgyNiAwMDAwMCBuIAowMDAwMDA3OTA3IDAwMDAwIG4gCjAwMDAwMDgwNDQgMDAwMDAgbiAKMDAwMDAxMDQ0OCAwMDAwMCBuIAowMDAwMDEwNDY5IDAwMDAwIG4gCjAwMDAwMTA1NzYgMDAwMDAgbiAKMDAwMDAxMDY4OCAwMDAwMCBuIAp0cmFpbGVyCjw8Ci9TaXplIDQyCi9Sb290IDIgMCBSCi9JbmZvIDQgMCBSCi9JRCBbPEZCMTQ5OTUwODYyNDg3NkE4RDEwRUQ4NDlGOEY2ODVFPiA8RkIxNDk5NTA4NjI0ODc2QThEMTBFRDg0OUY4RjY4NUU+XQo+PgpzdGFydHhyZWYKMTExODgKJSVFT0YK
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-08 18:14:30.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-08 16:31:55.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398285" stop="25398285"
			mutation="G12C" refAllele="C" varAllele="A">
			<lastEditedBy>Lillian Sui</lastEditedBy>
			<lastUpdated>2012-04-04 17:57:21.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analyses of clinical trial data
						demonstrate that the presences of this mutation may be predictive
						of resistance to EGFR </significanceComment>
					<significanceReference>pmid:18626007, pmid:16043828
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Cell line data showed G12C to be associated
						with reduced response to cisplatin and an increased sensitivity to
						paclitaxel and pemetrexed</significanceComment>
					<significanceReference>21169473</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies suggested that KRAS
						mutations are a negative prognostic factor </significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>pancreas carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective analysis of a clinical trial did
						not demonstrate a role for this mutation in predicting sensitivity
						to EGFR tyrosine kinase inhibitors</significanceComment>
					<significanceReference>pmid:18626007</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Comment: Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-04 17:57:32.0</date>
					<userName>lsiu</userName>
					<name>Lillian Sui</name>
					<comment></comment>
					<body><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Mutation report for KRAS G12C</title>

</head>
<body>
	<p>
	Status: 
	
	<span class="statuscomplete">COMPLETE</span>
	
	
	and confirmed
	
	&#x2014; 
	
	Last saved by: Lillian Sui on 04/04/2012 05:57 PM
	
	</p>
	  
	<hr />
	<h3>Frequency of G12C mutation in KRAS in the top tumour types</h3>
	
	<table>
	<thead>
		<tr>
			<th align="left" width="30"></th>
			<th align="left" width="220">Tumour</th>
			<th align="left" width="80">Frequency</th>
			<th align="left" width="100">Samples</th>
		</tr>
	</thead>
	<tbody>
		
		
		
			<tr>
				<td>1.</td>
				<td>lung carcinoma</td>
				<td>6.7990%</td>
				<td>(1014/14914 samples)</td>
				
			</tr>
		
			<tr>
				<td>2.</td>
				<td>large intestine carcinoma</td>
				<td>3.0176%</td>
				<td>(872/28897 samples)</td>
				
			</tr>
		
			<tr>
				<td>3.</td>
				<td>pancreas carcinoma</td>
				<td>2.0823%</td>
				<td>(82/3938 samples)</td>
				
			</tr>
		
			<tr>
				<td>4.</td>
				<td>breast carcinoma</td>
				<td>0.8333%</td>
				<td>(5/600 samples)</td>
				
			</tr>
		
			<tr>
				<td>5.</td>
				<td>ovary carcinoma</td>
				<td>0.2684%</td>
				<td>(5/1863 samples)</td>
				
			</tr>
		
		
	</tbody>
	</table>
	
	<hr />
	<h3>KRAS characteristics</h3>
	
	<h4>Full name: v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog</h4>
	
	<p>This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. (provided by RefSeq)</p>
	               
	<hr />
	<h3>KRAS G12C characteristics</h3>
	  	
	<p>The functional consequence of this mutation is: <b>activating</b>.
	   Reference (PMID): pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a></p>
	
	
					
	<hr />
	<h3>Clinical and Preclinical Studies</h3>
	
	
	
	
	  	
	
	<h4>1. lung carcinoma
	
	- 6.7990%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Post-hoc analyses of clinical trial data demonstrate that the presences of this mutation may be predictive of resistance to EGFR </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18626007'>18626007</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/16043828'>16043828</a> - evidence IIB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retrospective studies suggested that KRAS mutations are a negative prognostic factor </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21187500'>21187500</a> - evidence VD</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>Cell line data showed G12C to be associated with reduced response to cisplatin and an increased sensitivity to paclitaxel and pemetrexed</p>
				<p>Reference: 21169473 - evidence VD</p>
			
		
	
		
	
	<h4>2. large intestine carcinoma
	
	- 3.0176%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Comment: Several randomized phase III trials demonstrated that the presence of this mutation confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18316791'>18316791</a> - evidence IB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21118963'>21118963</a> - evidence VD</p>
			
		
	
		
	
	<h4>3. pancreas carcinoma
	
	- 2.0823%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18626007'>18626007</a> - evidence IIB</p>
			
		
	
		
	
	<h4>4. breast carcinoma
	
	- 0.8333%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>5. ovary carcinoma
	
	- 0.2684%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	  	
	<hr />
	<h3>Availability of Investigational Agents</h3>
	  	
	
		<p>
		The available investigational agents <i>MEK inhibitors, BRAF inhibitors</i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
	
	<hr />
	<h3>Sensitivity and Resistance Conferred by Mutation</h3>
	
	
		<p>There are standard of care guidelines that suggest this mutation confers <b>resistance</b> to: EGFR monoclonal antibodies</p>
	
		<p>This mutation <b>may</b> confer <b>resistance</b> to: EGFR tyrosine kinase inhibitors</p>
	
		<p>This mutation <b>may</b> confer <b>sensitivity</b> to: MEK inhibitors</p>
	
	
	<hr />
	<h3>Report History</h3>
	  	
	
		<table>
			<thead>
				<tr>
					<th align="left" width="120">Date</th>
					<th align="left" width="100">Confirmed by</th>
					<th align="left" width="220">Comment</th>
				</tr>
			</thead>
			<tbody>
	  			
	  				<tr>
	 					<td>04/04/2012 05:57 PM</td>
	  					<td>Lillian Sui</td>
	  					<td></td>
	 				</tr>
	  			
	  				<tr>
	 					<td>04/03/2012 05:37 PM</td>
	  					<td>Lillian Sui</td>
	  					<td></td>
	 				</tr>
	  			
	 		</tbody>
		</table>
	
</body>
</html>

					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2012-04-03 17:37:31.0</date>
					<userName>lsiu</userName>
					<name>Lillian Sui</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398284" stop="25398284"
			mutation="G12D" refAllele="C" varAllele="T">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-02-15 17:25:53.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>A preclinical study in a lung cancer cell line
						model suggests that this mutation may be sensitive to the
						combination of a PI3K and MEK inhibitor</significanceComment>
					<significanceReference>pmid:19029981</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer</significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791, pmid:20978259
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective and meta-analysis studies
						suggested that KRAS mutations may be negative prognostic factor
					</significanceComment>
					<significanceReference>pmid:15597105</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in KRAS mutant tumors </significanceComment>
					<significanceReference>pmid:18390968</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>pancreas carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective analysis of a clinical trial did
						not demonstrate a role for this mutation in predicting sensitivity
						to EGFR tyrosine kinase inhibitors </significanceComment>
					<significanceReference>pmid:20824720</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analyses of clinical trial data and
						meta-analyses of observational studies demonstrate that the
						presence of this mutation may be predictive of lack of response to
						EGFR tyrosine kinase inhibitors </significanceComment>
					<significanceReference>pmid:16043828, pmid:18626007, pmid:20022659
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>ovary carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that ovarian
						tumors with KRAS mutations may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:19018267</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies in colonrectal carcinoma
					</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:21311774, pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-08-04 16:44:39.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body><?xml version="1.0" encoding="iso-8859-1"?>

<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US" xml:lang="en-US">
<head>
<title>Mutation Report for G12D in KRAS</title>
<meta name="date" content=" 4 August, 2011 at 04:44:39 PM" />
</head>
<body>
<h2>Frequency of G12D mutation in KRAS in the top tumour types</h2><table><tr><th width="24" /> <th width="200"><p>Tumour</p></th> <th width="80"><p>Frequency</p></th> <th width="140"><p>Samples</p></th></tr> <tr><td><p>1 .</p></td> <td><p>large intestine carcinoma</p></td> <td><p>12.4650</p></td> <td><p>(3602/28897 samples)</p></td></tr> <tr><td><p>2 .</p></td> <td><p>lung carcinoma</p></td> <td><p>3.0106</p></td> <td><p>(449/14914 samples)</p></td></tr> <tr><td><p>3 .</p></td> <td><p>breast carcinoma</p></td> <td><p>0.6667</p></td> <td><p>(4/600 samples)</p></td></tr> <tr><td><p>4 .</p></td> <td><p>ovary carcinoma</p></td> <td><p>4.1868</p></td> <td><p>(78/1863 samples)</p></td></tr> <tr><td><p>5 .</p></td> <td><p>pancreas carcinoma</p></td> <td><p>35.6272</p></td> <td><p>(1403/3938 samples)</p></td></tr></table><hr /><h2><i>KRAS G12D</i> Characteristics</h2><p>The functional consequence of this mutation is  <b>Activating</b> : Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21311774">pmid:21311774</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a></p><hr /><h2>Clinical and Preclinical Studies</h2><h3>1. large intestine carcinoma 12.4650%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390968">pmid:18390968</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21118963">pmid:21118963</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Several randomized phase III trials demonstrated that the presence of this mutation confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18316791">pmid:18316791</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20978259">pmid:20978259</a> <br /> Evidence: IB</p><h3>2. lung carcinoma 3.0106%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Post-hoc analyses of clinical trial data and meta-analyses of observational studies demonstrate that the presence of this mutation may be predictive of lack of response to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/16043828">pmid:16043828</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18626007">pmid:18626007</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20022659">pmid:20022659</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">A preclinical study in a lung cancer cell line model suggests that this mutation may be sensitive to the combination of a PI3K and MEK inhibitor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19029981">pmid:19029981</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective and meta-analysis studies suggested that KRAS mutations may be negative prognostic factor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15597105">pmid:15597105</a> <br /> Evidence: IIB</p><h3>3. breast carcinoma 0.6667%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>is UNKNOWN:</em></p><p class="indented"></p><p class="indented">Reference (PMID):  <br /> Evidence: </p><h3>4. ovary carcinoma 4.1868%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies suggest that ovarian tumors with KRAS mutations may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19018267">pmid:19018267</a> <br /> Evidence: VD</p><h3>5. pancreas carcinoma 35.6272%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20824720">pmid:20824720</a> <br /> Evidence: IIB</p><hr /><h2>Availability of Investigational Agents</h2><p class="indented" id="0.0266534791789645 details">The available investigational agents  <em>MEK inhibitors, BRAF inhibitors</em>  have documented efficacy  <em>Unknown</em></p><hr /><h2>Sensitivity and Resistance Conferred by Mutation</h2><p>This mutation  <em>may</em>  confer  <em>resistance</em>  to  <em>EGFR tyrosine kinase inhibitors</em></p><p>This mutation  <em>may</em>  confer  <em>sensitivity</em>  to  <em>MEK inhibitors</em></p><p>There are standard of care guidelines that suggest this mutation confers  <em>resistance</em>  to  <em>EGFR monoclonal antibodies in colonrectal carcinoma</em></p><hr /><h2>Report History</h2><table border="1"><tr><th align="left" width="100"><p>Date</p></th> <th align="left" width="100"><p>Confirmed by</p></th> <th align="left" width="250"><p>Comment</p></th></tr> <tr><td><p>2011-08-04 16:44:39</p></td> <td><p>Dancey</p></td> <td><p></p></td></tr> <tr><td><p>2011-08-04 16:44:33</p></td> <td><p>Dancey</p></td> <td><p></p></td></tr> <tr><td><p>2011-06-08 16:31:30</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:49:54</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:27:55</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:18:57</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:15:18</p></td> <td><p></p></td> <td><p></p></td></tr></table>
</body>
</html>
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-08-04 16:44:33.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body><?xml version="1.0" encoding="iso-8859-1"?>

<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US" xml:lang="en-US">
<head>
<title>Mutation Report for G12D in KRAS</title>
<meta name="date" content=" 4 August, 2011 at 04:44:33 PM" />
</head>
<body>
<h2>Frequency of G12D mutation in KRAS in the top tumour types</h2><table><tr><th width="24" /> <th width="200"><p>Tumour</p></th> <th width="80"><p>Frequency</p></th> <th width="140"><p>Samples</p></th></tr> <tr><td><p>1 .</p></td> <td><p>large intestine carcinoma</p></td> <td><p>12.4650</p></td> <td><p>(3602/28897 samples)</p></td></tr> <tr><td><p>2 .</p></td> <td><p>lung carcinoma</p></td> <td><p>3.0106</p></td> <td><p>(449/14914 samples)</p></td></tr> <tr><td><p>3 .</p></td> <td><p>breast carcinoma</p></td> <td><p>0.6667</p></td> <td><p>(4/600 samples)</p></td></tr> <tr><td><p>4 .</p></td> <td><p>ovary carcinoma</p></td> <td><p>4.1868</p></td> <td><p>(78/1863 samples)</p></td></tr> <tr><td><p>5 .</p></td> <td><p>pancreas carcinoma</p></td> <td><p>35.6272</p></td> <td><p>(1403/3938 samples)</p></td></tr></table><hr /><h2><i>KRAS G12D</i> Characteristics</h2><p>The functional consequence of this mutation is  <b>Activating</b> : Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21311774">pmid:21311774</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a></p><hr /><h2>Clinical and Preclinical Studies</h2><h3>1. large intestine carcinoma 12.4650%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390968">pmid:18390968</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21118963">pmid:21118963</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Several randomized phase III trials demonstrated that the presence of this mutation confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18316791">pmid:18316791</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20978259">pmid:20978259</a> <br /> Evidence: IB</p><h3>2. lung carcinoma 3.0106%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Post-hoc analyses of clinical trial data and meta-analyses of observational studies demonstrate that the presence of this mutation may be predictive of lack of response to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/16043828">pmid:16043828</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18626007">pmid:18626007</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20022659">pmid:20022659</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">A preclinical study in a lung cancer cell line model suggests that this mutation may be sensitive to the combination of a PI3K and MEK inhibitor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19029981">pmid:19029981</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective and meta-analysis studies suggested that KRAS mutations may be negative prognostic factor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15597105">pmid:15597105</a> <br /> Evidence: IIB</p><h3>3. breast carcinoma 0.6667%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>is UNKNOWN:</em></p><p class="indented"></p><p class="indented">Reference (PMID):  <br /> Evidence: </p><h3>4. ovary carcinoma 4.1868%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies suggest that ovarian tumors with KRAS mutations may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19018267">pmid:19018267</a> <br /> Evidence: VD</p><h3>5. pancreas carcinoma 35.6272%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20824720">pmid:20824720</a> <br /> Evidence: IIB</p><hr /><h2>Availability of Investigational Agents</h2><p class="indented" id="0.982731565439281 details">The available investigational agents  <em>MEK inhibitors, BRAF inhibitors</em>  have documented efficacy  <em>Unknown</em></p><hr /><h2>Sensitivity and Resistance Conferred by Mutation</h2><p>This mutation  <em>may</em>  confer  <em>resistance</em>  to  <em>EGFR tyrosine kinase inhibitors</em></p><p>There are standard of care guidelines that suggest this mutation confers  <em>resistance</em>  to  <em>EGFR monoclonal antibodies in colonrectal carcinoma</em></p><p>This mutation  <em>may</em>  confer  <em>sensitivity</em>  to  <em>MEK inhibitors</em></p><hr /><h2>Report History</h2><table border="1"><tr><th align="left" width="100"><p>Date</p></th> <th align="left" width="100"><p>Confirmed by</p></th> <th align="left" width="250"><p>Comment</p></th></tr> <tr><td><p>2011-08-04 16:44:33</p></td> <td><p>Dancey</p></td> <td><p></p></td></tr> <tr><td><p>2011-06-08 16:31:30</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:49:54</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:27:55</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:18:57</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:15:18</p></td> <td><p></p></td> <td><p></p></td></tr></table>
</body>
</html>
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-08 16:31:30.0</date>
					<userName></userName>
					<name></name>
					<comment></comment>
					<body><?xml version="1.0" encoding="iso-8859-1"?>

<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US" xml:lang="en-US">
<head>
<title>Mutation Report for G12D in KRAS</title>
<meta name="date" content=" 8 June, 2011 at 04:31:30 PM" />
</head>
<body>
<h2>Frequency of G12D mutation in KRAS in the top tumour types</h2><table><tr><th width="24" /> <th width="200"><p>Tumour</p></th> <th width="80"><p>Frequency</p></th> <th width="140"><p>Samples</p></th></tr> <tr><td><p>1 .</p></td> <td><p>large intestine carcinoma</p></td> <td><p>12.3584</p></td> <td><p>(3010/24356 samples)</p></td></tr> <tr><td><p>2 .</p></td> <td><p>lung carcinoma</p></td> <td><p>3.0630</p></td> <td><p>(426/13908 samples)</p></td></tr> <tr><td><p>3 .</p></td> <td><p>breast carcinoma</p></td> <td><p>0.4854</p></td> <td><p>(2/412 samples)</p></td></tr> <tr><td><p>4 .</p></td> <td><p>ovary carcinoma</p></td> <td><p>4.3845</p></td> <td><p>(78/1779 samples)</p></td></tr> <tr><td><p>5 .</p></td> <td><p>pancreas carcinoma</p></td> <td><p>35.2518</p></td> <td><p>(1323/3753 samples)</p></td></tr></table><hr /><h2><i>KRAS G12D</i> Characteristics</h2><p>The functional consequence of this mutation is  <b>Activating</b> : Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21311774">pmid:21311774</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a></p><hr /><h2>Clinical and Preclinical Studies</h2><h3>1. large intestine carcinoma 12.3584%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Several randomized phase III trials demonstrated that the presence of this mutation confers resitance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18316791">pmid:18316791</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20978259">pmid:20978259</a> <br /> Evidence: IB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21118963">pmid:21118963</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390968">pmid:18390968</a> <br /> Evidence: IIB</p><h3>2. lung carcinoma 3.0630%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Post-hoc analyses of clinical trial data and meta-analyses of observational studies demonstrate that the presence of this mutation may be predictive of lack of response to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/16043828">pmid:16043828</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18626007">pmid:18626007</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20022659">pmid:20022659</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective and meta-analysis studies suggested that KRAS mutations may be negative prognostic factor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15597105">pmid:15597105</a> <br /> Evidence: IIB</p><h3>3. breast carcinoma 0.4854%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>is UNKNOWN:</em></p><p class="indented"></p><p class="indented">Reference (PMID):  <br /> Evidence: </p><h3>4. ovary carcinoma 4.3845%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies suggest that ovarian tumors with KRAS mutations may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19018267">pmid:19018267</a> <br /> Evidence: VD</p><h3>5. pancreas carcinoma 35.2518%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20824720">pmid:20824720</a> <br /> Evidence: IIB</p><hr /><h2>Availability of Investigational Agents</h2><p class="indented" id="0.596421441828141 details">The available investigational agents  <em>MEK inhibittors, BRAF inhibitors</em>  have documented efficacy  <em>Unknown</em></p><hr /><h2>Sensitivity and Resistance Conferred by Mutation</h2><p>There are standard of care guidelines that suggest this mutation confers  <em>resistance</em>  to  <em>EGFR monoclonal antibodies in colonrectal carcinoma</em></p><p>This mutation  <em>may</em>  confer  <em>sensitivity</em>  to  <em>MEK inhibitors</em></p><p>This mutation  <em>may</em>  confer  <em>resistance</em>  to  <em>EGFR tyrosine kinase inhibitors</em></p><hr /><h2>Report History</h2><table border="1"><tr><th align="left" width="100"><p>Date</p></th> <th align="left" width="100"><p>Confirmed by</p></th> <th align="left" width="250"><p>Comment</p></th></tr> <tr><td><p>2011-06-08 16:31:30</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:49:54</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:27:55</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:18:57</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:15:18</p></td> <td><p></p></td> <td><p></p></td></tr></table>
</body>
</html>
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-01 17:49:54.0</date>
					<userName></userName>
					<name></name>
					<comment></comment>
					<body><?xml version="1.0" encoding="iso-8859-1"?>

<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US" xml:lang="en-US">
<head>
<title>Mutation Report for G12D in KRAS</title>
<meta name="date" content=" 1 June, 2011 at 05:49:54 PM" />
</head>
<body>
<h2>Frequency of G12D mutation in KRAS in the top tumour types</h2><table><tr><th width="24" /> <th width="200"><p>Tumour</p></th> <th width="80"><p>Frequency</p></th> <th width="140"><p>Samples</p></th></tr> <tr><td><p>1 .</p></td> <td><p>large intestine carcinoma</p></td> <td><p>12.3584</p></td> <td><p>(3010/24356 samples)</p></td></tr> <tr><td><p>2 .</p></td> <td><p>lung carcinoma</p></td> <td><p>3.0630</p></td> <td><p>(426/13908 samples)</p></td></tr> <tr><td><p>3 .</p></td> <td><p>breast carcinoma</p></td> <td><p>0.4854</p></td> <td><p>(2/412 samples)</p></td></tr> <tr><td><p>4 .</p></td> <td><p>ovary carcinoma</p></td> <td><p>4.3845</p></td> <td><p>(78/1779 samples)</p></td></tr> <tr><td><p>5 .</p></td> <td><p>pancreas carcinoma</p></td> <td><p>35.2518</p></td> <td><p>(1323/3753 samples)</p></td></tr></table><hr /><h2><i>KRAS G12D</i> Characteristics</h2><p>The functional consequence of this mutation is  <b>Activating</b> : Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21311774">pmid:21311774</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a></p><hr /><h2>Clinical and Preclinical Studies</h2><h3>1. large intestine carcinoma 12.3584%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Several randomized phase III trials demonstrated that the presence of this mutation confers resitance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18316791">pmid:18316791</a> <br /> Evidence: IB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21118963">pmid:21118963</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390968">pmid:18390968</a> <br /> Evidence: IIB</p><h3>2. lung carcinoma 3.0630%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Post-hoc analyses of clinical trial data and meta-analyses of observational studies demonstrate that the presences of this mutation may be predictive of lack of response to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/16043828">pmid:16043828</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18626007">pmid:18626007</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20022659">pmid:20022659</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective and meta-analysis studies suggested that KRAS mutations may be negative prognostic factor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15597105">pmid:15597105</a> <br /> Evidence: IIB</p><h3>3. breast carcinoma 0.4854%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>is UNKNOWN:</em></p><p class="indented"></p><p class="indented">Reference (PMID):  <br /> Evidence: </p><h3>4. ovary carcinoma 4.3845%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies suggest that ovarian tumors with KRAS mutations may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19018267">pmid:19018267</a> <br /> Evidence: VD</p><h3>5. pancreas carcinoma 35.2518%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20824720">pmid:20824720</a> <br /> Evidence: IIB</p><hr /><h2>Availability of Investigational Agents</h2><p class="indented" id="0.5004976438412 details">The available investigational agents  <em>MEK inhibittors, BRAF inhibitors</em>  have documented efficacy  <em>Unknown</em></p><hr /><h2>Sensitivity and Resistance Conferred by Mutation</h2><p>There are standard of care guidelines that suggest this mutation confers  <em>resistance</em>  to  <em>EGFR monoclonal antibodies in colonrectal carcinoma</em></p><p>This mutation  <em>may</em>  confer  <em>sensitivity</em>  to  <em>MEK inhibitors</em></p><p>This mutation  <em>may</em>  confer  <em>resistance</em>  to  <em>EGFR tyrosine kinase inhibitors</em></p><hr /><h2>Report History</h2><table border="1"><tr><th align="left" width="100"><p>Date</p></th> <th align="left" width="100"><p>Confirmed by</p></th> <th align="left" width="250"><p>Comment</p></th></tr> <tr><td><p>2011-06-01 17:49:54</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:27:55</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:18:57</p></td> <td><p></p></td> <td><p></p></td></tr> <tr><td><p>2011-06-01 17:15:18</p></td> <td><p></p></td> <td><p></p></td></tr></table>
</body>
</html>
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-01 17:27:55.0</date>
					<userName></userName>
					<name></name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-01 17:18:57.0</date>
					<userName></userName>
					<name></name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-01 17:15:18.0</date>
					<userName></userName>
					<name></name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398284" stop="25398285"
			mutation="G12F" refAllele="CC" varAllele="AA">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 14:42:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>unknown</type>
					<significanceComment>Several randomized phase III trials
						demonstrated that the presence of activating KRAS mutations
						confers resistance to EGFR monoclonal antibodies (cetuximab,
						panitumumab) in colorectal cancer. Due to the rarity of this
						specific mutation </significanceComment>
					<significanceReference></significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19584155</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398285" stop="25398285"
			mutation="G12R" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 14:35:33.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analyses of clinical trial data
						demonstrate that the presences of this mutation may be predictive
						of resistance to EGFR tyrosine kinase inhibitors
					</significanceComment>
					<significanceReference>pmid:16043828</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies suggested that KRAS
						mutations are a negative prognostic factor </significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Comment: Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398285" stop="25398285"
			mutation="G12S" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-20 14:35:44.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies suggested that KRAS
						mutations are a negative prognostic factor</significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Comment: Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies and post-hoc analyses of
						clinical trial data demonstrate that the presences of this
						mutation may be predictive of resistance to EGFR tyrosine kinase
						inhibitors</significanceComment>
					<significanceReference>pmid:18626007, pmid:16043828
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398284" stop="25398284"
			mutation="G12V" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 14:37:00.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>pancreas carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Retrospective analysis of a clinical trial did
						not demonstrate a role for this mutation in predicting sensitivity
						to EGFR tyrosine kinase inhibitors</significanceComment>
					<significanceReference>pmid:18626007</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies suggested that KRAS
						mutations are a negative prognostic factor
					</significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Post-hoc analyses of clinical trial data
						demonstrate that the presences of this mutation may be predictive
						of resistance to EGFR tyrosine kinase inhibitors
					</significanceComment>
					<significanceReference>pmid:18626007, pmid:16043828
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>ovary carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that ovarian
						tumors with KRAS mutations may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:19018267</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-09-21 10:47:37.0</date>
					<userName>Janet Dancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body><?xml version="1.0" encoding="iso-8859-1"?>

<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US" xml:lang="en-US">
<head>
<title>Mutation Report for G12V in KRAS</title>
<meta name="date" content="21 September, 2011 at 10:47:37 AM" />
</head>
<body>
<h2>Frequency of G12V mutation in KRAS in the top tumour types</h2><table><tr><th width="24" /> <th width="200"><p>Tumour</p></th> <th width="80"><p>Frequency</p></th> <th width="140"><p>Samples</p></th></tr> <tr><td><p>1 .</p></td> <td><p>large intestine carcinoma</p></td> <td><p>8.0043</p></td> <td><p>(2313/28897 samples)</p></td></tr> <tr><td><p>2 .</p></td> <td><p>lung carcinoma</p></td> <td><p>3.3660</p></td> <td><p>(502/14914 samples)</p></td></tr> <tr><td><p>3 .</p></td> <td><p>breast carcinoma</p></td> <td><p>0.6667</p></td> <td><p>(4/600 samples)</p></td></tr> <tr><td><p>4 .</p></td> <td><p>ovary carcinoma</p></td> <td><p>3.3280</p></td> <td><p>(62/1863 samples)</p></td></tr> <tr><td><p>5 .</p></td> <td><p>pancreas carcinoma</p></td> <td><p>21.9655</p></td> <td><p>(865/3938 samples)</p></td></tr></table><hr /><h2><i>KRAS G12V</i> Characteristics</h2><p>The functional consequence of this mutation is  <b>Activating</b> : Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21169357">pmid:21169357</a></p><hr /><h2>Clinical and Preclinical Studies</h2><h3>1. large intestine carcinoma 8.0043%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390968">pmid:18390968</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Several randomized phase III trials demonstrated that the presence of this mutation confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18946061">pmid:18946061</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18316791">pmid:18316791</a> <br /> Evidence: IB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21118963">pmid:21118963</a> <br /> Evidence: VD</p><h3>2. lung carcinoma 3.3660%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Post-hoc analyses of clinical trial data and meta-analyses of observational studies demonstrate that the presence of this mutation may be predictive of lack of response to EGFR tyrosine kinase inhibitors </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/16043828">pmid:16043828</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18626007">pmid:18626007</a> ,  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20022659">pmid:20022659</a> <br /> Evidence: IIB</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">A preclinical study in a lung cancer cell line model suggests that mutations in this gene may be sensitive to the combination of a PI3K and MEK inhibitor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19029981">pmid:19029981</a> <br /> Evidence: VD</p><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by RETROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective and meta-analysis studies suggested that KRAS mutations may be negative prognostic factor</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15597105">pmid:15597105</a> <br /> Evidence: IIB</p><h3>3. breast carcinoma 0.6667%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>is UNKNOWN:</em></p><p class="indented"></p><p class="indented">Reference (PMID):  <br /> Evidence: </p><h3>4. ovary carcinoma 3.3280%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PRECLINICAL study:</em></p><p class="indented">Preclinical studies suggest that ovarian tumors with KRAS mutations may be sensitive to MEK inhibitors
 </p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19018267">pmid:19018267</a> <br /> Evidence: VD</p><h3>5. pancreas carcinoma 21.9655%</h3><p class="indented">In this tumour type, the clinical significance of this mutation <em>has been examined by PROSPECTIVE clinical trials:</em></p><p class="indented">Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors</p><p class="indented">Reference (PMID):  <a href="http://www.ncbi.nlm.nih.gov/pubmed/20824720">pmid:20824720</a> <br /> Evidence: IIB</p><hr /><h2>Availability of Investigational Agents</h2><p class="indented" id="0.602025806863967 details">The available investigational agents  <em>MEK inhibitors, BRAF inhibitors</em>  have documented efficacy  <em>Unknown</em></p><hr /><h2>Sensitivity and Resistance Conferred by Mutation</h2><p>This mutation  <em>may</em>  confer  <em>sensitivity</em>  to  <em>MEK inhibitors</em></p><p>This mutation  <em>may</em>  confer  <em>resistance</em>  to  <em>EGFR tyrosine kinase inhibitors</em></p><p>There are standard of care guidelines that suggest this mutation confers  <em>resistance</em>  to  <em>EGFR monoclonal antibodies</em></p><hr /><h2>Report History</h2><table border="1"><tr><th align="left" width="100"><p>Date</p></th> <th align="left" width="100"><p>Confirmed by</p></th> <th align="left" width="250"><p>Comment</p></th></tr> <tr><td><p>2011-09-21 10:47:37</p></td> <td><p>Janet Dancey</p></td> <td><p></p></td></tr></table>
</body>
</html>
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398281" stop="25398281"
			mutation="G13D" refAllele="C" varAllele="T">
			<lastEditedBy>Lillian Sui</lastEditedBy>
			<lastUpdated>2012-04-04 17:20:45.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in KRAS mutant tumors </significanceComment>
					<significanceReference>pmid:18390968</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies suggested that KRAS
						mutations are a negative prognostic factor</significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Several randomized phase III trials
						demonstrated that the presence of this mutation confers resistance
						to EGFR monoclonal antibodies (cetuximab, panitumumab) in
						colorectal </significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>pancreas carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective analysis of a clinical trial did
						not demonstrate a role for this mutation in predicting sensitivity
						to EGFR tyrosine kinase inhibitors</significanceComment>
					<significanceReference>pmid:18626007</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analyses of clinical trial data
						demonstrate that the presences of this mutation may be predictive
						of resistance to EGFR tyrosine kinase inhibitors
					</significanceComment>
					<significanceReference>pmid:18626007, pmid:16043828
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retropective analysis of data from RCTs showed
						that KRAS G13D may confer sensitivity to anti-EGFR agents
					</significanceComment>
					<significanceReference>20978259</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monocolonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-04 17:21:02.0</date>
					<userName>lsiu</userName>
					<name>Lillian Sui</name>
					<comment></comment>
					<body><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Mutation report for KRAS G13D</title>

</head>
<body>
	<p>
	Status: 
	
	<span class="statuscomplete">COMPLETE</span>
	
	
	and confirmed
	
	&#x2014; 
	
	Last saved by: Lillian Sui on 04/04/2012 05:20 PM
	
	</p>
	  
	<hr />
	<h3>Frequency of G13D mutation in KRAS in the top tumour types</h3>
	
	<table>
	<thead>
		<tr>
			<th align="left" width="30"></th>
			<th align="left" width="220">Tumour</th>
			<th align="left" width="80">Frequency</th>
			<th align="left" width="100">Samples</th>
		</tr>
	</thead>
	<tbody>
		
		
		
			<tr>
				<td>1.</td>
				<td>large intestine carcinoma</td>
				<td>6.9523%</td>
				<td>(2009/28897 samples)</td>
				
			</tr>
		
			<tr>
				<td>2.</td>
				<td>breast carcinoma</td>
				<td>1.6667%</td>
				<td>(10/600 samples)</td>
				
			</tr>
		
			<tr>
				<td>3.</td>
				<td>ovary carcinoma</td>
				<td>0.5904%</td>
				<td>(11/1863 samples)</td>
				
			</tr>
		
			<tr>
				<td>4.</td>
				<td>lung carcinoma</td>
				<td>0.4090%</td>
				<td>(61/14914 samples)</td>
				
			</tr>
		
			<tr>
				<td>5.</td>
				<td>pancreas carcinoma</td>
				<td>0.3301%</td>
				<td>(13/3938 samples)</td>
				
			</tr>
		
		
	</tbody>
	</table>
	
	<hr />
	<h3>KRAS characteristics</h3>
	
	<h4>Full name: v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog</h4>
	
	<p>This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. (provided by RefSeq)</p>
	               
	<hr />
	<h3>KRAS G13D characteristics</h3>
	  	
	<p>The functional consequence of this mutation is: <b>activating</b>.
	   Reference (PMID): pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a></p>
	
	
					
	<hr />
	<h3>Clinical and Preclinical Studies</h3>
	
	
	
	
	  	
	
	<h4>1. large intestine carcinoma
	
	- 6.9523%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Several randomized phase III trials demonstrated that the presence of this mutation confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18316791'>18316791</a> - evidence IB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21118963'>21118963</a> - evidence VD</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18390968'>18390968</a> - evidence IIB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retropective analysis of data from RCTs showed that KRAS G13D may confer sensitivity to anti-EGFR agents</p>
				<p>Reference: 20978259 - evidence IIB</p>
			
		
	
		
	
	<h4>2. breast carcinoma
	
	- 1.6667%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>3. ovary carcinoma
	
	- 0.5904%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>4. lung carcinoma
	
	- 0.4090%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Post-hoc analyses of clinical trial data demonstrate that the presences of this mutation may be predictive of resistance to EGFR tyrosine kinase inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18626007'>18626007</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/16043828'>16043828</a> - evidence IIB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retrospective studies suggested that KRAS mutations are a negative prognostic factor</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21187500'>21187500</a> - evidence VD</p>
			
		
	
		
	
	<h4>5. pancreas carcinoma
	
	- 0.3301%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retrospective analysis of a clinical trial did not demonstrate a role for this mutation in predicting sensitivity to EGFR tyrosine kinase inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18626007'>18626007</a> - evidence IIB</p>
			
		
	
		
	
	  	
	<hr />
	<h3>Availability of Investigational Agents</h3>
	  	
	
		<p>
		The available investigational agents <i>MEK inhibitors, BRAF inhibitors</i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
	
	<hr />
	<h3>Sensitivity and Resistance Conferred by Mutation</h3>
	
	
		<p>There are standard of care guidelines that suggest this mutation confers <b>resistance</b> to: EGFR monocolonal antibodies</p>
	
		<p>This mutation <b>may</b> confer <b>resistance</b> to: EGFR tyrosine kinase inhibitors</p>
	
		<p>This mutation <b>may</b> confer <b>sensitivity</b> to: MEK inhibitors</p>
	
	
	<hr />
	<h3>Report History</h3>
	  	
	
		<table>
			<thead>
				<tr>
					<th align="left" width="120">Date</th>
					<th align="left" width="100">Confirmed by</th>
					<th align="left" width="220">Comment</th>
				</tr>
			</thead>
			<tbody>
	  			
	  				<tr>
	 					<td>04/04/2012 05:21 PM</td>
	  					<td>Lillian Sui</td>
	  					<td></td>
	 				</tr>
	  			
	 		</tbody>
		</table>
	
</body>
</html>

					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398281" stop="25398281"
			mutation="G13V" refAllele="C" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-04-11 17:59:11.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in KRAS mutant tumors </significanceComment>
					<significanceReference>18390968</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This is a rare KRAS mutation. Retrospective
						studies suggested that KRAS mutations are a negative prognostic
						factor. </significanceComment>
					<significanceReference>pmid:21187500</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Comment: This is a rare KRAS mutation.
						Retrospective analysis of several randomized phase III trials
						demonstrated that the presence of mutations in this gene confers
						resistance to EGFR monoclonal antibodies (cetuximab, panitumumab)
						in colorectal cancer </significanceComment>
					<significanceReference>pmid:18946061</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective analyses from several randomized
						trials suggest KRAS mutations correlate with absence of response
						to EGFR tyrosine kinase inhibitors</significanceComment>
					<significanceReference>pmid:16043828, pmid:18626007, pmid:20022659
					</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>EGFR tyrosine kinase inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18946061</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-11 17:59:44.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Mutation report for KRAS G13V</title>

</head>
<body>
	<p>
	Status: 
	
	<span class="statuscomplete">COMPLETE</span>
	
	
	and confirmed
	
	&#x2014; 
	
	Last saved by: Janet Dancey on 04/11/2012 05:59 PM
	
	</p>
	  
	<hr />
	<h3>Frequency of G13V mutation in KRAS in the top tumour types</h3>
	
	<table>
	<thead>
		<tr>
			<th align="left" width="30"></th>
			<th align="left" width="220">Tumour</th>
			<th align="left" width="80">Frequency</th>
			<th align="left" width="100">Samples</th>
		</tr>
	</thead>
	<tbody>
		
		
		
			<tr>
				<td>1.</td>
				<td>small intestine carcinoma</td>
				<td>0.8130%</td>
				<td>(1/123 samples)</td>
				
			</tr>
		
			<tr>
				<td>2.</td>
				<td>soft tissue leiomyosarcoma</td>
				<td>0.6757%</td>
				<td>(1/148 samples)</td>
				
			</tr>
		
			<tr>
				<td>3.</td>
				<td>ovary carcinoma</td>
				<td>0.1074%</td>
				<td>(2/1863 samples)</td>
				
			</tr>
		
			<tr>
				<td>4.</td>
				<td>large intestine carcinoma</td>
				<td>0.0415%</td>
				<td>(12/28897 samples)</td>
				
			</tr>
		
			<tr>
				<td>5.</td>
				<td>lung carcinoma</td>
				<td>0.0134%</td>
				<td>(2/14914 samples)</td>
				
			</tr>
		
		
	</tbody>
	</table>
	
	<hr />
	<h3>KRAS characteristics</h3>
	
	<h4>Full name: v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog</h4>
	
	<p>This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. (provided by RefSeq)</p>
	               
	<hr />
	<h3>KRAS G13V characteristics</h3>
	  	
	<p>The functional consequence of this mutation is: <b>activating</b>.
	   Reference (PMID): pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a></p>
	
	
					
	<hr />
	<h3>Clinical and Preclinical Studies</h3>
	
	
	
	
	  	
	
	<h4>1. small intestine carcinoma
	
	- 0.8130%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>2. soft tissue leiomyosarcoma
	
	- 0.6757%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>3. ovary carcinoma
	
	- 0.1074%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation is <b>unknown</b>.</p>
			
		
	
		
	
	<h4>4. large intestine carcinoma
	
	- 0.0415%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Comment: This is a rare KRAS mutation. Retrospective analysis of several randomized phase III trials demonstrated that the presence of mutations in this gene confers resistance to EGFR monoclonal antibodies (cetuximab, panitumumab) in colorectal cancer </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18946061'>18946061</a> - evidence IB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>Preclinical studies demonstrate that KRAS mutant tumors may be sensitive to MEK inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21118963'>21118963</a> - evidence VD</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>prospective</b> clinical trials.</p>
			
				<p>Phase 1 study of a MEK inhibitor demonstrated activity in KRAS mutant tumors </p>
				<p>Reference: 18390968 - evidence VD</p>
			
		
	
		
	
	<h4>5. lung carcinoma
	
	- 0.0134%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>This is a rare KRAS mutation. Retrospective studies suggested that KRAS mutations are a negative prognostic factor. </p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/21187500'>21187500</a> - evidence IIB</p>
			
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> clinical trials.</p>
			
				<p>Retrospective analyses from several randomized trials suggest KRAS mutations correlate with absence of response to EGFR tyrosine kinase inhibitors</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/16043828'>16043828</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18626007'>18626007</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/20022659'>20022659</a> - evidence IIB</p>
			
		
	
		
	
	  	
	<hr />
	<h3>Availability of Investigational Agents</h3>
	  	
	
		<p>
		The available investigational agents <i>MEK inhibitors, BRAF inhibitors</i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
	
	<hr />
	<h3>Sensitivity and Resistance Conferred by Mutation</h3>
	
	
		<p>There are standard of care guidelines that suggest this mutation confers <b>resistance</b> to: EGFR monoclonal antibodies</p>
	
		<p>This mutation <b>may</b> confer <b>resistance</b> to: EGFR tyrosine kinase inhibitors</p>
	
		<p>This mutation <b>may</b> confer <b>sensitivity</b> to: MEK inhibitors</p>
	
	
	<hr />
	<h3>Report History</h3>
	  	
	
		<table>
			<thead>
				<tr>
					<th align="left" width="120">Date</th>
					<th align="left" width="100">Confirmed by</th>
					<th align="left" width="220">Comment</th>
				</tr>
			</thead>
			<tbody>
	  			
	  				<tr>
	 					<td>04/11/2012 05:59 PM</td>
	  					<td>Janet Dancey</td>
	  					<td></td>
	 				</tr>
	  			
	  				<tr>
	 					<td>04/11/2012 05:23 PM</td>
	  					<td>Lillian Siu</td>
	  					<td></td>
	 				</tr>
	  			
	 		</tbody>
		</table>
	
</body>
</html>

					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2012-04-11 17:23:53.0</date>
					<userName>lsiu</userName>
					<name>Lillian Siu</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovVGl0bGUgKE11dGF0aW9uIHJlcG9ydCBmb3IgS1JBUyBHMTNWKQovUHJvZHVjZXIgKEFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzKQovQ3JlYXRpb25EYXRlIChEOjIwMTIwNDExMTcyMzUzLTA0JzAtNDgwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwgL04gMwovTGVuZ3RoIDEzIDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnicnZZ3VFPZFofPvTe9UJIQipTQa2hSAkgNvUiRLioxCRBKwJAAIjZEVHBEUZGmCDIo4ICjQ5GxIoqFAVGx6wQZRNRxcBQblklkrRnfvHnvzZvfH/d+a5+9z91n733WugCQ/IMFwkxYCYAMoVgU4efFiI2LZ2AHAQzwAANsAOBws7NCFvhGApkCfNiMbJkT+Be9ug4g+fsq0z+MwQD/n5S5WSIxAFCYjOfy+NlcGRfJOD1XnCW3T8mYtjRNzjBKziJZgjJWk3PyLFt89pllDznzMoQ8GctzzuJl8OTcJ+ONORK+jJFgGRfnCPi5Mr4mY4N0SYZAxm/ksRl8TjYAKJLcLuZzU2RsLWOSKDKCLeN5AOBIyV/w0i9YzM8Tyw/FzsxaLhIkp4gZJlxTho2TE4vhz89N54vFzDAON40j4jHYmRlZHOFyAGbP/FkUeW0ZsiI72Dg5ODBtLW2+KNR/Xfybkvd2ll6Ef+4ZRB/4w/ZXfpkNALCmZbXZ+odtaRUAXesBULv9h81gLwCKsr51Dn1xHrp8XlLE4ixnK6vc3FxLAZ9rKS/o7/qfDn9DX3zPUr7d7+VhePOTOJJ0MUNeN25meqZExMjO4nD5DOafh/gfB/51HhYR/CS+iC+URUTLpkwgTJa1W8gTiAWZQoZA+J+a+A/D/qTZuZaJ2vgR0JZYAqUhGkB+HgAoKhEgCXtkK9DvfQvGRwP5zYvRmZid+8+C/n1XuEz+yBYkf45jR0QyuBJRzuya/FoCNCAARUAD6kAb6AMTwAS2wBG4AA/gAwJBKIgEcWAx4IIUkAFEIBcUgLWgGJSCrWAnqAZ1oBE0gzZwGHSBY+A0OAcugctgBNwBUjAOnoAp8ArMQBCEhcgQFVKHdCBDyByyhViQG+QDBUMRUByUCCVDQkgCFUDroFKoHKqG6qFm6FvoKHQaugANQ7egUWgS+hV6ByMwCabBWrARbAWzYE84CI6EF8HJ8DI4Hy6Ct8CVcAN8EO6ET8OX4BFYCj+BpxGAEBE6ooswERbCRkKReCQJESGrkBKkAmlA2pAepB+5ikiRp8hbFAZFRTFQTJQLyh8VheKilqFWoTajqlEHUJ2oPtRV1ChqCvURTUZros3RzugAdCw6GZ2LLkZXoJvQHeiz6BH0OPoVBoOhY4wxjhh/TBwmFbMCsxmzG9OOOYUZxoxhprFYrDrWHOuKDcVysGJsMbYKexB7EnsFO459gyPidHC2OF9cPE6IK8RV4FpwJ3BXcBO4GbwS3hDvjA/F8/DL8WX4RnwPfgg/jp8hKBOMCa6ESEIqYS2hktBGOEu4S3hBJBL1iE7EcKKAuIZYSTxEPE8cJb4lUUhmJDYpgSQhbSHtJ50i3SK9IJPJRmQPcjxZTN5CbiafId8nv1GgKlgqBCjwFFYr1Ch0KlxReKaIVzRU9FRcrJivWKF4RHFI8akSXslIia3EUVqlVKN0VOmG0rQyVdlGOVQ5Q3mzcovyBeVHFCzFiOJD4VGKKPsoZyhjVISqT2VTudR11EbqWeo4DUMzpgXQUmmltG9og7QpFYqKnUq0Sp5KjcpxFSkdoRvRA+jp9DL6Yfp1+jtVLVVPVb7qJtU21Suqr9XmqHmo8dVK1NrVRtTeqTPUfdTT1Lepd6nf00BpmGmEa+Rq7NE4q/F0Dm2OyxzunJI5h+fc1oQ1zTQjNFdo7tMc0JzW0tby08rSqtI6o/VUm67toZ2qvUP7hPakDlXHTUegs0PnpM5jhgrDk5HOqGT0MaZ0NXX9dSW69bqDujN6xnpReoV67Xr39An6LP0k/R36vfpTBjoGIQYFBq0Gtw3xhizDFMNdhv2Gr42MjWKMNhh1GT0yVjMOMM43bjW+a0I2cTdZZtJgcs0UY8oyTTPdbXrZDDazN0sxqzEbMofNHcwF5rvNhy3QFk4WQosGixtMEtOTmcNsZY5a0i2DLQstuyyfWRlYxVtts+q3+mhtb51u3Wh9x4ZiE2hTaNNj86utmS3Xtsb22lzyXN+5q+d2z31uZ27Ht9tjd9Oeah9iv8G+1/6Dg6ODyKHNYdLRwDHRsdbxBovGCmNtZp13Qjt5Oa12Oub01tnBWex82PkXF6ZLmkuLy6N5xvP48xrnjbnquXJc612lbgy3RLe9blJ3XXeOe4P7Aw99D55Hk8eEp6lnqudBz2de1l4irw6v12xn9kr2KW/E28+7xHvQh+IT5VPtc99XzzfZt9V3ys/eb4XfKX+0f5D/Nv8bAVoB3IDmgKlAx8CVgX1BpKAFQdVBD4LNgkXBPSFwSGDI9pC78w3nC+d3hYLQgNDtoffCjMOWhX0fjgkPC68JfxhhE1EQ0b+AumDJgpYFryK9Issi70SZREmieqMVoxOim6Nfx3jHlMdIY61iV8ZeitOIE8R1x2Pjo+Ob4qcX+izcuXA8wT6hOOH6IuNFeYsuLNZYnL74+BLFJZwlRxLRiTGJLYnvOaGcBs700oCltUunuGzuLu4TngdvB2+S78ov508kuSaVJz1Kdk3enjyZ4p5SkfJUwBZUC56n+qfWpb5OC03bn/YpPSa9PQOXkZhxVEgRpgn7MrUz8zKHs8yzirOky5yX7Vw2JQoSNWVD2Yuyu8U02c/UgMREsl4ymuOWU5PzJjc690iecp4wb2C52fJNyyfyffO/XoFawV3RW6BbsLZgdKXnyvpV0Kqlq3pX668uWj2+xm/NgbWEtWlrfyi0LiwvfLkuZl1PkVbRmqKx9X7rW4sVikXFNza4bKjbiNoo2Di4ae6mqk0fS3glF0utSytK32/mbr74lc1XlV992pK0ZbDMoWzPVsxW4dbr29y3HShXLs8vH9sesr1zB2NHyY6XO5fsvFBhV1G3i7BLsktaGVzZXWVQtbXqfXVK9UiNV017rWbtptrXu3m7r+zx2NNWp1VXWvdur2DvzXq/+s4Go4aKfZh9OfseNkY39n/N+rq5SaOptOnDfuF+6YGIA33Njs3NLZotZa1wq6R18mDCwcvfeH/T3cZsq2+nt5ceAockhx5/m/jt9cNBh3uPsI60fWf4XW0HtaOkE+pc3jnVldIl7Y7rHj4aeLS3x6Wn43vL7/cf0z1Wc1zleNkJwomiE59O5p+cPpV16unp5NNjvUt675yJPXOtL7xv8GzQ2fPnfM+d6ffsP3ne9fyxC84Xjl5kXey65HCpc8B+oOMH+x86Bh0GO4cch7ovO13uGZ43fOKK+5XTV72vnrsWcO3SyPyR4etR12/eSLghvcm7+ehW+q3nt3Nuz9xZcxd9t+Se0r2K+5r3G340/bFd6iA9Puo9OvBgwYM7Y9yxJz9l//R+vOgh+WHFhM5E8yPbR8cmfScvP174ePxJ1pOZp8U/K/9c+8zk2Xe/ePwyMBU7Nf5c9PzTr5tfqL/Y/9LuZe902PT9VxmvZl6XvFF/c+At623/u5h3EzO577HvKz+Yfuj5GPTx7qeMT59+A/eE8/sKZW5kc3RyZWFtCmVuZG9iago2IDAgb2JqClsvSUNDQmFzZWQgNSAwIFJdCmVuZG9iago3IDAgb2JqCjw8IC9UeXBlIC9NZXRhZGF0YQovU3VidHlwZSAvWE1MCi9MZW5ndGggMTQgMCBSCgo+PgpzdHJlYW0KPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4KCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPgo8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyIgcmRmOmFib3V0PSIiPgo8ZGM6dGl0bGU+TXV0YXRpb24gcmVwb3J0IGZvciBLUkFTIEcxM1Y8L2RjOnRpdGxlPgo8ZGM6ZGF0ZT4yMDEyLTA0LTExVDE3OjIzOjUzLTAtNDowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzPC9wZGY6UHJvZHVjZXI+CjwvcmRmOkRlc2NyaXB0aW9uPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyIgcmRmOmFib3V0PSIiPgo8eG1wOkNyZWF0ZURhdGU+MjAxMi0wNC0xMVQxNzoyMzo1My0wLTQ6MDA8L3htcDpDcmVhdGVEYXRlPgo8L3JkZjpEZXNjcmlwdGlvbj4KPC9yZGY6UkRGPgo8L3g6eG1wbWV0YT4KPD94cGFja2V0IGVuZD0iciI/PgoKCmVuZHN0cmVhbQplbmRvYmoKMTAgMCBvYmoKPDwgL1R5cGUgL0Fubm90Ci9TdWJ0eXBlIC9MaW5rCi9SZWN0IFsgMTQ1LjA4NDk5IDYzNC45MjEgMTg3Ljc4MSA2NDMuOCBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSA8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIxMTg3NTAwKQovUyAvVVJJID4+Ci9IIC9JCgo+PgplbmRvYmoKMTIgMCBvYmoKPDwgL0xlbmd0aCAxNSAwIFIKL0ZpbHRlciAvRmxhdGVEZWNvZGUgCj4+CnN0cmVhbQp4nKVXSW/cNhS+z6/gpYAN1DRJkVp8cxrbTVMD8XiQHoIcaA1HQ0SLI2mczL/voyRKlDRL0NqwxeVt/N57HyWKCPxeUfgXRAzF2eL7gjZrFAUMHrDybrW4vvcQJWi16TZBgQqCI0oI4YhzLIRAqwx9uXjc1bLWRX6JLhD8leq1KOtusinKbvRxefvcDR+o9/kSfUWrvxZ3q8WT45+07t0lwRi2YT2NQw3YECydBkuQx4YYP8lEtd6vKI0wieAnbEPoNViAPWZ2RprsciIGm2EIKNCR2MTyRbE5545HmPrMrJ90Jzgc3zvl6xCQDTpOJiPsT9AJMaOstSdwl5h0lyfdMJZlrPMik938qnsSTKjHf+uiNLjPTbMIe4AkINSY/2Aro97qyg53WbGzpVHvX9XvvYyyEaQ617FMu2mlk1xvYCGPrYTF2DWcjYtxK+3Gi1J2Uf2Umc7V2u7s20F3ojlYnqBYhB4h4fRoparLonpVca3f1AlMOKU49MFCMLUwPuk49QRxgkMxCNellmmF53I+xVHQZXM5jqkFr96ttbJQVLskUVXdA1Bvpe1Xp0stklZLltaarYlcJdJx8loWSV5UtY5t88u4Nv0/jTb0oHThVJ4NeKNKBWm9sYYyvb7p1NpyLpNBPwDtkJs2ndhhlIaBIGSgllZ5+bD48hVGa0Qw4yGnHvqxcKxwGAmfMJQhSgUOQmK6alhO0bPlmC6vBDnxuDrjgNy+UW96rYbS/fx+iPL7ggOxApmZPEcBhEHMIzUPHx7urplv0T+L3B6JwlkI5uhhYaSxAO2RPKyY+J8GSsdi2q+UAsdEQQROm7hv36RO5YtOdb2fttqH/A1KRydNafTNeZuovK5OkgL1fIN+X8urvtFl6y61c33QhexcNJPHu4+98Fa/aCizyjLIu+Xt/Wyzp4O+WtdFvMvAZN8FamPYJd7fnGEDTkJMmZgdaJd/y4sf+ZG8mruTQjkRv8mvMzV5puYysFNXy10/mncj5VvbE23fap+rAT/AkfCiqLtjnlVeaWjuoQRkbpFaqkpXtUPEfxQ5tHA5Y1Tn1eBUZYQR5oQbcrSVMVBNOVAYBCBL66IvyHgQSXbQY8ClPdE5xNZx3tkLI26OUp27EaAGvCAglM+iLx1wjh7aEwLuAzZTbmIrLA/ePdwvbZRFXsRp2w5TOoVk44hB6vzWiMxr/VK0fD+ThbcpwrkpiQ7rI0AcPboPJBqYF4+ZrUzuTxw5gJOGwSG9AfYzrincokDZprSnNn4JdSpCHIUAFD8Yw0Hg6z1cplBS3fSbzmU1ENVALzOguQevd9yhu/8B9MTWLwM90ftPQE9sVC4vnESaAxOZ950DQQxIHyLyIwzKRIBJQKOINgzqTNNm6g/TkZazfpRBjZSwtifawmqfYVAWcOjpqGfQpfsd9CdUZ1HuT2BuXpsFZA6QiloD72WtpoVF2VzOsK8usxH7Tr5sDmpl5vo7ycweAYyJZ15tGh3Crym9ZoSyzhURN8zrxp8eDwU7NfG3TlMtLds+6537IfgviJ5RHAplbmRzdHJlYW0KZW5kb2JqCjExIDAgb2JqClsKMTAgMCBSCl0KZW5kb2JqCjkgMCBvYmoKPDwgL1R5cGUgL1BhZ2UKL1BhcmVudCAxIDAgUgovTWVkaWFCb3ggWyAwIDAgNTk1IDc5MiBdCi9UcmltQm94IFsgMCAwIDU5NSA3OTIgXQovQmxlZWRCb3ggWyAwIDAgNTk1IDc5MiBdCi9SZXNvdXJjZXMgMyAwIFIKL0NvbnRlbnRzIDEyIDAgUgovQW5ub3RzIDExIDAgUgo+PgplbmRvYmoKMTMgMCBvYmoKMjU5NgplbmRvYmoKMTQgMCBvYmoKNzI2CmVuZG9iagoxNSAwIG9iagoxMTU0CmVuZG9iagoxNiAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyA0MzEuMDMgNDE4Ljg1MyA0NzMuNzI2IDQyNy43MzIgXQovQyBbIDAgMCAwIF0KL0JvcmRlciBbIDAgMCAwIF0KL0EgPDwgL1VSSSAoaHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODk0NjA2MSkKL1MgL1VSSSA+PgovSCAvSQoKPj4KZW5kb2JqCjE4IDAgb2JqCjw8IC9UeXBlIC9Bbm5vdAovU3VidHlwZSAvTGluawovUmVjdCBbIDE0NS4wODQ5OSAxNTMuNDEzIDE4Ny43ODEgMTYyLjI5MTk5IF0KL0MgWyAwIDAgMCBdCi9Cb3JkZXIgWyAwIDAgMCBdCi9BIDw8IC9VUkkgKGh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg5NDYwNjEpCi9TIC9VUkkgPj4KL0ggL0kKCj4+CmVuZG9iagoxOSAwIG9iago8PCAvVHlwZSAvQW5ub3QKL1N1YnR5cGUgL0xpbmsKL1JlY3QgWyAxNDUuMDg0OTkgOTAuMDUzMDEgMTg3Ljc4MSA5OC45MzIwMSBdCi9DIFsgMCAwIDAgXQovQm9yZGVyIFsgMCAwIDAgXQovQSA8PCAvVVJJIChodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIxMTE4OTYzKQovUyAvVVJJID4+Ci9IIC9JCgo+PgplbmRvYmoKMjAgMCBvYmoKPDwgL0xlbmd0aCAyMSAwIFIKL0ZpbHRlciAvRmxhdGVEZWNvZGUgCj4+CnN0cmVhbQp4nN1ZS3PcNhK+z6/gZaukKgsCQIAP3xxbVmkd1yrSVPYQ5cCZwcyglo8xH3K0v34bJAGCICmNc0q2/BABohv97q8p4mH4c0XgvzCm3jZbfVuRdo94IYUfsPPTenX92fcI9tb7/iUQEI5RTDDGzGMMcc69deb9dvG1qZNaFvmld+HBv1KcirLuF/ui7J++PHx47B9vif/rpfe7t/7n6ma9+sW6H3fX21ucUqTF+mUsakgHYYkrLPZ8Osh4nxxEd/sVIXF3tzlKQ+TT0XFy6RyBl1EEmpPRMc3uotgvMmcxIgGO43hESd0LOAMtydIFc7ZqDWDpH6PAMUCEKKEdo0dwUVO97x3w8V9f73++Wd/0yyTf9U/bIt/LMhN6/URp2D/+nFTaqVXybE5sXjTTT0kuRdovHkReNL1RLkxoYHZNMfwlRG/Q91Q/338dYuLbikGsgX+VQSAASPeUgVLDKlUrMqxsEmv76P17la9++x1O78Bs31cYMe921dIGmu+YNtC0j2BxkwuIuwb2Y8iHUPm2NfLnUnxrRL590XrvRwHfPmbjZJH6wUoPs1cfhX4qTvqpyYpG51T9chJVbzUloxsCPvYCENunSptWxHVP7iQAnxy0dHEyYcr0MclOqSXIXCyGFGEOJH08EjThOzlTZUmaGpvUoqplrg2yTcqtzIssmVPF4YNRRHz8jzlFnJNPF+SaUN+EeavW06VLCZnlIx4S43g6p41zpir2On9qWVWN1iQVssheigoUWlDHYYRREPJwVh3nZKsOi95WJ+YIx2AGv6Pz59RxzhTPSflyjjMcOowIDtms9M7Jpwt6TaLgDG8QHKBAVzo2J/zoRJqUuhn8WFyNuGCEGeGziozOgRPoNY2iODxDERIhohKLdbR8VhfnUNrkh7Okd+hAAeLPe8I92rqCxYQtqOBWbEIjFKnnuC3Z1jJtl+GwHFFZ+4tVWzHzNW/nTl9Tv1G3CQMHBZAnUaefVXy3x6RMtrUoJYTF9rXiCmyCENHIj+Owr5mNqVd5kgndGJ+vvsirMqmoLvWyrGph4FIytNW+BHRUskw0tyLfFgdhgvRYZEVaHF6ttySKEMMM41629VFWPbni9E63/gWZqjdu7sBdWWSTVpUlGdRtmUx5WXz2SSbTFy0EtJliJypHpFNZ1EL1wkmWxNB2KZg96FSrj8aE0mWSiWwjdLs0/XiQ1u4xt+v7pDIvmpMoOzFRv/VBv5L5IdXn4ERe6Oet3BnyDcRP3ditXstWiupU5JXcGCYDSk5m9KWEIMb6VITYlM+AIEzOa0ChpVwPoKFM8gpYZ8NhY9PeDMZwIFOT1pUrqoQ8l9ukNnDP0EL5l0WjzymPH/Ik30pRvTNHt2mza++eaAQgLg4gOPmkhCU7QI6mjr0zSqq1ua49NLzdNdva5IpVA5ecfgJBS2Hi0oa/aVGKOWaTQgxK+Awxlf29Zz6kUDVy8MWziSFlvMH4qUh2+s5ax4yyY5Iby7epMJDU3/U5CfgBXGnoB9ft5H5vQnwGO368ArkgBoxSpThY8fKkguJZ7pSLJypCnYR+bOrkRnf8B7F/FN8W6z/lChiTOAo7yD4sW8zOo2E5orL2l1E7MGOat3Mn09Rv1H8ahihUMxmZ1H8Lqi+1grlyS+N2zDMdc8jCfZNvVX4OMQW532FrfcQKUZN57pygZ7fFdkQxzMmMxTGfCGPXjEUdKAth7sRz9GjwuigtuZ9gZrv79HSpG90pk7v3/RXdjFoeLGABDsLAGtCpewGJYhbggAzh1JE/3OoIwIhCrnEKgWDx8THASQ4bXMUCJhALAYAae1/Fwig2feIjHMDQ5rexaS3TdkmH5YjK2l+MTXWKa94ONdfUc7GJvYMdTYDBUBRwAyw+pjKHMqwjaChY91Ctxu8ea6i5rw6FwJ5DQ4lAMDIMY5Nu+AoybtdX/c/xdDWfHYDLkHI37jv2XT4N+Mlg++7SrWSOqhW0HLmHjR/MpLcSKSAo9iOVCK7cTf6fvPiev6KrjxnESTyhRK87JPZ1qJh5slPxzKHR8Yg9IM57hBGGVO+K/2YeceU+3yMu5eseYT5HMR86hK89sjD3Og6wZ9wFB/AQYagIUfg3c4Aj9w84wKF8wwFhhNqMsMb6LvTPm94dh9iz+oJDoCepkRf/BRxyNNh0I8xQJv5Qs4b14fUNp6kqzyNohdFEN0B81UlsO6i6aBOGOWLdp2uXwVhTFzZy6Gt2qtUAcdNqBkJzH+IKyiTtnfyxyDKR1xpPPIpnMQzBMM3sikz+11jgdBzGtbu7O23V9rJ+sRMZoC0YhIYJxkLO1kQA88+PATL1pVyU1YxOzEcsNJAZGAN8tNxvkP/N7ecHzbuAmSe1MCJMBHJTdI28h1pbUTd/yCzZ6JiDKQYGzKyBLQXEx/B/ZpIBESYffkHcgCFV58LeVwbjnQfqQkBPEVMh4jI6E9MxgGvfVzYbDmz8gEYAoQjhKIywMqa1ryDU+HceI/g0IhrLZNcEoWaewS13P83YJgJOBMjJ/19JcHU72UhyuZZDHcBBEEfBhEGrWgc+ZzIdIgFFMPDTvoBMgWulgaubuNO8tcY1ZaXc5DP4ohw+SbwYg+krRF5Jaz43qfj15otJoKPcyLqYy+yAhqNq9adTxWVECYFsUV+6zxh/bDYwL3M/IP44Vaz981PFlemVVPn1k/3L2/8BZ+YG3QplbmRzdHJlYW0KZW5kb2JqCjE3IDAgb2JqClsKMTYgMCBSCjE4IDAgUgoxOSAwIFIKXQplbmRvYmoKOCAwIG9iago8PCAvVHlwZSAvUGFnZQovUGFyZW50IDEgMCBSCi9NZWRpYUJveCBbIDAgMCA1OTUgNzkyIF0KL1RyaW1Cb3ggWyAwIDAgNTk1IDc5MiBdCi9CbGVlZEJveCBbIDAgMCA1OTUgNzkyIF0KL1Jlc291cmNlcyAzIDAgUgovQ29udGVudHMgMjAgMCBSCi9Bbm5vdHMgMTcgMCBSCj4+CmVuZG9iagoyMSAwIG9iagoyMDIxCmVuZG9iagoyMiAwIG9iago8PCAvVHlwZSAvRm9udAovU3VidHlwZSAvVHlwZTEKL05hbWUgL0YxCi9CYXNlRm9udCAvSGVsdmV0aWNhCi9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nID4+CmVuZG9iagoyMyAwIG9iago8PCAvVHlwZSAvRm9udAovU3VidHlwZSAvVHlwZTEKL05hbWUgL0YzCi9CYXNlRm9udCAvSGVsdmV0aWNhLUJvbGQKL0VuY29kaW5nIC9XaW5BbnNpRW5jb2RpbmcgPj4KZW5kb2JqCjEgMCBvYmoKPDwgL1R5cGUgL1BhZ2VzCi9Db3VudCAyCi9LaWRzIFs4IDAgUiA5IDAgUiBdID4+CmVuZG9iagoyIDAgb2JqCjw8IC9UeXBlIC9DYXRhbG9nCi9QYWdlcyAxIDAgUgovTWV0YWRhdGEgNyAwIFIKPj4KZW5kb2JqCjMgMCBvYmoKPDwKL0ZvbnQgPDwKICAvRjEgMjIgMCBSCiAgL0YzIDIzIDAgUgo+PgovUHJvY1NldCBbIC9QREYgL0ltYWdlQiAvSW1hZ2VDIC9UZXh0IF0KL0NvbG9yU3BhY2UgPDwKICAvRGVmYXVsdFJHQiA2IDAgUgo+Pgo+PgplbmRvYmoKeHJlZgowIDI0CjAwMDAwMDAwMDAgNjU1MzUgZiAKMDAwMDAwODUyMSAwMDAwMCBuIAowMDAwMDA4NTg1IDAwMDAwIG4gCjAwMDAwMDg2NTAgMDAwMDAgbiAKMDAwMDAwMDAxNSAwMDAwMCBuIAowMDAwMDAwMTU0IDAwMDAwIG4gCjAwMDAwMDI4MzEgMDAwMDAgbiAKMDAwMDAwMjg2NCAwMDAwMCBuIAowMDAwMDA4MTA2IDAwMDAwIG4gCjAwMDAwMDUxMzEgMDAwMDAgbiAKMDAwMDAwMzY3NSAwMDAwMCBuIAowMDAwMDA1MTA0IDAwMDAwIG4gCjAwMDAwMDM4NzMgMDAwMDAgbiAKMDAwMDAwNTMwNCAwMDAwMCBuIAowMDAwMDA1MzI1IDAwMDAwIG4gCjAwMDAwMDUzNDUgMDAwMDAgbiAKMDAwMDAwNTM2NiAwMDAwMCBuIAowMDAwMDA4MDY1IDAwMDAwIG4gCjAwMDAwMDU1NjMgMDAwMDAgbiAKMDAwMDAwNTc2NSAwMDAwMCBuIAowMDAwMDA1OTY3IDAwMDAwIG4gCjAwMDAwMDgyNzkgMDAwMDAgbiAKMDAwMDAwODMwMCAwMDAwMCBuIAowMDAwMDA4NDA4IDAwMDAwIG4gCnRyYWlsZXIKPDwKL1NpemUgMjQKL1Jvb3QgMiAwIFIKL0luZm8gNCAwIFIKL0lEIFs8Q0JFOUI0Q0Q5NjI2QzZFQjIyRTkzODJCMjdBOUU3OUI+IDxDQkU5QjRDRDk2MjZDNkVCMjJFOTM4MkIyN0E5RTc5Qj5dCj4+CnN0YXJ0eHJlZgo4Nzg3CiUlRU9GCg==
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380283" stop="25380283"
			mutation="A59T" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 14:18:10.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MEK inhibitiors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:12438234</actionReference>
					<actionComment>This mutation has only been found very rarely thus
						the functional consequence of this mutation is unknown
					</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380277" stop="25380277"
			mutation="Q61E" refAllele="G" varAllele="C">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-20 14:11:41.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation may be associated with a poorer
						survival compared with KRAS wild type patients with non-small cell
						lung cancer</significanceComment>
					<significanceReference>pmid:8395679</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:8395679</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380277" stop="25380277"
			mutation="Q61K" refAllele="G" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 15:18:21.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analysis of clinical trial data
						demonstrates that this mutation may be associated with a poorer
						survival in patients with advanced colorectal cancer
					</significanceComment>
					<significanceReference>pmid:19884549</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation may be associated with a poorer
						survival compared with KRAS wild type patients with non-small cell
						lung cancer</significanceComment>
					<significanceReference>pmid:8395679</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19884549</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380276" stop="25380276"
			mutation="Q61L" refAllele="T" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 15:20:05.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analysis of clinical trial data
						demonstrates that this mutation may be associated with a poorer
						survival in patients with advanced colorectal cancer
					</significanceComment>
					<significanceReference>pmid:19884549</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19884549</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380276" stop="25380276"
			mutation="Q61P" refAllele="T" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-20 14:50:41.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation may be associated with a poorer
						survival compared with KRAS wild type patients with non small cell
						lung cancer</significanceComment>
					<significanceReference>pmid:8395679</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:9159349</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380276" stop="25380276"
			mutation="Q61R" refAllele="T" varAllele="C">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 15:22:23.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation may be associated with a poorer
						survival compared with KRAS wild type patients with non-small cell
						lung cancer</significanceComment>
					<significanceReference>pmid:8395679</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analysis of clinical trial data
						demonstrates that this mutation may be associated with a poorer
						survival in patients with advanced colorectal cancer
					</significanceComment>
					<significanceReference>pmid:19884549</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19884549</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25380275" stop="25380275"
			mutation="Q61H" refAllele="T" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-04-27 15:18:08.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Post-hoc analysis of clinical trial data
						demonstrates that this mutation may be associated with a poorer
						survival in patients with advanced colorectal cancer
					</significanceComment>
					<significanceReference>pmid:19884549</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors, BRAF inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:19884549</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="MET" start="116411923" stop="116411923"
			mutation="R970C" refAllele="C" varAllele="T">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-20 16:39:33.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:20670955</actionReference>
					<actionComment>MET R970C lacks transforming capacity and MET
						receptor retains wild type function. MET R970C has been found at
						low frequency in all tumor types and is present at the same
						frequency in the germline DNA of normal individuals. As such, MET
						R970C is likely to be a normal SNP variation rather than a
						pathogenic mutation. As such MET R970C has been removed from the
						COSMIC database.</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-08-31 14:35:56.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="MET" start="116411990" stop="116411990"
			mutation="T992I" refAllele="C" varAllele="T">
			<lastEditedBy>Dancey</lastEditedBy>
			<lastUpdated>2011-06-09 13:06:25.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MET inhibitors (e.g .ARQ197, foretinib (XL880), XL184,
						METMab)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:20670955, pmid:20670955, pmid:11042681,
						pmid:14559814</actionReference>
					<actionComment>MET T992I is also known as I1010I. This mutation
						lacks transforming capacity. MET T992I has been found at low
						frequency in most tumor types and is present at near the same
						frequency in the germline DNA of normal individuals. As such, MET
						T992I may be a normal SNP variation rather than a oncogenic
						mutation. Some laboratory studies suggest that this mutation may
						confer a small increase in proliferation rate, and cytoskeletal
						function. </actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-06-09 13:06:25.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-08 16:49:32.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="MET" start="116423414" stop="116423414"
			mutation="Y1230C" refAllele="A" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-05-10 16:24:49.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>upper aerodigestive tract carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>MET Y1230C (also known as Y1248C) mutation has
						been identified in cases of head and neck squamous cell carcinoma.

						It has been hypothesized that this mutation confers an increase in
						metastatic potential to the tumor cells. In fact, one study has
						shown that in cases where metastatic lymph nodes harbored the
						Y1230C mutation, the mutation was barely detectable in the primary
						tumor, suggesting an enrichment in MET mutant cells in the
						metastatic sites.

						Moreover, in vitro studies published in the same paper suggested that
						transfection of cells with the MET Y1230C variant resulted in an
						invasive phenotype in tranfected cells.
					</significanceComment>
					<significanceReference>pmid:10734314</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>kidney carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been identified in cases of
						hereditary papillary renal cell carcinoma.
						MET mutations as a group are believed to be responsible for most
						cases of hereditary papillary renal cell carcinomas.
					</significanceComment>
					<significanceReference>pmid:10327054</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>MET inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MET inhibitors such as: PF-02341066, EMD 1214063, AMG 208,
						INC280)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20145145, pmid:19459657</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="MET" start="116423428" stop="116423428"
			mutation="Y1235D" refAllele="T" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-05-10 16:19:24.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>upper aerodigestive tract carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>MET Y1235D (also known as Y1253D) mutation has
						been identified in 10-20% cases of head and neck squamous cell
						carcinoma.

						It has been hypothesized that this mutation confers an increase in
						metastatic potential to the tumor cells. In fact, one study has
						shown that in cases where metastatic lymph nodes harbored the
						Y1235D mutation, the mutation was barely detectable in the primary
						tumor, suggesting an enrichment in MET mutant cells in the
						metastatic sites.

						One study suggested that presence of Y1235D MET mutation was
						associated with a decreased metastasis free survival after
						radiation therapy while another report suggested a decrease in
						local control after radiation therapy.

						Moreover, in vitro studies published in the same paper suggested that
						transfection of cells with the MET Y1230C variant resulted in an
						invasive phenotype in tranfected cells.
					</significanceComment>
					<significanceReference>pmid:10734314, pmid:19639388, pmid:14627992
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>MET inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MET inhibitors such as: PF-02341066, EMD 1214063, AMG 208,
						INC280)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:10734314</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="MET" start="116423474" stop="116423474"
			mutation="M1250T" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-05-10 16:25:27.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>kidney carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been found in sporadic and
						hereditary case of renal cell carcinoma of the papillary subtype.
						Met mutations in general are found in most hereditary cases of the
						papillary subtype of renal cell carcinoma and in a fraction of the
						sporadic cases.
					</significanceComment>
					<significanceReference>pmid:18636147, pmid:9140397
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>MET inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MET inhibitors such as: PF-02341066, EMD 1214063, AMG 208,
						INC280)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20145145, pmid:9826708</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-03-21 09:47:48.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>PGh0bWwgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGh0bWwiPgo8aGVhZD4KPHRpdGxlPk11dGF0aW9uIHJlcG9ydCBmb3IgTUVUIE0xMjUwVDwvdGl0bGU+Cgo8L2hlYWQ+Cjxib2R5PgoJPHA+CglTdGF0dXM6IAoJCgk8c3BhbiBjbGFzcz0ic3RhdHVzY29tcGxldGUiPkNPTVBMRVRFPC9zcGFuPgoJCgkKCWFuZCBjb25maXJtZWQKCQoJJiN4MjAxNDsgCgkKCUxhc3Qgc2F2ZWQgYnk6IFZpbmNlbnQgQ2FzdG9uZ3VheSBvbiAwNS8xMC8yMDExIDA0OjI1IFBNCgkKCTwvcD4KCSAgCgk8aHIgLz4KCTxoMz5GcmVxdWVuY3kgb2YgTTEyNTBUIG11dGF0aW9uIGluIE1FVCBpbiB0aGUgdG9wIHR1bW91ciB0eXBlczwvaDM+CgkKCTx0YWJsZT4KCTx0aGVhZD4KCQk8dHI+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjMwIj48L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIyMjAiPlR1bW91cjwvdGg+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjgwIj5GcmVxdWVuY3k8L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIxMDAiPlNhbXBsZXM8L3RoPgoJCTwvdHI+Cgk8L3RoZWFkPgoJPHRib2R5PgoJCQoJCQoJCQoJCQk8dHI+CgkJCQk8dGQ+MS48L3RkPgoJCQkJPHRkPmtpZG5leSBjYXJjaW5vbWE8L3RkPgoJCQkJPHRkPjEuMDAwMCU8L3RkPgoJCQkJPHRkPigwLzAgc2FtcGxlcyk8L3RkPgoJCQkJCgkJCTwvdHI+CgkJCgkJCgk8L3Rib2R5PgoJPC90YWJsZT4KCQoJPGhyIC8+Cgk8aDM+TUVUIGNoYXJhY3RlcmlzdGljczwvaDM+CgkKCTxoND5GdWxsIG5hbWU6IG1ldCBwcm90by1vbmNvZ2VuZSAoaGVwYXRvY3l0ZSBncm93dGggZmFjdG9yIHJlY2VwdG9yKTwvaDQ+CgkKCTxwPk1FVCAoTWVzZW5jaHltYWwgZXBpdGhlbGlhbCB0cmFuc2l0aW9uIGZhY3RvciksIGFsc28ga25vd24gYXMgaGVwYXRvY3l0ZSBncm93dGggZmFjdG9yIHJlY2VwdG9yIChIR0ZSKSBpcyBhIHByb3RvLW9uY29nZW5pYyByZWNlcHRvciB0eXJvc2luZSBraW5hc2UuIFRoZSBlbmRvZ2Vub3VzIGxpZ2FuZCBmb3IgTUVUIGlzIGhlcGF0b2N5dGUgZ3Jvd3RoIGZhY3Rvci9zY2F0dGVyIGZhY3RvciAoSEdGKSwgYSBkaXN1bGZpZGUtbGlua2VkIGhldGVyb2RpbWVyaWMgbW9sZWN1bGUgcHJvZHVjZWQgcHJlZG9taW5hbnRseSBieSBtZXNlbmNoeW1hbCBjZWxscy4gSW4gdGhlIGFkdWx0LCBNRVQgZXhwcmVzc2lvbiBpcyBsaW1pdGVkIHRvIHN0ZW0gYW5kIHByb2dlbml0b3IgY2VsbHMgYW5kIGlzIG5lY2Vzc2FyeSBmb3Igd291bmQgaGVhbGluZyBhbmQgaGVwYXRvY3l0ZSByZWdlbmVyYXRpb24uIEluIHRoZSBlbWJyeW8sIE1FVCByZWNlcHRvcnMgYXJlIGV4cHJlc3NlZCBvbiBjZWxscyBvZiBlcGl0aGVsaWFsIG9yaWdpbi4gVGhleSBhcmUgZXNzZW50aWFsIGZvciBpbnZhc2l2ZSBncm93dGggYW5kIG1lZGlhdGUgZXBpdGhlbGlhbC1tZXNlbmNoeW1hbCB0cmFuc2l0aW9uIChFTVQpLiBBYmJlcmFudCBhY3RpdmF0aW9uIG9mIHRoZSBIR0YvTUVUIHBhdGh3YXkgbGVhZHMgdG8gYSB2YXJpZXR5IG9mIGNhbmNlcnMuIE1FVCBtdXRhdGlvbiBpcyBhc3NvY2lhdGVkIHdpdGggYSBwb29yIHByb2dub3NpcyBhcyBpdCBjYW4gdHJpZ2dlciB0dW1vciBncm93dGgsIGFuZ2lvZ2VuZXNpcyBhbmQgbWV0YXN0YXNpcy48L3A+CgkgICAgICAgICAgICAgICAKCTxociAvPgoJPGgzPk1FVCBNMTI1MFQgY2hhcmFjdGVyaXN0aWNzPC9oMz4KCSAgCQoJPHA+VGhlIGZ1bmN0aW9uYWwgY29uc2VxdWVuY2Ugb2YgdGhpcyBtdXRhdGlvbiBpczogPGI+YWN0aXZhdGluZzwvYj4uCgkgICBSZWZlcmVuY2UgKFBNSUQpOiBwbWlkOjxhIGhyZWY9J2h0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjAxNDUxNDUnPjIwMTQ1MTQ1PC9hPiwgcG1pZDo8YSBocmVmPSdodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzk4MjY3MDgnPjk4MjY3MDg8L2E+PC9wPgoJCgkKCQkJCQkKCTxociAvPgoJPGgzPkNsaW5pY2FsIGFuZCBQcmVjbGluaWNhbCBTdHVkaWVzPC9oMz4KCQoJCgkKCQoJICAJCgkKCTxoND4xLiBraWRuZXkgY2FyY2lub21hCgk8L2g0PgoJCgkKCQoJCQoJCQk8cD5JbiB0aGlzIHR1bW91ciB0eXBlLCB0aGUgY2xpbmljYWwgc2lnbmlmaWNhbmNlIG9mIHRoaXMgbXV0YXRpb24gaGFzIGJlZW4gZXhhbWluZWQgYnkgPGI+cmV0cm9zcGVjdGl2ZTwvYj4gY2xpbmljYWwgdHJpYWxzLjwvcD4KCQkJCgkJCQk8cD5UaGlzIG11dGF0aW9uIGhhcyBiZWVuIGZvdW5kIGluIHNwb3JhZGljIGFuZCBoZXJlZGl0YXJ5IGNhc2Ugb2YgcmVuYWwgY2VsbCBjYXJjaW5vbWEgb2YgdGhlIHBhcGlsbGFyeSBzdWJ0eXBlLgpNZXQgbXV0YXRpb25zIGluIGdlbmVyYWwgYXJlIGZvdW5kIGluIG1vc3QgaGVyZWRpdGFyeSBjYXNlcyBvZiB0aGUgcGFwaWxsYXJ5IHN1YnR5cGUgb2YgcmVuYWwgY2VsbCBjYXJjaW5vbWEgYW5kIGluIGEgZnJhY3Rpb24gb2YgdGhlIHNwb3JhZGljIGNhc2VzLjwvcD4KCQkJCTxwPlJlZmVyZW5jZTogcG1pZDo8YSBocmVmPSdodHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE4NjM2MTQ3Jz4xODYzNjE0NzwvYT4sIHBtaWQ6PGEgaHJlZj0naHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC85MTQwMzk3Jz45MTQwMzk3PC9hPiAtIGV2aWRlbmNlIElWRDwvcD4KCQkJCgkJCgkKCQkKCQoJICAJCgk8aHIgLz4KCTxoMz5BdmFpbGFiaWxpdHkgb2YgSW52ZXN0aWdhdGlvbmFsIEFnZW50czwvaDM+CgkgIAkKCQoJCTxwPgoJCVRoZSBhdmFpbGFibGUgaW52ZXN0aWdhdGlvbmFsIGFnZW50cyA8aT5NRVQgaW5oaWJpdG9ycyBzdWNoIGFzOiBQRi0wMjM0MTA2NiwgRU1EIDEyMTQwNjMsIEFNRyAyMDgsIElOQzI4MCk8L2k+IGhhdmUgZG9jdW1lbnRlZCBlZmZpY2FjeTogCgkJPGI+dW5rbm93bjwvYj4KCQk8L3A+CgkKCQoJPGhyIC8+Cgk8aDM+U2Vuc2l0aXZpdHkgYW5kIFJlc2lzdGFuY2UgQ29uZmVycmVkIGJ5IE11dGF0aW9uPC9oMz4KCQoJCgkJPHA+VGhpcyBtdXRhdGlvbiA8Yj5tYXk8L2I+IGNvbmZlciA8Yj5zZW5zaXRpdml0eTwvYj4gdG86IE1FVCBpbmhpYml0b3JzPC9wPgoJCgkKCTxociAvPgoJPGgzPlJlcG9ydCBIaXN0b3J5PC9oMz4KCSAgCQoJCgkJPHRhYmxlPgoJCQk8dGhlYWQ+CgkJCQk8dHI+CgkJCQkJPHRoIGFsaWduPSJsZWZ0IiB3aWR0aD0iMTIwIj5EYXRlPC90aD4KCQkJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIxMDAiPkNvbmZpcm1lZCBieTwvdGg+CgkJCQkJPHRoIGFsaWduPSJsZWZ0IiB3aWR0aD0iMjIwIj5Db21tZW50PC90aD4KCQkJCTwvdHI+CgkJCTwvdGhlYWQ+CgkJCTx0Ym9keT4KCSAgCQkJCgkgIAkJCQk8dHI+CgkgCQkJCQk8dGQ+MDMvMjEvMjAxMiAwOTo0NyBBTTwvdGQ+CgkgIAkJCQkJPHRkPkphbmV0IERhbmNleTwvdGQ+CgkgIAkJCQkJPHRkPjwvdGQ+CgkgCQkJCTwvdHI+CgkgIAkJCQoJIAkJPC90Ym9keT4KCQk8L3RhYmxlPgoJCjwvYm9keT4KPC9odG1sPgo=
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258747" stop="115258747"
			mutation="G12A" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:13:30.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study suggests that this
						mutation may be associated with a poorer prognosis
					</significanceComment>
					<significanceReference>pmid:15046639</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15046639</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258747" stop="115258747"
			mutation="G12D" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:13:55.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20619739</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258747" stop="115258747"
			mutation="G12V" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:12:29.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study suggests that this
						mutation may be associated with a poorer prognosis
					</significanceComment>
					<significanceReference>pmid:15046639</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15046639</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258748" stop="115258748"
			mutation="G12C" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:10:53.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20619739</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258748" stop="115258748"
			mutation="G12R" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:11:34.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monocolonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15897885</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258748" stop="115258748"
			mutation="G12S" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:12:00.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>A retrospective study suggests that the
						presence of this mutation may be associated with a poorer
						prognosis</significanceComment>
					<significanceReference>pmid:15046639</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies </significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15046639</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258744" stop="115258744"
			mutation="G13A" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:16:31.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be a negative prognostic factor
					</significanceComment>
					<significanceReference>pmid:12947056</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:12947056</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258744" stop="115258744"
			mutation="G13D" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:17:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>unknown</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:2674680</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258744" stop="115258744"
			mutation="G13V" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:16:06.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:8780392</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258745" stop="115258745"
			mutation="G13C" refAllele="C" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:14:45.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16404744</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258745" stop="115258745"
			mutation="G13R" refAllele="C" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:15:11.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20619739</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258745" stop="115258745"
			mutation="G13S" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:15:41.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:1574246</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115258730" stop="115258730"
			mutation="A18T" refAllele="C" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 13:57:21.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:11406571</actionReference>
					<actionComment>This mutation has only been found very rarely thus
						the functional consequences of this mutation are unknown
					</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256529" stop="115256529"
			mutation="Q61L" refAllele="T" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:18:59.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						may be a mechanism of resistance to BRAF inhibitors
					</significanceComment>
					<significanceReference>pmid:20689758</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						increases sensitivity to MEK inhibitors</significanceComment>
					<significanceReference>pmid:21245089</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:21245089</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256529" stop="115256529"
			mutation="Q61P" refAllele="T" varAllele="G">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:19:59.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation may increase the risk of tumor
						progression</significanceComment>
					<significanceReference>pmid:8120410</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:8120410</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256529" stop="115256529"
			mutation="Q61R" refAllele="T" varAllele="C">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:19:21.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in NRAS mutant tumors </significanceComment>
					<significanceReference>pmid:18390968</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						increases sensitivity to MEK inhibitors</significanceComment>
					<significanceReference>pmid:21245089</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						may be a mechanism of resistance to BRAF inhibitors
					</significanceComment>
					<significanceReference>pmid:20689758</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:20619739</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256528" stop="115256528"
			mutation="Q61H" refAllele="T" varAllele="A">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:18:36.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16098042</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256530" stop="115256530"
			mutation="Q61E" refAllele="G" varAllele="C">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:17:47.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>BRAF inhibitors AND EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:2283998</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="1" gene="NRAS" start="115256530" stop="115256530"
			mutation="Q61K" refAllele="G" varAllele="T">
			<lastEditedBy>Daniel Renouf</lastEditedBy>
			<lastUpdated>2011-05-11 14:18:15.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Retrospective studies demonstrate that the
						presences of this mutation may be predictive of resistance to EGFR
						monoclonal antibodies</significanceComment>
					<significanceReference>pmid:20619739</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						may be a mechanism of resistance to BRAF inhibitors
					</significanceComment>
					<significanceReference>pmid:21107323</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid neoplasm</tumourType>
					<type>prospective</type>
					<significanceComment>Comment: Retrospective studies demonstrate
						that the presences of this mutation may be a negative prognostic
						factor </significanceComment>
					<significanceReference>pmid:19837916</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase 1 study of a MEK inhibitor demonstrated
						activity in NRAS mutant tumors </significanceComment>
					<significanceReference>pmid:18390968</significanceReference>
					<significanceEvidence>IIB</significanceEvidence>
				</significance>
				<significance>
					<tumourType>skin malignant melanoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies suggest that this mutation
						increases sensitivity to MEK inhibitors</significanceComment>
					<significanceReference>pmid:21245089</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies AND BRAF inhibitors</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:21107323</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55141036" stop="55141036"
			mutation="V561D" refAllele="T" varAllele="A">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>gastrointestinal stromal tumour</tumourType>
					<type>preclinical</type>
					<significanceComment>In one retropective study, this mutation
						confers a more benign clinical course for GIST
					</significanceComment>
					<significanceReference>pmid:15146165</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15146165</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55152095" stop="55152109"
			mutation="I843_S847&gt;T" refAllele="ATCATGCATGATTCG" varAllele="ACN">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>gastrointestinal stromal tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation confers a more aggressive
						behavior for GIST and seems to occur more in younger patients.
					</significanceComment>
					<significanceReference>pmid:16776995</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16776995</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55152093" stop="55152093"
			mutation="D842V" refAllele="A" varAllele="T">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>gastrointestinal stromal tumour</tumourType>
					<type>retrospective</type>
					<significanceComment>Retropective clinical studies have shown that
						this mutation can be common and often of gastric in origin. There
						is also evidence linking this mutation to a more benign course.
					</significanceComment>
					<significanceReference>pmid:15154005, pmid:15146165, pmid:17171690
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>gastrointestinal stromal tumour</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation confers resistance to imatinib
					</significanceComment>
					<significanceReference>pmid:15928335</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>imatinib</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15928335</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55144547" stop="55144547"
			mutation="T674I" refAllele="C" varAllele="T">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:0000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55151636" stop="55151636"
			mutation="F808L" refAllele="T" varAllele="C">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>haematopoietic and lymphoid tissue lymphoid neoplasm
					</tumourType>
					<type>unknown</type>
					<significanceComment></significanceComment>
					<significanceReference>pmid:15673455</significanceReference>
					<significanceEvidence></significanceEvidence>
				</significance>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:15674355</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55152104" stop="55152104"
			mutation="D846Y" refAllele="G" varAllele="T">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>gastrointestinal stromal tumour</tumourType>
					<type>preclinical</type>
					<significanceComment>Pre-clinical study showed that this mutation
						confers sensitivity to imatinib</significanceComment>
					<significanceReference>pmid:15928335</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>imatinib</agents>
					<sensitivityType>sensitivity</sensitivityType>
				</sensitivity>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15928335</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55153643" stop="55153643"
			mutation="N870S" refAllele="A" varAllele="G">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:16776995</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55161380" stop="55161380"
			mutation="D1071N" refAllele="G" varAllele="A">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18948947</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55152092" stop="55152103"
			mutation="D842_H845del" refAllele="GACATCATGCAT" varAllele="-">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:1894897</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55152095" stop="55152106"
			mutation="I843_D846del" refAllele="ATCATGCATGAT" varAllele="-">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:17171690</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55141050" stop="55141067"
			mutation="S566_E571&gt;K" refAllele="AGCCCAGATGGACATGAA" varAllele="-">
			<lastEditedBy />
			<lastUpdated>2011-03-24 20:59:17.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:1567433, pmid:16776995</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178916876"
			stop="178916876" mutation="R88Q" refAllele="G" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:15:33.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>The presence of this mutation is present in
						over 10% of samples tested. There was preliminary evidence of
						worse outcome in this mutation.</significanceComment>
					<significanceReference>pmid:18224685</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>cervix carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation is present over 10% of cervical
						cancers. Its impact onto clinical outcome remains unknown.
					</significanceComment>
					<significanceReference>pmid:19148475</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation is present over 7% of breast
						cancers. Its impact onto clinical outcome remains unknown
					</significanceComment>
					<significanceReference>pmid:15254419, pmid:19924296
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15647370, pmid:15930273</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178952084"
			stop="178952084" mutation="H1047Y" refAllele="C" varAllele="T">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 00:56:34.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>endometrium carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>The presence of this mutation is frequently
						observed together with KRAS mutations. Additionally, its presence
						conferred worse prognosis with higher rates of metastases.
					</significanceComment>
					<significanceReference>pmid:19839777</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation seems to occur early in breast
						cancers and seems to predominate the lobular histology subtype. In
						one study, the presence of this mutation occurs more frequently in
						lobular breasts cancers. Additionally, the presence of this
						mutation confers worse outcome (progression free and overall
						survival.</significanceComment>
					<significanceReference>pmid:19418217, pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>P13K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15647370, pmid:15930273</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178916726"
			stop="178916726" mutation="R38H" refAllele="G" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:46:07.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation confers increased oncogenicity
						in animal models. </significanceComment>
					<significanceReference>pmid:16339315</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:16339315</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178947827"
			stop="178947827" mutation="C901F" refAllele="G" varAllele="T">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:51:02.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:00000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178952074"
			stop="178952074" mutation="M1043I" refAllele="G" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:57:43.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:0000000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178921553"
			stop="178921553" mutation="N345K" refAllele="T" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:26:33.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation was found with increased
						frequency in breast cancer cell lines.</significanceComment>
					<significanceReference>pmid:18676830</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation represents over 10% of all
						PIK3CA mutations in colon cancers. No clinical significane
						determined at present time for colon cancers for this type of
						mutation.</significanceComment>
					<significanceReference>pmid:15016963</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation was present in approximately 7%
						of breast cancers. Presence for this mutation may confer worse
						prognosis</significanceComment>
					<significanceReference>pmid:19924296, pmid:18183466
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:19671852, pmid:18183466</actionReference>
					<actionComment>Unknown/Unclear</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178927980"
			stop="178927980" mutation="C420R" refAllele="T" varAllele="C">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-05-23 21:45:04.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation was found with increased
						frequency in breast cancer cell lines.</significanceComment>
					<significanceReference>pmid:18676830</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation represents over 10% of all
						PIK3CA mutations in colon cancers. No clinical significane
						determined at present time for colon cancers for this type of
						mutation.</significanceComment>
					<significanceReference>pmid:15016963</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:18183466, pmid:15805248</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178936074"
			stop="178936074" mutation="P539R" refAllele="C" varAllele="G">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:59:13.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:0000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178936082"
			stop="178936082" mutation="E542K" refAllele="G" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-07-21 18:56:19.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>case</type>
					<significanceComment>In one study, the presence of this mutation
						occurs more frequently in lobular breasts cancers. Additionally,
						the presence of this mutation confers worse outcome (progression
						free and overall survival).</significanceComment>
					<significanceReference>pmid:17947469</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>In this study, the presence of E542K mutation
						of the P1K3CA gene confers higher mitogenic activities compared to
						its wild-type cells.</significanceComment>
					<significanceReference>pmid:15930273</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>The effect of this mutation has been studied
						in cell line and animal pre-clinical models. In both models,
						presence of P1K3CA mutation is associated with increased
						anti-tumor effect from a P13K inhibitor.</significanceComment>
					<significanceReference>pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<effectiveness>
					<agents>AKT inhibitor MK2206</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>mTOR inhibitor temsirolimus, everolimus</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>PI3K Inhibitors SF1126, BEZ235, XL147, BKM120</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15647370, pmid:15930273</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-07-21 18:56:19.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-05-18 17:01:56.0</date>
					<userName>Janet Dancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body></body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178936091"
			stop="178936091" mutation="E545K" refAllele="G" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-04-11 17:41:47.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>In one study, the presence of this mutation
						occurs more frequently in lobular breasts cancers. Additionally,
						the presence of this mutation confers worse progression free and
						overall survival.</significanceComment>
					<significanceReference>pmid:17947469</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>The effect of this mutation has been studied
						in cell line and animal pre-clinical models. In both models,
						presence of P1K3CA mutation is associated with increased
						anti-tumor effect from a P13K inhibitor.</significanceComment>
					<significanceReference>pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>In this study, the presence of E542K mutation
						of the P1K3CA gene confers higher mitogenic activities compared to
						its wild-type cells.</significanceComment>
					<significanceReference>pmid:15930273</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR TKI</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>P13K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>AKT inhibitors (e.g. MK2206), mTOR inhibitors
						(e.g.temsirolimus), PI3K inhibitors (e.g. BKM120, SF1126, XL147,
						BEZ235)</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15647370, pmid:15930273</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-11 17:42:05.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2012-04-11 17:13:45.0</date>
					<userName>lsiu</userName>
					<name>Lillian Siu</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178936094"
			stop="178936094" mutation="Q546K" refAllele="C" varAllele="A">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 02:07:41.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation seems to be present in colon
						cancer (&lt;3%) and confers worse outcome (relapse free and
						overall survival).</significanceComment>
					<significanceReference>pmid:15016963, pmid:19903786, pmid:18224685
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:0000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178938860"
			stop="178938860" mutation="H701P" refAllele="A" varAllele="C">
			<lastEditedBy>Albiruni Razak</lastEditedBy>
			<lastUpdated>2011-04-30 01:54:18.0</lastUpdated>
			<annotation>
				<sensitivity>
					<agents>PI3K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MK2206, Temsirolimus based, BKM120, SF1126, XL147, BEZ235
					</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:00000000</actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178952085"
			stop="178952085" mutation="H1047L" refAllele="A" varAllele="T">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-04-25 11:27:18.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>The effect of this mutation has been studied
						in cell line and animal pre-clinical models. In both models,
						presence of a similar P1K3CA mutation H1047R is associated with
						increased anti-tumour effect from a P13K inhibitor. PIK3CA
						oncogenic mutant, p110alpha E545K, was sufficient to abrogate
						gefitinib-induced apoptosis in an EGFR mutant cell line.
					</significanceComment>
					<significanceReference>pmid:19513541, pmid:19029981, pmid:16906227
					</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>In this tumour type, the clinical significance
						of this specific mutation is unknown. Preclinical studies compared
						a panel colon cancer cell lines with wild-type and other mutations
						in PI3K should mutant cell lines were resistant to growth factor
						deprivation stress-induced apoptosis and hypersensitive PI3K
						inhibitor induced apoptosis.</significanceComment>
					<significanceReference></significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>case</type>
					<significanceComment>This mutation and other PI3KCA mutations seem
						to occur early in breast cancers and seems to predominate the
						lobular histology subtype. In one study, the presence of mutations
						in this gene occurred more frequently in lobular breasts cancers.
						Additionally, the presence of PI3CA mutations may confer worse
						outcome (progression free and overall survival.
					</significanceComment>
					<significanceReference>pmid:19418217, pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>endometrium carcinoma</tumourType>
					<type>case</type>
					<significanceComment>The presence of mutations in this gene is
						frequently observed together with KRAS mutations. Additionally,
						its presence conferred worse prognosis with higher rates of
						metastases.</significanceComment>
					<significanceReference>pmid:19839777</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>P13K, AKT and MTOR inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>Akt inhibitors e.g. MK2206, </agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>mTOR inhibitors e.g. temsirolimus, everolimus</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>PI3K inhibitors e.g. BKM120, SF1126, XL147, BEZ235</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:18951408, pmid:15647370, pmid:15930273
					</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-25 11:27:32.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Mutation report for PIK3CA H1047L</title>

</head>
<body>
	<p>
	Status: 
	
	<span class="statusincomplete">incomplete</span>
	
	
	and confirmed
	
	&#x2014; 
	
	Last saved by: Janet Dancey on 04/25/2012 11:27 AM
	
	</p>
	  
	<hr />
	<h3>Frequency of H1047L mutation in PIK3CA in the top tumour types</h3>
	
	<table>
	<thead>
		<tr>
			<th align="left" width="30"></th>
			<th align="left" width="220">Tumour</th>
			<th align="left" width="80">Frequency</th>
			<th align="left" width="100">Samples</th>
		</tr>
	</thead>
	<tbody>
		
		
		
			<tr>
				<td>1.</td>
				<td>breast carcinoma</td>
				<td>1.2570%</td>
				<td>(65/5171 samples)</td>
				
			</tr>
		
			<tr>
				<td>2.</td>
				<td>endometrium carcinoma</td>
				<td>0.8140%</td>
				<td>(7/860 samples)</td>
				
			</tr>
		
			<tr>
				<td>3.</td>
				<td>large intestine carcinoma</td>
				<td>0.4148%</td>
				<td>(23/5545 samples)</td>
				
			</tr>
		
			<tr>
				<td>4.</td>
				<td>lung carcinoma</td>
				<td>0.0471%</td>
				<td>(1/2122 samples)</td>
				
			</tr>
		
		
	</tbody>
	</table>
	
	<hr />
	<h3>PIK3CA characteristics</h3>
	
	<h4>Full name: phosphoinositide-3-kinase, catalytic, alpha polypeptide</h4>
	
	<p>PI 3-Kinases (phosphoinositide 3-kinases, PI3Ks) are family of lipid kinases capable of phosphorylating the 3'OH of the inositol ring of phosphoinositides. They are responsible for coordinating a diverse range of cell functions including proliferation, cell survival, degranulation, vesicular trafficking and cell migration. The PI 3-kinases are grouped into three distinct classes. Class I PI 3-kinases are heteromeric consisting of a regulatory subunit and a 110 kDA catalytic subunits (3 forms in class 1A : alpha-, beta- and delta- and one in class 1B : gamma-). PI 3-kinases p110 alpha- and beta- are ubiquitously expressed whilst p110 delta- expression is associated with leukocytes. Activating mutations in the p110alpha- subunit have recently been discovered in certain types of cancer cell. Class II PI 3-kinases are large homomeric enzymes (C2alpha-, beta- and gamma-) that are sensitive to wortmannin (although less sensitive than Class 1 PI 3-kinases) but are resistant to LY 292002. Class III contains just one member, hVps34p, which is thought to play an important role in both protein sorting and nutrient sensing in concert with the mTOR pathway.</p>
	               
	<hr />
	<h3>PIK3CA H1047L characteristics</h3>
	  	
	<p>The functional consequence of this mutation is: <b>activating</b>.
	   Reference (PMID): pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/18951408'>18951408</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/15647370'>15647370</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/15930273'>15930273</a></p>
	
	
					
	<hr />
	<h3>Clinical and Preclinical Studies</h3>
	
	
	
	
	  	
	
	<h4>1. breast carcinoma
	
	- 1.2570%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> case studies.</p>
			
				<p>This mutation and other PI3KCA mutations seem to occur early in breast cancers and seems to predominate the lobular histology subtype. In one study, the presence of mutations in this gene occurred more frequently in lobular breasts cancers. Additionally, the presence of PI3CA mutations may confer worse outcome (progression free and overall survival.</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19418217'>19418217</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19513541'>19513541</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19029981'>19029981</a> - evidence IVD</p>
			
		
	
		
	
	<h4>2. endometrium carcinoma
	
	- 0.8140%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>retrospective</b> case studies.</p>
			
				<p>The presence of mutations in this gene is frequently observed together with KRAS mutations. Additionally, its presence conferred worse prognosis with higher rates of metastases.</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19839777'>19839777</a> - evidence IVD</p>
			
		
	
		
	
	<h4>3. large intestine carcinoma
	
	- 0.4148%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>In this tumour type, the clinical significance of this specific mutation is unknown. Preclinical studies compared a panel colon cancer cell lines with wild-type and other mutations in PI3K should mutant cell lines were resistant to growth factor deprivation stress-induced apoptosis and  hypersensitive PI3K inhibitor induced apoptosis.</p>
				<p>Reference:  - evidence VD</p>
			
		
	
		
	
	<h4>4. lung carcinoma
	
	- 0.0471%
	</h4>
	
	
	
		
			<p>In this tumour type, the clinical significance of this mutation has been examined by <b>preclinical</b> studies.</p>
			
				<p>The effect of this mutation has been studied in cell line and animal pre-clinical models. In both models, presence of a similar P1K3CA mutation H1047R is associated with increased anti-tumour effect from a P13K inhibitor. PIK3CA oncogenic mutant, p110alpha E545K, was sufficient to abrogate gefitinib-induced apoptosis in an EGFR mutant cell line.</p>
				<p>Reference: pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19513541'>19513541</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/19029981'>19029981</a>, pmid:<a href='http://www.ncbi.nlm.nih.gov/pubmed/16906227'>16906227</a> - evidence VD</p>
			
		
	
		
	
	  	
	<hr />
	<h3>Availability of Investigational Agents</h3>
	  	
	
		<p>
		The available investigational agents <i>Akt inhibitors e.g. MK2206, </i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
		<p>
		The available investigational agents <i>mTOR inhibitors e.g. temsirolimus, everolimus</i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
		<p>
		The available investigational agents <i>PI3K inhibitors e.g. BKM120,  SF1126, XL147, BEZ235</i> have documented efficacy: 
		<b>unknown</b>
		</p>
	
	
	<hr />
	<h3>Sensitivity and Resistance Conferred by Mutation</h3>
	
	
		<p>This mutation <b>may</b> confer <b>sensitivity</b> to: P13K, AKT and MTOR inhibitors</p>
	
	
	<hr />
	<h3>Report History</h3>
	  	
	
		<table>
			<thead>
				<tr>
					<th align="left" width="120">Date</th>
					<th align="left" width="100">Confirmed by</th>
					<th align="left" width="220">Comment</th>
				</tr>
			</thead>
			<tbody>
	  			
	  				<tr>
	 					<td>04/25/2012 11:27 AM</td>
	  					<td>Janet Dancey</td>
	  					<td></td>
	 				</tr>
	  			
	  				<tr>
	 					<td>08/31/2011 02:33 PM</td>
	  					<td>Dancey</td>
	  					<td></td>
	 				</tr>
	  			
	  				<tr>
	 					<td>07/21/2011 07:03 PM</td>
	  					<td>Dancey</td>
	  					<td></td>
	 				</tr>
	  			
	 		</tbody>
		</table>
	
</body>
</html>

					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-08-31 14:33:21.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-07-21 19:03:32.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178952085"
			stop="178952085" mutation="H1047R" refAllele="A" varAllele="G">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2011-06-17 10:16:40.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>endometrium carcinoma</tumourType>
					<type>case</type>
					<significanceComment>The presence of this mutation is frequently
						observed together with KRAS mutations. Additionally, its presence
						conferred worse prognosis with higher rates of metastases.
					</significanceComment>
					<significanceReference>pmid:19839777</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>This mutation confers oncogenic properties in
						colon cancer cell lines with high enzymatic and transforming
						activities.</significanceComment>
					<significanceReference>pmid:15930273</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>breast carcinoma</tumourType>
					<type>case</type>
					<significanceComment>This mutation seems to occur early in breast
						cancers and seems to predominate the lobular histology subtype. In
						one study, the presence of this mutation occurred more frequently
						in lobular breasts cancers. Additionally, the presence of this
						mutation confers worse outcome (progression free and overall
						survival.</significanceComment>
					<significanceReference>pmid:19418217, pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>lung carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>The effect of this mutation has been studied
						in cell line and animal pre-clinical models. In both models,
						presence of P1K3CA mutation is associated with increased
						anti-tumor effect from a P13K inhibitor.</significanceComment>
					<significanceReference>pmid:19513541, pmid:19029981
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>P13K, AKT and MTOR inhibitor</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>inhibiting PI3K, Akt and mTOR (NVP-BEZ235, GSK2126458,
						MK2206, temsirolimus) </agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15647370, pmid:15930273, pmid:15016963
					</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-06-17 10:16:40.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-17 10:09:42.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-17 10:02:39.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2011-06-17 01:49:05.0</date>
					<userName>Dancey</userName>
					<name>Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43609948" stop="43609948"
			mutation="C634R" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 11:05:03.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Mutations in RET codon 634 have been
						associated with the hereditary syndrome Multiple Endocrine
						Neoplasia 2A (MEN2A) and Familial Medullary Thyroid Cancer (FMTC).
						MEN2A is known to convey a high risk of Medullary Thyroid Cancer
						(nearly 100% penetrance) and Pheochromocytoma (about 40% lifetime
						penetrance). Moreover RET mutations at codon 634 have been
						associated with high rates of hyperparathyroidism.

					</significanceComment>
					<significanceReference>pmid:7907913, pmid:12686527
					</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase I and II studies of patients with
						advanced or metastatic MTC treated with multikinase inhibitors
						known to inhibit RET have shown potential activity. In a study of
						30 patients treated with vandetanib, 73% of patients achieved a
						stable disease or better for 24 weeks or more. In a similar phase
						II trial of motesanib, 48% of 91 patients had stable disease for
						24 weeks or more and 2 additional patients had a partial response.

						In the vandetanib trial, 5 patients had a RET C634R mutation and 3
						achieved a stable disease for 24 weeks or longer.

						Preliminary results suggest that encouraging results are also observed with
						sorafenib and sunitinib multitarget TKIs known to inhibit RET as
						well.
					</significanceComment>
					<significanceReference>pmid:20065189, pmid:19564535, pmid:20368568,
						pmid:18378960</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>adrenal gland pheochromocytoma</tumourType>
					<type>prospective</type>
					<significanceComment>Mutations in RET codon 634 have been
						associated with the hereditary syndrome Multiple Endocrine
						Neoplasia 2A (MEN2A) and Familial Medullary Thyroid Cancer (FMTC).
						MEN2A is known to convey a high risk of Medullary Thyroid Cancer
						(nearly 100% penetrance) and Pheochromocytoma (about 40% lifetime
						penetrance). Moreover RET mutations at codon 634 have been
						associated with high rates of hyperparathyroidism.
					</significanceComment>
					<significanceReference>pmid:7907913, pmid:12686527
					</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>RET inhibitors: Vandetanib, mosetanib, XL184, sorafenib,
						sunitinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>RET inhibitors, vandetanib, mosetanib, XL184</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15277225, pmid:9012462</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43609950" stop="43609950"
			mutation="C634W" refAllele="C" varAllele="G">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 10:58:15.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase I and II studies of patients with
						advanced or metastatic MTC treated with multikinase inhibitors
						known to inhibit RET have shown potential activity. In a study of
						30 patients treated with vandetanib, 73% of patients achieved a
						stable disease or better for 24 weeks or more. In a similar phase
						II trial of motesanib, 48% of 91 patients had stable disease for
						24 weeks or more and 2 additional patients had a partial response.

						No data is available for patients with the C634W specific mutation
						in these trials.

						Preliminary results suggest that encouraging results are also observed with
						sorafenib and sunitinib multitarget TKIs known to inhibit RET as
						well.
					</significanceComment>
					<significanceReference>pmid:20065189, pmid:19564535, pmid:20368568,
						pmid:18378960</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutations in RET codon 634 have been
						associated with the hereditary syndrome Multiple Endocrine
						Neoplasia 2A (MEN2A) and Familial Medullary Thyroid Cancer (FMTC).
						MEN2A is known to convey a high risk of Medullary Thyroid Cancer
						(nearly 100% penetrance) and Pheochromocytoma (about 40% lifetime
						penetrance). Moreover RET mutations at codon 634 have been
						associated with high rates of hyperparathyroidism.
					</significanceComment>
					<significanceReference>pmid:7907913, pmid:12686527
					</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>RET inhibitors: Vandetanib, mosetanib, XL184, sorafenib,
						sunitinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15277225, pmid:9012462</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43609949" stop="43609949"
			mutation="C634Y" refAllele="G" varAllele="A">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 11:04:40.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutations in RET codon 634 have been
						associated with the hereditary syndrome Multiple Endocrine
						Neoplasia 2A (MEN2A) and Familial Medullary Thyroid Cancer (FMTC).
						MEN2A is known to convey a high risk of Medullary Thyroid Cancer
						(nearly 100% penetrance) and Pheochromocytoma (about 40% lifetime
						penetrance). Moreover RET mutations at codon 634 have been
						associated with high rates of hyperparathyroidism.
					</significanceComment>
					<significanceReference>pmid:7907913, pmid:12686527
					</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<significance>
					<tumourType>adrenal gland pheochromocytoma</tumourType>
					<type>retrospective</type>
					<significanceComment>Mutations in RET codon 634 have been
						associated with the hereditary syndrome Multiple Endocrine
						Neoplasia 2A (MEN2A) and Familial Medullary Thyroid Cancer (FMTC).
						MEN2A is known to convey a high risk of Medullary Thyroid Cancer
						(nearly 100% penetrance) and Pheochromocytoma (about 40% lifetime
						penetrance). Moreover RET mutations at codon 634 have been
						associated with high rates of hyperparathyroidism.
					</significanceComment>
					<significanceReference>pmid:7907913, pmid:12686527
					</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase I and II studies of patients with
						advanced or metastatic MTC treated with multikinase inhibitors
						known to inhibit RET have shown potential activity. In a study of
						30 patients treated with vandetanib, 73% of patients achieved a
						stable disease or better for 24 weeks or more. In a similar phase
						II trial of motesanib, 48% of 91 patients had stable disease for
						24 weeks or more and 2 additional patients had a partial response.

						In the vandetanib trial, 2 patients had a RET C634Y mutation and 1
						achieved a 1 partial response, and 1 achieved a stable disease for
						longer than 24 weeks.

						Preliminary results suggest that encouraging results are also observed with
						sorafenib and sunitinib multitarget TKIs known to inhibit RET as
						well.
					</significanceComment>
					<significanceReference>pmid:20065189, pmid:19564535, pmid:20368568,
						pmid:18378960</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>RET inhibitors: Vandetanib, mosetanib, XL184, sorafenib,
						sunitinib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:15277225, pmid:9012462</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43609942" stop="43609942"
			mutation="E632_L633del" refAllele="G" varAllele="GAGCTG">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 11:21:58.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>adrenal gland pheochromocytoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been reported in one case of
						sporadic pheochromocytoma.

						Clinical significance is unknown
					</significanceComment>
					<significanceReference>pmid:7852530</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>This mutation has been reported in 6 patients
						with medullary thyroid cancer, all of whom had sporadic medullary
						thyroid cancer.
						Cases of Familial Medullary Thyroid Cancer or MEN2 harboring this
						mutation have not been reported in the litterature.

						Clinical significance is unknown.
					</significanceComment>
					<significanceReference>pmid:18282654, pmid:9191060
					</significanceReference>
					<significanceEvidence>IVD</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184, sunitinib,
						sorafenib</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:9191060</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43617416" stop="43617416"
			mutation="M918T" refAllele="T" varAllele="C">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 11:48:42.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>retrospective</type>
					<significanceComment>RET M918T has been identified in over 95% of
						cases of Multiple Endocrine Neoplasia Type 2B syndrome(MEN2B).
						MEN2B is known to be associated with Medullary Thyroid Cancer
						(MTC) (100% penetrance), pheochromocytoma (Lifetime penetrance
						around 40%),

						M918T has also been identified in about half of the cases of sporatic
						MTC.
					</significanceComment>
					<significanceReference>pmid:19401695, pmid:7906866, pmid:18073307,
						pmid:7913021</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<significance>
					<tumourType>thyroid carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>Phase I and II studies of patients with
						advanced or metastatic MTC treated with multikinase inhibitors
						known to inhibit RET have shown potential activity. In a study of
						30 patients treated with vandetanib, 73% of patients achieved a
						stable disease or better for 24 weeks or more. In a similar phase
						II trial of motesanib, 48% of 91 patients had stable disease for
						24 weeks or more and 2 additional patients had a partial response.

						In the vandetanib trial, 3 patients had a RET M918T mutation: 1
						achieved a partial response and 1 had stable disease for 24 weeks
						or longer, the last patient progressed early.

						Specific results for the M918T mutation were not reported in the mosetanib
						trial, but 26/47 patients for whom mutation testing was available
						had the M918T mutation.
						Preliminary results suggest that encouraging results are also observed with
						sorafenib and sunitinib multitarget TKIs known to inhibit RET as
						well.
					</significanceComment>
					<significanceReference>pmid:20065189, pmid:19564535, pmid:20368568,
						pmid:18378960</significanceReference>
					<significanceEvidence>IA</significanceEvidence>
				</significance>
				<significance>
					<tumourType>adrenal gland pheochromocytoma</tumourType>
					<type>retrospective</type>
					<significanceComment>RET M918T has been identified in over 95% of
						cases of Multiple Endocrine Neoplasia Type 2B syndrome(MEN2B).
						MEN2B is known to be associated with Medullary Thyroid Cancer
						(MTC) (100% penetrance), pheochromocytoma (Lifetime penetrance
						around 40%),

						M918T has also been identified in about half of the cases of sporatic
						MTC.
					</significanceComment>
					<significanceReference>pmid:19401695, pmid:7906866, pmid:18073307,
						pmid:7913021</significanceReference>
					<significanceEvidence>IIC</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>RET inhibitors: vandetanib, mosetanib, XL184</agents>
					<effectiveness>effective</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:7824936</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2011-10-05 20:49:24.0</date>
					<userName>DANCEY</userName>
					<name>DANCEY</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="10" gene="RET" start="43610039" stop="43610039"
			mutation="A664D" refAllele="C" varAllele="A">
			<lastEditedBy>Vincent Castonguay</lastEditedBy>
			<lastUpdated>2011-04-06 09:59:09.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference>pmid:8635999</actionReference>
					<actionComment>There is no available information in the litterature
						as to whether this mutation is activating, inactivating or silent.
					</actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="PDGFRA" start="55144678" stop="55144678"
			mutation="R718W" refAllele="C" varAllele="T">
			<lastEditedBy>Stuart Watt</lastEditedBy>
			<lastUpdated>2011-10-21 11:34:29.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>unknown</action>
					<actionReference></actionReference>
					<actionComment></actionComment>
					<agentsAvailable>not available</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="EGFR" start="55249062" stop="55249062"
			mutation="Q787L" refAllele="A" varAllele="T">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-08 08:46:07.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference></actionReference>
					<actionComment>This mutation has not been reported in the COSMIC
						database. The functional consequence of this mutation is Unknown.
					</actionComment>
					<agentsAvailable>unknown</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="4" gene="KIT" start="55599340" stop="55599340"
			mutation="N822K" refAllele="T" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-08 08:55:25.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>activating</action>
					<actionReference>pmid:21262832</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>unknown</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="KRAS" start="25398255" stop="25398255"
			mutation="Q22K" refAllele="G" varAllele="T">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-01-04 14:33:57.0</lastUpdated>
			<annotation>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>preclinical</type>
					<significanceComment>Preclinical studies demonstrate that KRAS
						mutant tumors may be sensitive to MEK inhibitors
					</significanceComment>
					<significanceReference>pmid:21118963</significanceReference>
					<significanceEvidence>VD</significanceEvidence>
				</significance>
				<significance>
					<tumourType>large intestine carcinoma</tumourType>
					<type>prospective</type>
					<significanceComment>There is limited information on the clinical
						significance of this mutation. Several randomized phase III trials
						demonstrated that the presence of activating mutations in KRAS
						confers resistance to EGFR monoclonal antibodies (cetuximab,
						panitumumab) in colorectal cancer</significanceComment>
					<significanceReference>pmid:18946061, pmid:18316791
					</significanceReference>
					<significanceEvidence>IB</significanceEvidence>
				</significance>
				<sensitivity>
					<agents>EGFR monoclonal antibodies</agents>
					<sensitivityType>maybe_resistance</sensitivityType>
				</sensitivity>
				<sensitivity>
					<agents>MEK inhibitors</agents>
					<sensitivityType>maybe_sensitivity</sensitivityType>
				</sensitivity>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>11095964</actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-01-04 14:34:11.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
				<confirmation>
					<date>2012-01-04 13:08:00.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovVGl0bGUgKE11dGF0aW9uIHJlcG9ydCBmb3IgS1JBUyBRMjJLKQovUHJvZHVjZXIgKEFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzKQovQ3JlYXRpb25EYXRlIChEOjIwMTIwMTA0MTMwODAwLTA1JzAtNjAwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwgL04gMwovTGVuZ3RoIDEwIDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnicnZZ3VFPZFofPvTe9UJIQipTQa2hSAkgNvUiRLioxCRBKwJAAIjZEVHBEUZGmCDIo4ICjQ5GxIoqFAVGx6wQZRNRxcBQblklkrRnfvHnvzZvfH/d+a5+9z91n733WugCQ/IMFwkxYCYAMoVgU4efFiI2LZ2AHAQzwAANsAOBws7NCFvhGApkCfNiMbJkT+Be9ug4g+fsq0z+MwQD/n5S5WSIxAFCYjOfy+NlcGRfJOD1XnCW3T8mYtjRNzjBKziJZgjJWk3PyLFt89pllDznzMoQ8GctzzuJl8OTcJ+ONORK+jJFgGRfnCPi5Mr4mY4N0SYZAxm/ksRl8TjYAKJLcLuZzU2RsLWOSKDKCLeN5AOBIyV/w0i9YzM8Tyw/FzsxaLhIkp4gZJlxTho2TE4vhz89N54vFzDAON40j4jHYmRlZHOFyAGbP/FkUeW0ZsiI72Dg5ODBtLW2+KNR/Xfybkvd2ll6Ef+4ZRB/4w/ZXfpkNALCmZbXZ+odtaRUAXesBULv9h81gLwCKsr51Dn1xHrp8XlLE4ixnK6vc3FxLAZ9rKS/o7/qfDn9DX3zPUr7d7+VhePOTOJJ0MUNeN25meqZExMjO4nD5DOafh/gfB/51HhYR/CS+iC+URUTLpkwgTJa1W8gTiAWZQoZA+J+a+A/D/qTZuZaJ2vgR0JZYAqUhGkB+HgAoKhEgCXtkK9DvfQvGRwP5zYvRmZid+8+C/n1XuEz+yBYkf45jR0QyuBJRzuya/FoCNCAARUAD6kAb6AMTwAS2wBG4AA/gAwJBKIgEcWAx4IIUkAFEIBcUgLWgGJSCrWAnqAZ1oBE0gzZwGHSBY+A0OAcugctgBNwBUjAOnoAp8ArMQBCEhcgQFVKHdCBDyByyhViQG+QDBUMRUByUCCVDQkgCFUDroFKoHKqG6qFm6FvoKHQaugANQ7egUWgS+hV6ByMwCabBWrARbAWzYE84CI6EF8HJ8DI4Hy6Ct8CVcAN8EO6ET8OX4BFYCj+BpxGAEBE6ooswERbCRkKReCQJESGrkBKkAmlA2pAepB+5ikiRp8hbFAZFRTFQTJQLyh8VheKilqFWoTajqlEHUJ2oPtRV1ChqCvURTUZros3RzugAdCw6GZ2LLkZXoJvQHeiz6BH0OPoVBoOhY4wxjhh/TBwmFbMCsxmzG9OOOYUZxoxhprFYrDrWHOuKDcVysGJsMbYKexB7EnsFO459gyPidHC2OF9cPE6IK8RV4FpwJ3BXcBO4GbwS3hDvjA/F8/DL8WX4RnwPfgg/jp8hKBOMCa6ESEIqYS2hktBGOEu4S3hBJBL1iE7EcKKAuIZYSTxEPE8cJb4lUUhmJDYpgSQhbSHtJ50i3SK9IJPJRmQPcjxZTN5CbiafId8nv1GgKlgqBCjwFFYr1Ch0KlxReKaIVzRU9FRcrJivWKF4RHFI8akSXslIia3EUVqlVKN0VOmG0rQyVdlGOVQ5Q3mzcovyBeVHFCzFiOJD4VGKKPsoZyhjVISqT2VTudR11EbqWeo4DUMzpgXQUmmltG9og7QpFYqKnUq0Sp5KjcpxFSkdoRvRA+jp9DL6Yfp1+jtVLVVPVb7qJtU21Suqr9XmqHmo8dVK1NrVRtTeqTPUfdTT1Lepd6nf00BpmGmEa+Rq7NE4q/F0Dm2OyxzunJI5h+fc1oQ1zTQjNFdo7tMc0JzW0tby08rSqtI6o/VUm67toZ2qvUP7hPakDlXHTUegs0PnpM5jhgrDk5HOqGT0MaZ0NXX9dSW69bqDujN6xnpReoV67Xr39An6LP0k/R36vfpTBjoGIQYFBq0Gtw3xhizDFMNdhv2Gr42MjWKMNhh1GT0yVjMOMM43bjW+a0I2cTdZZtJgcs0UY8oyTTPdbXrZDDazN0sxqzEbMofNHcwF5rvNhy3QFk4WQosGixtMEtOTmcNsZY5a0i2DLQstuyyfWRlYxVtts+q3+mhtb51u3Wh9x4ZiE2hTaNNj86utmS3Xtsb22lzyXN+5q+d2z31uZ27Ht9tjd9Oeah9iv8G+1/6Dg6ODyKHNYdLRwDHRsdbxBovGCmNtZp13Qjt5Oa12Oub01tnBWex82PkXF6ZLmkuLy6N5xvP48xrnjbnquXJc612lbgy3RLe9blJ3XXeOe4P7Aw99D55Hk8eEp6lnqudBz2de1l4irw6v12xn9kr2KW/E28+7xHvQh+IT5VPtc99XzzfZt9V3ys/eb4XfKX+0f5D/Nv8bAVoB3IDmgKlAx8CVgX1BpKAFQdVBD4LNgkXBPSFwSGDI9pC78w3nC+d3hYLQgNDtoffCjMOWhX0fjgkPC68JfxhhE1EQ0b+AumDJgpYFryK9Issi70SZREmieqMVoxOim6Nfx3jHlMdIY61iV8ZeitOIE8R1x2Pjo+Ob4qcX+izcuXA8wT6hOOH6IuNFeYsuLNZYnL74+BLFJZwlRxLRiTGJLYnvOaGcBs700oCltUunuGzuLu4TngdvB2+S78ov508kuSaVJz1Kdk3enjyZ4p5SkfJUwBZUC56n+qfWpb5OC03bn/YpPSa9PQOXkZhxVEgRpgn7MrUz8zKHs8yzirOky5yX7Vw2JQoSNWVD2Yuyu8U02c/UgMREsl4ymuOWU5PzJjc690iecp4wb2C52fJNyyfyffO/XoFawV3RW6BbsLZgdKXnyvpV0Kqlq3pX668uWj2+xm/NgbWEtWlrfyi0LiwvfLkuZl1PkVbRmqKx9X7rW4sVikXFNza4bKjbiNoo2Di4ae6mqk0fS3glF0utSytK32/mbr74lc1XlV992pK0ZbDMoWzPVsxW4dbr29y3HShXLs8vH9sesr1zB2NHyY6XO5fsvFBhV1G3i7BLsktaGVzZXWVQtbXqfXVK9UiNV017rWbtptrXu3m7r+zx2NNWp1VXWvdur2DvzXq/+s4Go4aKfZh9OfseNkY39n/N+rq5SaOptOnDfuF+6YGIA33Njs3NLZotZa1wq6R18mDCwcvfeH/T3cZsq2+nt5ceAockhx5/m/jt9cNBh3uPsI60fWf4XW0HtaOkE+pc3jnVldIl7Y7rHj4aeLS3x6Wn43vL7/cf0z1Wc1zleNkJwomiE59O5p+cPpV16unp5NNjvUt675yJPXOtL7xv8GzQ2fPnfM+d6ffsP3ne9fyxC84Xjl5kXey65HCpc8B+oOMH+x86Bh0GO4cch7ovO13uGZ43fOKK+5XTV72vnrsWcO3SyPyR4etR12/eSLghvcm7+ehW+q3nt3Nuz9xZcxd9t+Se0r2K+5r3G340/bFd6iA9Puo9OvBgwYM7Y9yxJz9l//R+vOgh+WHFhM5E8yPbR8cmfScvP174ePxJ1pOZp8U/K/9c+8zk2Xe/ePwyMBU7Nf5c9PzTr5tfqL/Y/9LuZe902PT9VxmvZl6XvFF/c+At623/u5h3EzO577HvKz+Yfuj5GPTx7qeMT59+A/eE8/sKZW5kc3RyZWFtCmVuZG9iago2IDAgb2JqClsvSUNDQmFzZWQgNSAwIFJdCmVuZG9iago3IDAgb2JqCjw8IC9UeXBlIC9NZXRhZGF0YQovU3VidHlwZSAvWE1MCi9MZW5ndGggMTEgMCBSCgo+PgpzdHJlYW0KPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4KCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPgo8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyIgcmRmOmFib3V0PSIiPgo8ZGM6dGl0bGU+TXV0YXRpb24gcmVwb3J0IGZvciBLUkFTIFEyMks8L2RjOnRpdGxlPgo8ZGM6ZGF0ZT4yMDEyLTAxLTA0VDEzOjA4OjAwLTAtNTowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzPC9wZGY6UHJvZHVjZXI+CjwvcmRmOkRlc2NyaXB0aW9uPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyIgcmRmOmFib3V0PSIiPgo8eG1wOkNyZWF0ZURhdGU+MjAxMi0wMS0wNFQxMzowODowMC0wLTU6MDA8L3htcDpDcmVhdGVEYXRlPgo8L3JkZjpEZXNjcmlwdGlvbj4KPC9yZGY6UkRGPgo8L3g6eG1wbWV0YT4KPD94cGFja2V0IGVuZD0iciI/PgoKCmVuZHN0cmVhbQplbmRvYmoKOSAwIG9iago8PCAvTGVuZ3RoIDEyIDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnic1RnLbtw28L5fsZcCNhAzJEW9cnMdJ03doI69QA91Dlwt10tUj40eDvz3HUoiRVHSbgL0UgeOOdTMcN6ckcgaw78rAv+FMV0n2erbirR7ZB1S+AM7v25Wbz94a4LXm33/EAiIj1HgsTj214wh3/fXm2z998Xnpua1LPLL9cUafktxLMq6B/ZF2a/uHq4f++UXSu8u11/Xm99Xt5vVF+t83B1vb/mUIi3Wl7GoIR2EJa6weO3RQcZ7/iy6068IiRGO4SfqRDAUNEQeVU9GlOTSQYOHUUQwJiM0h/NFsT93HIsRCajaP3mcz0B979RZc4ZsrWMZJ0aBY50IUUI7fo/gv6Z613vn5s/P93/cbm57kOe7fpUU+V6WmdDwE6Vhv/yDV9rjFX8xGNtXzfR3nguN8Z7niXjtARM2mLzF7C3FhJqNd1jzv/88xMu3FYM4BN8rF0BwkG6VgU4DlCqIDJBNYm0f1n+t8tXfXwF7B1b7vsKIrT+uWtpA8x3TBpr2EQxu8gT5rn29GMUkVNHU2vhDKb41Ik+M3vtRMrTLbJxIUi+s1DF79UHoVXHUqyYrGp1v9etRVL3VlIxuBHh4HYDYEPGgTSvipid3ssKfIFq6OKkxZfrIs2NqCTIXiiFF2AeSPhwJmvCd4FQZT1Njk1pUtcy1QRJeJjIvMj6nisMHo4h4+Jc5RRzMpwvyllDPRHmr1tOlSwmJ5SE/JMbxdE4bB+fARcbBj4UUtUwmiZe+ZsdDITVYy6pqxOTZ5JDYhwoBCnjdIbkojimvsjmrOPJghL0wnLWKg6msQgMfnzcLwQEKdMXx5owywkh5qSv2zzl4xAUUIV40q8gI7+kCSk8UxeGCHm7ZIQTuCh/MELZ1xwLTFgwGcERl7S+WHoUVad4OdaSpzxQf4vmIwEUds04/q4IkB17ypBalBJMmpyoEsPF9FAYM46hP/MYkXc4zoYv7y9WdvCp5pSv3nSyrWph+gA9XQ5m0XuuoZMk1tyJPimdhHHwosiItnk8WDRKCOSJmwntzkFVPrji90Vm0IFN15uSueymLbFJvM55B8ZF8ysvis+eZTF+1EFAri52oHJGOZVELVdAnqRJFiGFQLexUqw/GhNJlkolsK3TNN5fKIK1dKD9u7nllHjRHUXZion7rWj+S+XOq8QAjL/Q6MUWoarYQP3Vj31datlJUxyKv5NYwGdpAPqdvDHcl9eI46PSF8JQvcBPm2g/6YtSCbobLr+R5BdyzAdmYtbeEsR2I1aR15UorIdVlwmvTtRjaF17KotF4yunPOfQuUlRvDGqSNrv2bFcpSghirM+/tDHi8Z3IC1PB3hgNFWzOapGGp7smqU2uWNVvyelHkLIUJi7tFi4tSjHHbFKQVTdFUayyv287r1OoGjk44sXEkLLcYPlU8J0+s9Yxo4zIc2P2NhUGkvq7xpNVofxo6Ae/7eR+b0J8pgG6uQK5IACMUqV4toLlSUXEi9yJyR0JKnoMscgzdXKr27MHsX8U3xbrP2UR8mKiuu+27xzAtvFk4QCOqKz95dYTsCLN26GONPWZ+k+DAJEYm+ZlMnydvArmyi2NQqRigfi63JrcbvJEJecQU5D7XYOoUawQNWnnNrt6/li8jiiGQZC106crjF0wFnVQ9vN9PEePBq+L0pL7CQaPT++fLvVFRwiOfUiJhajwMEE+izBmbVRYYNqCeABHVNb+YlQoZljzds7EmvrcSAIzo8cCc53fpDKHyqf9NpSJe6gR42ePNZS5k/MEsFcjjw9NBxn6+MkddKKXa+Gr/u+4MZ+PSS8A3WHEivp78lM+DbPJTPTm0q0fjqoVVHm5h42fjN9z4QvCxl6kws+Vu8n/yYvv+QldPcwQDuIJJTrtkIiiNkroMIp0Xc5/MW90baAZKhzv2QPEvPcY9tT7FtPl/F+858r9495zKU97j1G4m9hQwz3tvR8cjVyHWIPQgkOYDwWyfaX0/3KII/dPOMShRAuFnfkxYkGo0k4VdgtMWzAawBGVtb9Y2BVWrHk71LGmPlPYWRgimMJN5b1+4TLlW5nKevK+6VP+oiLmmY/u7GuYXerTHQCLIxSSwBq4zIjQHZcOQTl3BO+PaIHPt3cG+SC3si5K/ejATX+5K5ImAyrTmou9iqTk9Vyv4HnQ/xCGCZuIPY4O19M+oSigDFOv9bQFpi1IBnBEZe0veloxI5q3cybR1Gc87XvAjbYvAbrXawLmLGh+BkcPZfxBVNDYWXl3U+TQ35TW61ntDZN8J/zv+wRFSuR4MnCPk3fRKwFGVL0RjSe8Mv564uwQ0i0K5+j6dtOMB4tHEzWNxXFrbodHaZlpUQSisrEbFOZkqAvdIt5+/PCgrVLAoJfaGZDXcltYfdQk+gIfhdDL0biLvgFsoy9gAziisvaXow+YUc3bOZNq6nPR1779i0wuPdifen4DKxbl68k7LYDCS2KKSR++72HsdqcyQqd4N86nh+3k1TOdpcpU9TgZ1QEBGxMSh/0oMPsZIurX5jPEWFiHxdy3DnfwDChUbOjH46VjCX5HfV2c5491WCwe234a+hfl03CtCmVuZHN0cmVhbQplbmRvYmoKOCAwIG9iago8PCAvVHlwZSAvUGFnZQovUGFyZW50IDEgMCBSCi9NZWRpYUJveCBbIDAgMCA1OTUgNzkyIF0KL1RyaW1Cb3ggWyAwIDAgNTk1IDc5MiBdCi9CbGVlZEJveCBbIDAgMCA1OTUgNzkyIF0KL1Jlc291cmNlcyAzIDAgUgovQ29udGVudHMgOSAwIFIKPj4KZW5kb2JqCjEwIDAgb2JqCjI1OTYKZW5kb2JqCjExIDAgb2JqCjcyNgplbmRvYmoKMTIgMCBvYmoKMTkyMgplbmRvYmoKMTMgMCBvYmoKPDwgL1R5cGUgL0ZvbnQKL1N1YnR5cGUgL1R5cGUxCi9OYW1lIC9GMQovQmFzZUZvbnQgL0hlbHZldGljYQovRW5jb2RpbmcgL1dpbkFuc2lFbmNvZGluZyA+PgplbmRvYmoKMTQgMCBvYmoKPDwgL1R5cGUgL0ZvbnQKL1N1YnR5cGUgL1R5cGUxCi9OYW1lIC9GMwovQmFzZUZvbnQgL0hlbHZldGljYS1Cb2xkCi9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nID4+CmVuZG9iagoxIDAgb2JqCjw8IC9UeXBlIC9QYWdlcwovQ291bnQgMQovS2lkcyBbOCAwIFIgXSA+PgplbmRvYmoKMiAwIG9iago8PCAvVHlwZSAvQ2F0YWxvZwovUGFnZXMgMSAwIFIKL01ldGFkYXRhIDcgMCBSCj4+CmVuZG9iagozIDAgb2JqCjw8Ci9Gb250IDw8CiAgL0YxIDEzIDAgUgogIC9GMyAxNCAwIFIKPj4KL1Byb2NTZXQgWyAvUERGIC9JbWFnZUIgL0ltYWdlQyAvVGV4dCBdCi9Db2xvclNwYWNlIDw8CiAgL0RlZmF1bHRSR0IgNiAwIFIKPj4KPj4KZW5kb2JqCnhyZWYKMCAxNQowMDAwMDAwMDAwIDY1NTM1IGYgCjAwMDAwMDYxMTMgMDAwMDAgbiAKMDAwMDAwNjE3MSAwMDAwMCBuIAowMDAwMDA2MjM2IDAwMDAwIG4gCjAwMDAwMDAwMTUgMDAwMDAgbiAKMDAwMDAwMDE1NCAwMDAwMCBuIAowMDAwMDAyODMxIDAwMDAwIG4gCjAwMDAwMDI4NjQgMDAwMDAgbiAKMDAwMDAwNTY3MyAwMDAwMCBuIAowMDAwMDAzNjc1IDAwMDAwIG4gCjAwMDAwMDU4MzAgMDAwMDAgbiAKMDAwMDAwNTg1MSAwMDAwMCBuIAowMDAwMDA1ODcxIDAwMDAwIG4gCjAwMDAwMDU4OTIgMDAwMDAgbiAKMDAwMDAwNjAwMCAwMDAwMCBuIAp0cmFpbGVyCjw8Ci9TaXplIDE1Ci9Sb290IDIgMCBSCi9JbmZvIDQgMCBSCi9JRCBbPDE4QUJCMTQ5RDM2ODdDRjkyQUQzMDIwNTZDN0IwOEFEPiA8MThBQkIxNDlEMzY4N0NGOTJBRDMwMjA1NkM3QjA4QUQ+XQo+PgpzdGFydHhyZWYKNjM3MwolJUVPRgo=
					</pdf>
				</confirmation>
				<confirmation>
					<date>2012-01-04 10:25:03.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="7" gene="BRAF" start="140481411" stop="140481411"
			mutation="G466E" refAllele="C" varAllele="T">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-07 17:56:51.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>MEK inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>inactivating</action>
					<actionReference>15035987</actionReference>
					<actionComment>function is unknown</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-03-07 17:53:37.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>PGh0bWwgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGh0bWwiPgo8aGVhZD4KPHRpdGxlPk11dGF0aW9uIHJlcG9ydCBmb3IgQlJBRiBHNDY2RTwvdGl0bGU+Cgo8L2hlYWQ+Cjxib2R5PgoJPHA+CglTdGF0dXM6IAoJCgk8c3BhbiBjbGFzcz0ic3RhdHVzY29tcGxldGUiPkNPTVBMRVRFPC9zcGFuPgoJCgkKCWFuZCBjb25maXJtZWQKCQoJJiN4MjAxNDsgCgkKCUxhc3Qgc2F2ZWQgYnk6IEphbmV0IERhbmNleSBvbiAwMy8wNy8yMDEyIDA1OjUzIFBNCgkKCTwvcD4KCSAgCgk8aHIgLz4KCTxoMz5GcmVxdWVuY3kgb2YgRzQ2NkUgbXV0YXRpb24gaW4gQlJBRiBpbiB0aGUgdG9wIHR1bW91ciB0eXBlczwvaDM+CgkKCTx0YWJsZT4KCTx0aGVhZD4KCQk8dHI+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjMwIj48L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIyMjAiPlR1bW91cjwvdGg+CgkJCTx0aCBhbGlnbj0ibGVmdCIgd2lkdGg9IjgwIj5GcmVxdWVuY3k8L3RoPgoJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIxMDAiPlNhbXBsZXM8L3RoPgoJCTwvdHI+Cgk8L3RoZWFkPgoJPHRib2R5PgoJCQoJCQoJCQoJPC90Ym9keT4KCTwvdGFibGU+CgkKCTxociAvPgoJPGgzPkJSQUYgY2hhcmFjdGVyaXN0aWNzPC9oMz4KCQoJPGg0PkZ1bGwgbmFtZTogdi1yYWYgbXVyaW5lIHNhcmNvbWEgdmlyYWwgb25jb2dlbmUgaG9tb2xvZyBCMTwvaDQ+CgkKCTxwPlJhZiBraW5hc2VzLCBhIGZhbWlseSBvZiB0aHJlZSBzZXJpbmUvdGhyZW9uaW5lIGtpbmFzZXMsIGFyZSBwYXJ0IG9mIHRoZSByYXMtTUFQSyBzaWduYWxpbmcgY2FzY2FkZSBhbmQgcGhvc3Bob3J5bGF0ZSBNRUsuIFVwb24gZ3Jvd3RoIGZhY3RvciBzdGltdWxhdGlvbiwgUmFmLTEgKG9yIGMtUmFmKSBpcyBhY3RpdmF0ZWQgYnkgR1RQLWJvdW5kIFJhcyBhbmQgcmVjcnVpdGVkIHRvIHRoZSBjZWxsIG1lbWJyYW5lLiBUaGlzIGFjdGl2YXRpb24gcHJvY2VzcyBpcyB0aWdodGx5IHJlZ3VsYXRlZCBieSBhIG51bWJlciBvZiBmYWN0b3JzIGluY2x1ZGluZyBwaG9zcGhhdGFzZXMgKGUuZy4gUFAxLCBQUDJBLCBQUDUpLCBraW5hc2VzIChlLmcuIFNyYywgRVJLLCBBa3QsIFBLQykgYW5kIHByb3RlaW5zIHRoYXQgYmluZCBkaXJlY3RseSB0byBSYWYtMSAoZS5nLiBSS0lQLCAxNC0zLTN6ZXRhLCBLU1IsIEhzcDkwKS4gUmFmLTEgaXMgYWxzbyB0aG91Z2h0IHRvIGJlIGFibGUgdG8gZGltZXJpemUgd2l0aCB3aWxkIHR5cGUgQi1SYWYgaW4gYSBSYXMtZGVwZW5kZW50IHByb2Nlc3MuIEItcmFmIGlzIGNvbW1vbmx5IG11dGF0ZWQgYW5kIHRoZXJlYnkgYWN0aXZhdGVkIGluIG1hbnkgaHVtYW4gY2FuY2VycywgdGhlIG1vc3QgZnJlcXVlbnQgbXV0YXRpb24gYmVpbmcgdGhlIFY2MDBFIG11dGF0aW9uIG9mIHRoZSBraW5hc2UgZG9tYWluLiBXaGlsc3Qgd3QgYi1SYWYgYW5kIFJhZi0xIGFyZSBzdHJvbmdseSBhY3RpdmF0ZWQgYnkgZ3Jvd3RoIGZhY3RvciBzaWduYWxzIHZpYSBSYXMgYW5kIFNyYywgYS1SYWYgaXMgb25seSBtb2Rlc3RseSBhY3RpdmF0ZWQgYW5kIGhhcyBsb3cgYmFzYWwgYWN0aXZpdHkuIEFsbCB0aHJlZSBpc29mb3JtcyBvZiBSYWYgYXJlIGNvbnNpZGVyZWQgdG8gYmUgb25jb2dlbmljLjwvcD4KCSAgICAgICAgICAgICAgIAoJPGhyIC8+Cgk8aDM+QlJBRiBHNDY2RSBjaGFyYWN0ZXJpc3RpY3M8L2gzPgoJICAJCgk8cD5UaGUgZnVuY3Rpb25hbCBjb25zZXF1ZW5jZSBvZiB0aGlzIG11dGF0aW9uIGlzOiA8Yj51bmtub3duPC9iPi4KCSAgIFJlZmVyZW5jZSAoUE1JRCk6IDwvcD4KCQoJCgkKCQkKCQk8cD5mdW5jdGlvbiBpcyB1bmtub3duPC9wPgoJCQoJCgkKCQkJCQkKCTxociAvPgoJPGgzPkNsaW5pY2FsIGFuZCBQcmVjbGluaWNhbCBTdHVkaWVzPC9oMz4KCQoJCgkKCQoJICAJCgkKCSAgCQoJPGhyIC8+Cgk8aDM+QXZhaWxhYmlsaXR5IG9mIEludmVzdGlnYXRpb25hbCBBZ2VudHM8L2gzPgoJICAJCgkKCQk8cD4KCQlUaGUgYXZhaWxhYmxlIGludmVzdGlnYXRpb25hbCBhZ2VudHMgPGk+TUVLIGluaGliaXRvcnM8L2k+IGhhdmUgZG9jdW1lbnRlZCBlZmZpY2FjeTogCgkJPGI+dW5rbm93bjwvYj4KCQk8L3A+CgkKCQoJPGhyIC8+Cgk8aDM+U2Vuc2l0aXZpdHkgYW5kIFJlc2lzdGFuY2UgQ29uZmVycmVkIGJ5IE11dGF0aW9uPC9oMz4KCQoJCgkKCTxociAvPgoJPGgzPlJlcG9ydCBIaXN0b3J5PC9oMz4KCSAgCQoJCgkJPHRhYmxlPgoJCQk8dGhlYWQ+CgkJCQk8dHI+CgkJCQkJPHRoIGFsaWduPSJsZWZ0IiB3aWR0aD0iMTIwIj5EYXRlPC90aD4KCQkJCQk8dGggYWxpZ249ImxlZnQiIHdpZHRoPSIxMDAiPkNvbmZpcm1lZCBieTwvdGg+CgkJCQkJPHRoIGFsaWduPSJsZWZ0IiB3aWR0aD0iMjIwIj5Db21tZW50PC90aD4KCQkJCTwvdHI+CgkJCTwvdGhlYWQ+CgkJCTx0Ym9keT4KCSAgCQkJCgkgIAkJCQk8dHI+CgkgCQkJCQk8dGQ+MDMvMDcvMjAxMiAwNTo1MyBQTTwvdGQ+CgkgIAkJCQkJPHRkPkphbmV0IERhbmNleTwvdGQ+CgkgIAkJCQkJPHRkPjwvdGQ+CgkgCQkJCTwvdHI+CgkgIAkJCQoJIAkJPC90Ym9keT4KCQk8L3RhYmxlPgoJCjwvYm9keT4KPC9odG1sPgo=
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178952077"
			stop="178952077" mutation="N1044K" refAllele="T" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-07 18:03:46.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>PI3K inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>unknown</action>
					<actionReference></actionReference>
					<actionComment>This rare variant has previously been reported to
						occur in human cancers. It occurs within the kinase domain of a
						known oncogene. The function and clinical significance are
						unknown.</actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-03-07 18:04:29.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="3" gene="PIK3CA" start="178916936"
			stop="178916936" mutation="R108H" refAllele="G" varAllele="A">
			<lastEditedBy>Janet Dancey</lastEditedBy>
			<lastUpdated>2012-03-14 13:51:41.0</lastUpdated>
			<annotation>
				<effectiveness>
					<agents>AKT inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>mTOR inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<effectiveness>
					<agents>PI3K inhibitors</agents>
					<effectiveness>unknown</effectiveness>
				</effectiveness>
				<characteristics>
					<action>activating</action>
					<actionReference>18829572 </actionReference>
					<actionComment></actionComment>
					<agentsAvailable>available</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-03-14 13:38:50.0</date>
					<userName>jdancey</userName>
					<name>Janet Dancey</name>
					<comment></comment>
					<body>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
					</body>
					<pdf>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
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
		<mutation chromosome="9" gene="ABL1" start="133738235" stop="133738235"
			mutation="T212M" refAllele="C" varAllele="T">
			<lastEditedBy />
			<lastUpdated />
			<annotation>
				<characteristics>
					<action>unknown</action>
					<actionReference></actionReference>
					<actionComment></actionComment>
					<agentsAvailable>unknown</agentsAvailable>
				</characteristics>
			</annotation>
		</mutation>
		<mutation chromosome="12" gene="CDK4" start="58142003" stop="58142003"
			mutation="R24L" refAllele="G" varAllele="T">
			<lastEditedBy>Stuart Watt</lastEditedBy>
			<lastUpdated>2012-04-04 09:48:22.0</lastUpdated>
			<annotation>
				<characteristics>
					<action>other</action>
					<actionReference></actionReference>
					<actionComment>Unknown</actionComment>
					<agentsAvailable>unknown</agentsAvailable>
				</characteristics>
				<confirmation>
					<date>2012-04-04 09:48:36.0</date>
					<userName>swatt</userName>
					<name>Stuart Watt</name>
					<comment>As requested by LLS</comment>
					<body>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
					</body>
					<pdf>JVBERi0xLjQKJaqrrK0KNCAwIG9iago8PAovVGl0bGUgKE11dGF0aW9uIHJlcG9ydCBmb3IgQ0RLNCBSMjRMKQovUHJvZHVjZXIgKEFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzKQovQ3JlYXRpb25EYXRlIChEOjIwMTIwNDA0MDk0ODM3LTA0JzAtNDgwJykKPj4KZW5kb2JqCjUgMCBvYmoKPDwgL04gMwovTGVuZ3RoIDEwIDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnicnZZ3VFPZFofPvTe9UJIQipTQa2hSAkgNvUiRLioxCRBKwJAAIjZEVHBEUZGmCDIo4ICjQ5GxIoqFAVGx6wQZRNRxcBQblklkrRnfvHnvzZvfH/d+a5+9z91n733WugCQ/IMFwkxYCYAMoVgU4efFiI2LZ2AHAQzwAANsAOBws7NCFvhGApkCfNiMbJkT+Be9ug4g+fsq0z+MwQD/n5S5WSIxAFCYjOfy+NlcGRfJOD1XnCW3T8mYtjRNzjBKziJZgjJWk3PyLFt89pllDznzMoQ8GctzzuJl8OTcJ+ONORK+jJFgGRfnCPi5Mr4mY4N0SYZAxm/ksRl8TjYAKJLcLuZzU2RsLWOSKDKCLeN5AOBIyV/w0i9YzM8Tyw/FzsxaLhIkp4gZJlxTho2TE4vhz89N54vFzDAON40j4jHYmRlZHOFyAGbP/FkUeW0ZsiI72Dg5ODBtLW2+KNR/Xfybkvd2ll6Ef+4ZRB/4w/ZXfpkNALCmZbXZ+odtaRUAXesBULv9h81gLwCKsr51Dn1xHrp8XlLE4ixnK6vc3FxLAZ9rKS/o7/qfDn9DX3zPUr7d7+VhePOTOJJ0MUNeN25meqZExMjO4nD5DOafh/gfB/51HhYR/CS+iC+URUTLpkwgTJa1W8gTiAWZQoZA+J+a+A/D/qTZuZaJ2vgR0JZYAqUhGkB+HgAoKhEgCXtkK9DvfQvGRwP5zYvRmZid+8+C/n1XuEz+yBYkf45jR0QyuBJRzuya/FoCNCAARUAD6kAb6AMTwAS2wBG4AA/gAwJBKIgEcWAx4IIUkAFEIBcUgLWgGJSCrWAnqAZ1oBE0gzZwGHSBY+A0OAcugctgBNwBUjAOnoAp8ArMQBCEhcgQFVKHdCBDyByyhViQG+QDBUMRUByUCCVDQkgCFUDroFKoHKqG6qFm6FvoKHQaugANQ7egUWgS+hV6ByMwCabBWrARbAWzYE84CI6EF8HJ8DI4Hy6Ct8CVcAN8EO6ET8OX4BFYCj+BpxGAEBE6ooswERbCRkKReCQJESGrkBKkAmlA2pAepB+5ikiRp8hbFAZFRTFQTJQLyh8VheKilqFWoTajqlEHUJ2oPtRV1ChqCvURTUZros3RzugAdCw6GZ2LLkZXoJvQHeiz6BH0OPoVBoOhY4wxjhh/TBwmFbMCsxmzG9OOOYUZxoxhprFYrDrWHOuKDcVysGJsMbYKexB7EnsFO459gyPidHC2OF9cPE6IK8RV4FpwJ3BXcBO4GbwS3hDvjA/F8/DL8WX4RnwPfgg/jp8hKBOMCa6ESEIqYS2hktBGOEu4S3hBJBL1iE7EcKKAuIZYSTxEPE8cJb4lUUhmJDYpgSQhbSHtJ50i3SK9IJPJRmQPcjxZTN5CbiafId8nv1GgKlgqBCjwFFYr1Ch0KlxReKaIVzRU9FRcrJivWKF4RHFI8akSXslIia3EUVqlVKN0VOmG0rQyVdlGOVQ5Q3mzcovyBeVHFCzFiOJD4VGKKPsoZyhjVISqT2VTudR11EbqWeo4DUMzpgXQUmmltG9og7QpFYqKnUq0Sp5KjcpxFSkdoRvRA+jp9DL6Yfp1+jtVLVVPVb7qJtU21Suqr9XmqHmo8dVK1NrVRtTeqTPUfdTT1Lepd6nf00BpmGmEa+Rq7NE4q/F0Dm2OyxzunJI5h+fc1oQ1zTQjNFdo7tMc0JzW0tby08rSqtI6o/VUm67toZ2qvUP7hPakDlXHTUegs0PnpM5jhgrDk5HOqGT0MaZ0NXX9dSW69bqDujN6xnpReoV67Xr39An6LP0k/R36vfpTBjoGIQYFBq0Gtw3xhizDFMNdhv2Gr42MjWKMNhh1GT0yVjMOMM43bjW+a0I2cTdZZtJgcs0UY8oyTTPdbXrZDDazN0sxqzEbMofNHcwF5rvNhy3QFk4WQosGixtMEtOTmcNsZY5a0i2DLQstuyyfWRlYxVtts+q3+mhtb51u3Wh9x4ZiE2hTaNNj86utmS3Xtsb22lzyXN+5q+d2z31uZ27Ht9tjd9Oeah9iv8G+1/6Dg6ODyKHNYdLRwDHRsdbxBovGCmNtZp13Qjt5Oa12Oub01tnBWex82PkXF6ZLmkuLy6N5xvP48xrnjbnquXJc612lbgy3RLe9blJ3XXeOe4P7Aw99D55Hk8eEp6lnqudBz2de1l4irw6v12xn9kr2KW/E28+7xHvQh+IT5VPtc99XzzfZt9V3ys/eb4XfKX+0f5D/Nv8bAVoB3IDmgKlAx8CVgX1BpKAFQdVBD4LNgkXBPSFwSGDI9pC78w3nC+d3hYLQgNDtoffCjMOWhX0fjgkPC68JfxhhE1EQ0b+AumDJgpYFryK9Issi70SZREmieqMVoxOim6Nfx3jHlMdIY61iV8ZeitOIE8R1x2Pjo+Ob4qcX+izcuXA8wT6hOOH6IuNFeYsuLNZYnL74+BLFJZwlRxLRiTGJLYnvOaGcBs700oCltUunuGzuLu4TngdvB2+S78ov508kuSaVJz1Kdk3enjyZ4p5SkfJUwBZUC56n+qfWpb5OC03bn/YpPSa9PQOXkZhxVEgRpgn7MrUz8zKHs8yzirOky5yX7Vw2JQoSNWVD2Yuyu8U02c/UgMREsl4ymuOWU5PzJjc690iecp4wb2C52fJNyyfyffO/XoFawV3RW6BbsLZgdKXnyvpV0Kqlq3pX668uWj2+xm/NgbWEtWlrfyi0LiwvfLkuZl1PkVbRmqKx9X7rW4sVikXFNza4bKjbiNoo2Di4ae6mqk0fS3glF0utSytK32/mbr74lc1XlV992pK0ZbDMoWzPVsxW4dbr29y3HShXLs8vH9sesr1zB2NHyY6XO5fsvFBhV1G3i7BLsktaGVzZXWVQtbXqfXVK9UiNV017rWbtptrXu3m7r+zx2NNWp1VXWvdur2DvzXq/+s4Go4aKfZh9OfseNkY39n/N+rq5SaOptOnDfuF+6YGIA33Njs3NLZotZa1wq6R18mDCwcvfeH/T3cZsq2+nt5ceAockhx5/m/jt9cNBh3uPsI60fWf4XW0HtaOkE+pc3jnVldIl7Y7rHj4aeLS3x6Wn43vL7/cf0z1Wc1zleNkJwomiE59O5p+cPpV16unp5NNjvUt675yJPXOtL7xv8GzQ2fPnfM+d6ffsP3ne9fyxC84Xjl5kXey65HCpc8B+oOMH+x86Bh0GO4cch7ovO13uGZ43fOKK+5XTV72vnrsWcO3SyPyR4etR12/eSLghvcm7+ehW+q3nt3Nuz9xZcxd9t+Se0r2K+5r3G340/bFd6iA9Puo9OvBgwYM7Y9yxJz9l//R+vOgh+WHFhM5E8yPbR8cmfScvP174ePxJ1pOZp8U/K/9c+8zk2Xe/ePwyMBU7Nf5c9PzTr5tfqL/Y/9LuZe902PT9VxmvZl6XvFF/c+At623/u5h3EzO577HvKz+Yfuj5GPTx7qeMT59+A/eE8/sKZW5kc3RyZWFtCmVuZG9iago2IDAgb2JqClsvSUNDQmFzZWQgNSAwIFJdCmVuZG9iago3IDAgb2JqCjw8IC9UeXBlIC9NZXRhZGF0YQovU3VidHlwZSAvWE1MCi9MZW5ndGggMTEgMCBSCgo+PgpzdHJlYW0KPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4KCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPgo8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyIgcmRmOmFib3V0PSIiPgo8ZGM6dGl0bGU+TXV0YXRpb24gcmVwb3J0IGZvciBDREs0IFIyNEw8L2RjOnRpdGxlPgo8ZGM6ZGF0ZT4yMDEyLTA0LTA0VDA5OjQ4OjM3LTAtNDowMDwvZGM6ZGF0ZT4KPC9yZGY6RGVzY3JpcHRpb24+CjxyZGY6RGVzY3JpcHRpb24geG1sbnM6cGRmPSJodHRwOi8vbnMuYWRvYmUuY29tL3BkZi8xLjMvIiByZGY6YWJvdXQ9IiI+CjxwZGY6UERGVmVyc2lvbj4xLjQ8L3BkZjpQREZWZXJzaW9uPgo8cGRmOlByb2R1Y2VyPkFwYWNoZSBGT1AgVmVyc2lvbiAwLjkzPC9wZGY6UHJvZHVjZXI+CjwvcmRmOkRlc2NyaXB0aW9uPgo8cmRmOkRlc2NyaXB0aW9uIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyIgcmRmOmFib3V0PSIiPgo8eG1wOkNyZWF0ZURhdGU+MjAxMi0wNC0wNFQwOTo0ODozNy0wLTQ6MDA8L3htcDpDcmVhdGVEYXRlPgo8L3JkZjpEZXNjcmlwdGlvbj4KPC9yZGY6UkRGPgo8L3g6eG1wbWV0YT4KPD94cGFja2V0IGVuZD0iciI/PgoKCmVuZHN0cmVhbQplbmRvYmoKOSAwIG9iago8PCAvTGVuZ3RoIDEyIDAgUgovRmlsdGVyIC9GbGF0ZURlY29kZSAKPj4Kc3RyZWFtCnicjVlJd9s2EL7rV+gYv2fTBLgqt9R20rR2m1rqy6HuASIhCc9cFC529O87oDAAuEhqEjsAhBnM+s0AInMX/t4Q+BUt6DzJZz9mpFsj84jCf7Dyy2p2+9mbE3e+2qgPgYAE1HGpv1j4c993giCYr/L5Px+e2oY1oiyu5h/m8FPxfVk1arIpKzW6u//dV8Nn6j9ezf+dr36bPaxmf1nnu8fj7aWAUgfF+qsvakSNsGQorDv3qJHxG9vy4+k3hCwcdwF/4qMImoJGjkflJz1KcjXYBh/GMXFd0ts24Pyh3Fw6zl84JKRy/exxgQ/qe+fOmjJkZx3LOAsnHFgndiihR35L8F9bf0RH/fn07fFh9aCmrEjVKCmLjahyjvMXSiM1fGQ1erxmb3rH+oBMl03LdFB8Zw0OddS4/i38oy6huLD46Mdq/OnJhMuPmR+4YBJXegBigxxHOahkZpmcETOzSazl3fz7rJj98y/sTsFo7zPX8edfZh1tiHz7tCHSLsHeOk2cYGheb+EsSCSDqTPx54r/aHmRHFDvTS8XumHezyOBAytz9Fqz4zgq9zhq87LFdGsOe14rq0kZhwHgufMQxIaAB206EVeKfJAUwWijpcsgM8ZMlyzfZ1qQofsi4lA59Dr3mZl0X+SamU1iLZ90H2yKkG+fNkLaC+6LIbuiowqW+ZMdq1jS8ErUjUjOmRdy0IW12JMJerRam2WKTcFyjomRHJJMFDcp3/Mi5QXmxasoWI0u9vVBU4lMPNeJXV+b/C59rTFDz7OvX64wySs8a8dBvTIHFRNMaBgX/LbZVbwsYNRnoeORIW+AiaYqUdd9VW4rXtddXPfDBUT3KUAuiK6ADc4o2+1uFOMJ17aTCuGyzgY4MuEaXt5FY7EQmBEV37YZa8oKc7Bu120hmvp6fF5ntdpB+MmaXV8ubS5jOA1cqdhsYIO09UjfwHNi35MFtNM3SV8V0ZYXXAtSFhnKGKBbAFURVDlHvetd+a4RodTnVzxpNIe0Epr0okVfZPQQlOOG6pGnRz6OTGG4CV+u0Fafyywr30WxndA+DBwvNBnBfzaQTSAIuAWdlIumBFuY4GtE3mbi+sp2jJrcW7ZTQ/5zr4PtGCIYoO1e+Z+nKCqoiokNbUqOO5kOKgldP3tBNVIpCqEZ8CWkHB06JZ8x1H5X1vBTHaQceN7z2qRKw0WBumacpZ0d++7NxJpXdp3QpcSqCRUr6qQSe2vbBoBLN2MP9LNjhjqd0jbRWG1rGceOLxFGIeIUey1FF8maY5K1lhIqrzCtRvZ5QN3v/8AP92V2ADQyYGh2N7tDLtIhItneven542FCswWUaQohGSr/HX2uFZBxMTpXAGgIcKCafiG3S9vuQloFpVi267qrlpCQ10Yy0pfsl37IXTpeummsCyXE8X2FLF/o7ZMOOmO8sYCnhYF4EW/9hkTFxyDa1hVnr6lBoomALFrAGJ3kvHjjWbnveXSkDTRzi9AuDQb1O/NPhJ4Ej1rUlmo6pzVMQ6kATGla0I1rjFSwoftWY2xDqOEDtdZlhL9BfCKa9svitGqe7/ixqQJHVIAOWhJeay37qfOdc43L0JHcoHf0hl7HYBS4SxOKRUQd1FhZ8hWNyNK0i4sh0o6E90MH4M4C8VOIewyXkbnyMuOJhfi12BYs0wbT14g9T8RG14F9KYoGN00E2LCeXQDRUWxLliNVg8gJABziyDRWaLeV2O6mGx4tnBV+2iYyyAqIXtzM8INc1CrAjEwJ62eemrSAvTuetpm2LRSOTGxUVeiV55FKIfS1PmSVwjsA6zLXRrauetCI5WVd5lpSgO2GrUUmmsNE/dxpRS51J2tUo7vtcANqSAS9J9IcrzB9q4JRoNW7nlAtlm08BKYCjPedyPSllJ3UC7CrAlDc8tx0x8bwMnyGGoDaIUoFmT9OAE18yCHjcmZisX3luUBZph20oI4LDQVRWuQ8Y+Aidh7T2qrqKoyOkJRXWpo3DoC3tQNLO2sPDYcdjg2rtryxqo8WFYCGl/uMyXuPSb6K7XVVW7eNxX6ol+d6TihbCH90STF6DLPDCCCbWJPGnCXYi5/oY7uad90TlLeN1VVCrvCtmLq+rLMywa78TvfnHWBA7Nsyj3QkgUNkM6GawbbIxKspMjqAag4I2Ks/R7vjBO7hlaWexJzJ27NHIZnhrk2O12drmnXT2Ex7VNb6yRu03BUg7wF1gNSXnkCgVMTygWt8kbZePU7dqaeuul4Yw+1/oV9VVhr/N22RyAjXsSPr/PGZArdYVUPj8fDJBR/BTt7rqUudyPclygyFKWWcnRGf0hBIqUyBISlm9zPvbo6JuY59e/p6/3L1cSLY4oXjSQ4qof4uXosObidDxYf089zYJX4XKtY066bUTHtU1vrJUJG7YuQ9oI6R+kKo+PJVzg0Wseoq7qD3EIkpk7owfYO7bf+zZQNt0skXJh96rcCNZIPfKW6mneKeZ6Y9Kmv9tOLAzEXegzNdpL6keCBNrKrxpzcmMlVkh0H71cZxrfwnKODN+ZzxI8+JgtDFx16TM+x4nPWcMnUEU0eoOq/fEtIyaWXN1CWcb6BdY8nhYgpFxAkiIuNiKFt7PojjyAlDH197rWnnyzg00x6VtX7al8CMIO/BmQSpL/gycAPHl+/Dyp1L3t217LKh4/iZw0WlYSbV78oCcr8a98vm25VJowQkdmIQUGW2Nc26aWSmPSpr/aRRJDMPeQ/O9JD6klE8aX6ii8Cz/e3Qr2CD7j3uzDtqAF04jUL9vHnf3bz7cEjoeN/d4NuK9ei5mk5S5bl5upvOqADQO1qELlU0/++ri76wAxYTX49MyDog+oRZ2b3H1xNX08fHpf092397+a0fCmVuZHN0cmVhbQplbmRvYmoKOCAwIG9iago8PCAvVHlwZSAvUGFnZQovUGFyZW50IDEgMCBSCi9NZWRpYUJveCBbIDAgMCA1OTUgNzkyIF0KL1RyaW1Cb3ggWyAwIDAgNTk1IDc5MiBdCi9CbGVlZEJveCBbIDAgMCA1OTUgNzkyIF0KL1Jlc291cmNlcyAzIDAgUgovQ29udGVudHMgOSAwIFIKPj4KZW5kb2JqCjEwIDAgb2JqCjI1OTYKZW5kb2JqCjExIDAgb2JqCjcyNgplbmRvYmoKMTIgMCBvYmoKMjE0NwplbmRvYmoKMTMgMCBvYmoKPDwgL1R5cGUgL0ZvbnQKL1N1YnR5cGUgL1R5cGUxCi9OYW1lIC9GMQovQmFzZUZvbnQgL0hlbHZldGljYQovRW5jb2RpbmcgL1dpbkFuc2lFbmNvZGluZyA+PgplbmRvYmoKMTQgMCBvYmoKPDwgL1R5cGUgL0ZvbnQKL1N1YnR5cGUgL1R5cGUxCi9OYW1lIC9GMwovQmFzZUZvbnQgL0hlbHZldGljYS1Cb2xkCi9FbmNvZGluZyAvV2luQW5zaUVuY29kaW5nID4+CmVuZG9iagoxIDAgb2JqCjw8IC9UeXBlIC9QYWdlcwovQ291bnQgMQovS2lkcyBbOCAwIFIgXSA+PgplbmRvYmoKMiAwIG9iago8PCAvVHlwZSAvQ2F0YWxvZwovUGFnZXMgMSAwIFIKL01ldGFkYXRhIDcgMCBSCj4+CmVuZG9iagozIDAgb2JqCjw8Ci9Gb250IDw8CiAgL0YxIDEzIDAgUgogIC9GMyAxNCAwIFIKPj4KL1Byb2NTZXQgWyAvUERGIC9JbWFnZUIgL0ltYWdlQyAvVGV4dCBdCi9Db2xvclNwYWNlIDw8CiAgL0RlZmF1bHRSR0IgNiAwIFIKPj4KPj4KZW5kb2JqCnhyZWYKMCAxNQowMDAwMDAwMDAwIDY1NTM1IGYgCjAwMDAwMDYzMzggMDAwMDAgbiAKMDAwMDAwNjM5NiAwMDAwMCBuIAowMDAwMDA2NDYxIDAwMDAwIG4gCjAwMDAwMDAwMTUgMDAwMDAgbiAKMDAwMDAwMDE1NCAwMDAwMCBuIAowMDAwMDAyODMxIDAwMDAwIG4gCjAwMDAwMDI4NjQgMDAwMDAgbiAKMDAwMDAwNTg5OCAwMDAwMCBuIAowMDAwMDAzNjc1IDAwMDAwIG4gCjAwMDAwMDYwNTUgMDAwMDAgbiAKMDAwMDAwNjA3NiAwMDAwMCBuIAowMDAwMDA2MDk2IDAwMDAwIG4gCjAwMDAwMDYxMTcgMDAwMDAgbiAKMDAwMDAwNjIyNSAwMDAwMCBuIAp0cmFpbGVyCjw8Ci9TaXplIDE1Ci9Sb290IDIgMCBSCi9JbmZvIDQgMCBSCi9JRCBbPDc0OTVCQUY4MUVCOUQ4MUMxQTg5MDFEMzREOTJCODlEPiA8NzQ5NUJBRjgxRUI5RDgxQzFBODkwMUQzNEQ5MkI4OUQ+XQo+PgpzdGFydHhyZWYKNjU5OAolJUVPRgo=
					</pdf>
				</confirmation>
			</annotation>
		</mutation>
	</mutations>
</data>